<html xmlns="http://www.w3.org/1999/xhtml" class=" js flexbox flexboxlegacy canvas canvastext webgl no-touch geolocation postmessage no-websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients no-cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths"><!--MODERNIZED PAGE--><head id="coid_website_head" profile="http://www.w3.org/2005/10/profile"><style type="text/css">@charset "UTF-8";[ng\:cloak],[ng-cloak],[data-ng-cloak],[x-ng-cloak],.ng-cloak,.x-ng-cloak,.ng-hide{display:none !important;}ng\:form{display:block;}.ng-animate-block-transitions{transition:0s all!important;-webkit-transition:0s all!important;}</style>
	<meta http-equiv="content-type" content="text/html; charset=UTF-8">
	<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<meta name="description" content="View on Westlaw or start a FREE TRIAL today, Medicines Company v. Hospira, Inc., Cases">







<script>
	

	(function () {
		window['$$errors'] = [];

		//handle js errors (it will be overwritten in GlobalPageHandlers.js. And any error will be processed when this script is loaded on the page.)
		window.onerror = function() {
			window['$$errors'].push(arguments);
		}
	})();
</script>




	<title>Medicines Company v. Hospira, Inc. | Cases | Westlaw</title>

	
	



	
	
	



	




    
    <link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/utilities.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/core.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/components.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/features.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/document.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/print.css" type="text/css" rel="stylesheet" media="print">
<!--[if gte IE 6]>
<link href='https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/ie.css' type='text/css' rel='stylesheet' />
<![endif]-->


	<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="https://ia.next.westlaw.com/favicon.ico">
	<link rel="apple-touch-icon" href="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/iphone-webclip-icon.png">
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.923c80f054c89ca796f84c4fbed803b0.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.e94d5ee75e94c1087b529e979a552bed.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.83634f9482d1ddf27e96c8f1d9498ac3.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.82967e6fecb235c1f97c6591de01f9f7.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/Website/Views/Document/DocumentTabView.bootstrap.js"></script><link id="Markman_MarkmanDisplayState"><link id="Markman"></head>



<body class="co_t2Left co_docDisplay">
	<div id="co_pageContainer" class="co_bodyToolbar">
		<div id="co_mainContainer">
			











<div id="co_headerWrapper" class="wlnv2 ">
	<div id="co_newHeader"><div id="co_privacyPolicyContainer"> 
	<p id="co_privacyPolicy">
		<b>We've updated our Privacy Statement.</b> Before you continue, please read our new <a id="coid_website_privacyPolicyLinkOut" href="javascript:void(0)">Privacy Statement</a> and familiarize yourself with the terms.
		<button type="button" id="coid_website_privacyPolicyAcknowledged" title="Close message to acknowledge privacy statement" class="co_absolute">
			<span class="icon25 icon_close_x"></span>
		</button>
	</p>
</div>
		<div id="co_headerContainer">
			<div id="co_newHeader_top" class="headerContent" role="banner">
					<div class="skipButtonContainer"><a href="javascript:void(0);" data-jumpto="co_docHeaderTitle" class="co_tbButton skipButton">Skip to Document</a><a href="javascript:void(0);" data-jumpto="co_footerLinks" class="co_tbButton skipButton">Skip to Footer</a></div>
						<ul id="co_mainNav" class="co_inlineList" role="navigation">
							
														<li id="co_kmFirmNameContainer"></li>


	<li id="co_clientIdContainer" class="navigation_link co_menuListFirst"><div id="co_clientID_title_0" class="co_dropdownTabCollapsed"><span class="co_clientID_label" id="co_clientID_label_0">Client ID:</span><span></span></div><div id="co_clientID_list_0" class="co_clientID_list co_hideState" aria-hidden="true">

<div class="co_dropdownBoxExpanded">
	<div class="co_dropdownBoxHeader">
		<span></span>
	</div>
	<div class="co_dropdownBoxContent">
		<button id="co_clientID_close_0" class="co_overlayBox_closeButton" type="button">Close</button>
		<div class="co_dropdownBoxContentRight" id="co_clientID_content_0"></div>
	</div>
	<div class="co_dropdownBoxFooter">
		<span></span>
	</div>
</div></div></li>
									<li id="co_recentHistoryContainer"><div id="tabIndicator" class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel"><span class="icon"></span>History</a><button class="co_hasTooltip co_dropdownArrowCollapsed" title="Recent History Menu"><span class="th_simple_icon icon_down_arrow reversed"></span><span class="co_accessibilityLabel" aria-hidden="true" id="coid_dropdownAriaLabel_1">History Menu</span> </button></div></div><div class="co_dropdownBoxCollapsed" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_1"><span class="co_accessibilityLabel">Beginning of history window.</span><div class="co_dropdownBoxContent"><div class="co_recentResearch iac-a11y-header-redesign" id="co_recentResearch">
	<div class="co_recentDocuments co_floatLeft">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentDocumentsHeader">Recent Documents</h3>
			<a class="co_floatRight co_recentDocumentsAll" href="javascript:void(0);" id="co_recentDocumentsLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentDocumentsList" id="co_recentDocumentsList"></ul>
		</div>
	</div>
	<div class="co_recentSearches co_floatRight">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentSearchesHeader">Recent Searches</h3>
			<a class="co_floatRight co_recentSearchesAll" href="javascript:void(0);" id="co_recentSearchesLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentSearchesList" id="co_recentSearchesList"></ul>
		</div>
	</div>
	<div class="co_clear"></div>
</div></div><button class="co_overlayBox_closeButton" type="button" title="Close history menu">Close Recent History window</button><span class="co_accessibilityLabel">End of history window.</span></div></li>
								<li id="co_signOffContainer" class="">

									<div class="co_dropdownTabCollapsed">
										<div class="co_dropdownTab">
											<button id="coid_website_signOffRegion" class="co_dropdownBoxanchorLabel co_hasTooltip iac-a11y-header-redesign" title="Settings &amp; Sign Off">
												<span class="th_simple_icon icon_user reversed"></span>
												<span class="th_simple_icon icon_down_arrow reversed"></span>
												<span class="co_accessibilityLabel" aria-hidden="true">Settings &amp; Sign Off</span>
											</button>
										</div>
									</div>
									<div class="co_dropdownBoxCollapsed co_globalNavDropdownBox" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_0"><span class="co_accessibilityLabel">Beginning of profile settings window.</span>
										<div class="co_globalNavDropdownBox_header">
											<h3 id="coid_dropdownAriaLabel_0">Profile Settings</h3>
										</div>
										<div class="co_globalNavDropdownBox_content">
											<div class="co_signOff_profile">
												<h4></h4>
												<ul>
													<li></li>
												</ul>
											</div>

											<div class="co_signOff_links">
												<ul>


	<li>
		<a id="coid_website_mycontent" href="/MyPlan/Show\?transitionType=Default&amp;contextData=(sc.Default)">My Content</a>
	</li>


													<li>
														<a id="coid_website_userSetting" href="javascript:void(0);">My Preferences</a>
													</li>
													<li>
														<a class="co_signOff_updateProfile" href="https://onepass.westlaw.com/v2/profile/general?productid=CBT&amp;viewproductid=&amp;returnto=1.next.westlaw.com">Update OnePass Profile</a>
													</li>
												</ul>

											</div>

											<div class="co_signOff_buttons">
												<div>
													<button type="button" class="co_primaryBtn js_website_signoff">Sign Off</button>
												</div>
											</div>
										</div>
									<button class="co_overlayBox_closeButton" type="button" title="Close profile menu">Close Profile Settings window</button><span class="co_accessibilityLabel">End of profile settings window.</span></div>

								</li>
						</ul>

			</div>
			<div id="co_newHeader_bottom" class="headerContent">







<div id="headerLogo" class="" data-compartment-start-page-id="">

	<a id="coid_website_logo" href="/?transitionType=Default&amp;contextData=(sc.Default)" tabindex="1" class="co_hasTooltip">
		<img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/logo.png" title="Westlaw Home">
		<span class="co_accessibilityLabel" aria-hidden="true">Westlaw Home</span>
	</a>
</div>







<div id="coid_website_searchWidget" style="display:none;"></div>
<div id="co_headerSearch" class="">
	<div id="co_searchWidgetInnerId" class="co_noAdvancedSearch">
		<form action="" onsubmit="return false;">
			<div id="co_searchFormLeft">
				<a href="javascript:void(0);" id="co_categorySearchButton">
					<span id="co_currentSelectedCategoryText">291 PATENTS</span>
					<span id="co_currentSelectedCategoryToggle" class="th_simple_icon icon_down_arrow co_hasTooltip">
						<span class="co_accessibilityLabel">Content Menu</span>
					</span>
				</a>
				<div class="co_dropdownBoxCollapsed" id="co_searchCategoryDropdown"><ul>  <li class="co_tabLeft" id="co_searchWidgetAllWestlawTab" title="Search All Content">    <div class="co_tabRight"><a href="#" onclick="return false;">All Content</a></div>  </li>  <li class="co_tabLeft co_hideState" id="co_searchWidgetCompartmentCustomTab" title="compartmentCustomTab">    <div id="compartmentCustomTabDivId" class="co_tabRight"><a title="Search " href="#" onclick="return false;">{compartmentCustomTabLinkText}</a></div>  </li>  <li class="co_tabActive co_tabLeft" id="co_searchWidgetCustomTab">    <div id="customTabDivId" class="co_tabRight"><a title="Search 291 PATENTS" href="#" onclick="return false;">291 PATENTS</a></div>  </li></ul>

				</div>
			</div>
			<div class="co_searchFormOuter">
				<div class="co_searchInputContainer" id="co_searchInputContainer">
					<div class="co_inputTop">
						<div class="co_inputTopRight"></div>
					</div>
					<div class="co_inputMidLeft">
						<div class="co_inputMidRight">
							<!-- Search text box -->
							<div class="co_textarea">
								<label id="searchInputIdLabel" for="searchInputId">Search:</label>
									<textarea style="" title="Search" name="searchInputId" aria-label="Westlaw Search. Search suggestions available after typing 3 characters. Use arrow keys to navigate suggestions." id="searchInputId" rows="1" spellcheck="false" autocorrect="off" autocapitalize="off" class="co_defaultInput"></textarea>
							</div>

							<!-- Medical litigator check box container -->
							<div id="co_medLitExpandedTerms" class="co_floatRight co_formInline"></div>



<!-- Recent search query toggle -->
<a id="co_searchLast10Link" class="th_simple_icon icon_down_arrow co_hasTooltip" href="#" onclick="return false;" title="Recent Searches Menu">
		<span class="co_accessibilityLabel">Recent Searches Menu</span>
</a>
						</div>
					</div>
					<div class="co_inputBottom">
						<div class="co_inputBottomRight"></div>
					</div>


<!-- Hold recent query drop down -->
<div id="co_recentQueryListBox" class="co_hideState">
	<ul class="co_searchSuggestionContainer" id="co_searchLast10List"></ul>
</div>
				<span role="application" id="searchBoxIndexSpan" style="display: none;"><p class="co_accessibilityLabel" id="co_resultsAvailable">Results are available, use up and down arrow keys to navigate</p><p class="co_accessibilityLabel" id="co_endOfList">End Of List</p><div id="co_typeAheadStatusAlert" aria-live="assertive" role="alert" aria-labelledby="co_resultsAvailable"></div><ul class="co_searchSuggestionContainer" aria-live="polite" aria-relevant="additions removals" id="co_searchSuggestion" style="display: none;" tabindex="-1"><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers_allcases" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_snapshotExactMatch_elastic_snapshots" style="display:none"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_case"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_docket"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_statute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_regulation"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_admindecision"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_analytical"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_pendingstatute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_othercourtdocument"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_snapshots"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions_allcases"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_it_depends_question"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_antitrust"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_arbitration"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_bankruptcy"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_capmarket_corpgovern"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_commtrans"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_corp_mna"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_empbenefits_excomp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_fedcivilpract"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_finance"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_inhousecounsel"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_intelprop_tech"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_labor_emp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_realestate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_startup_smallbus"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_trust_estate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_practicallaw"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_forms"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_secondarysrc"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_rulebooks"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicallaw"></li></ul></span></div>
			</div>
			<div id="co_searchFormRight">
				<div id="co_searchFormRightWrapper">
					<!-- Jurisdiction selected -->
					<div id="co_jurisdictionWidgetContainer" class="">

<a class="co_jurisdictionSelectorDropDownArrowCollapsed" href="javascript:void(0);" id="jurisdictionId">
    <span id="jurisdictionIdInner">Federal Circuit</span>
</a>
</div>
					<!-- Search button -->
					<button title="Search" id="searchButton" class="co_hasTooltip" aria-label="Search 291 PATENTS">


						Search Westlaw
						<span class="co_accessibilityLabel">Search 291 PATENTS</span>
					</button>
					<!-- Advanced search -->
					<a href="#" onclick="return false;" class="co_hideState" id="co_search_advancedSearchLink" title="Advanced Search">Advanced</a>
					<!-- Holder jurisdiction pop up -->
					<div id="co_searchJurisdictionHoverContainer"></div>
				</div>
			</div>
			<!-- Search error container -->
			<div id="co_searchInputErrorMessageContainer" class="co_hideState"></div>
		</form>
	</div>
</div>
						<div id="coid_website_searchWidget" class="co_hideState"></div>
						<div id="co_researchAcceleratorWrapper">
							
						</div>
						<div class="co_skipToLink">
							<a id="coid_website_startContent" name="coid_website_startContent"></a>
						</div>

			</div><!--newHeader_bottom-->
		</div><!--headerContainer-->
	</div><!--newHeader-->
</div><!--co_headerWrapper-->




	
	
<!-- moved delivery toolbar to separate ascx control -->	








	<div id="co_body">
		<!-- BODY HEADER -->
		<div id="co_bodyHeader"></div>
		

	
	<!-- Reporting Name is "CTA" for document with guid "I6cd77d0047f511e68e80d394640dd07e". -->
	
	<!-- CENTER COLUMN -->  
	<div id="co_contentWrapper">
		<div id="co_contentColumn">
			<div class="co_innertube">










<div id="co_docHeaderContainer">
	<a class="co_skipToLink" href="#coid_website_errorsSummaryPlaceHolder">
		Skip Page Header
	</a>
	<div id="co_docHeader">
		<div id="co_docFixedHeader"><div id="co_docHeaderCitatorFlag"><span class="co_citatorFlag"><a href="https://1.next.westlaw.com/Link/RelatedInformation/Flag?documentGuid=I6cd77d0047f511e68e80d394640dd07e&amp;transitionType=Document&amp;originationContext=docHeaderFlag&amp;contextData=(sc.CustomDigest)"><img class="crsw_DocumentIndicator" alt="KeyCite Yellow Flag - Negative Treatment" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/flag_yellow.png" title="KeyCite Yellow Flag - Negative Treatment"></a><span class="co_citatorFlagText">KeyCite Yellow Flag - Negative Treatment</span></span></div><div id="co_docHeaderTitle"><h2 id="co_docHeaderTitleLine" title="Medicines Company v. Hospira, Inc."><span id="title"><a class="co_drag" href="https://1.next.westlaw.com/Document/I6cd77d0047f511e68e80d394640dd07e/View/FullText.html?listSource=Search&amp;navigationPath=Search%2fv1%2fresults%2fnavigation%2fi0ad6ad3e0000016314b8705c8686bce0%3fNav%3dCUSTOMDIGEST%26fragmentIdentifier%3dI6cd77d0047f511e68e80d394640dd07e%26startIndex%3d1%26contextData%3d%2528sc.CustomDigest%2529%26transitionType%3dCustomDigestItem&amp;list=CUSTOMDIGEST&amp;rank=166&amp;listPageSource=1b34510ac2bede0102300be6a61ae1f3&amp;originationContext=docHeader&amp;contextData=(sc.CustomDigest)&amp;transitionType=Document&amp;needToInjectTerms=False&amp;enableBestPortion=True&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44">Medicines Company v. Hospira, Inc.</a></span></h2><ul id="co_documentStatusIcons" class="co_document_indicators"></ul><h3 id="co_docHeaderCitation" title="United States Court of Appeals, Federal Circuit. | July 11, 2016 | 827 F.3d 1363 | 119 U.S.P.Q.2d 1329&nbsp;(Approx. 20 pages)"><span id="courtline">United States Court of Appeals, Federal Circuit.</span><span id="filedate">July 11, 2016</span><span id="cite0">827 F.3d 1363</span><span id="cite1">119 U.S.P.Q.2d 1329</span><em>&nbsp;(Approx. 20 pages)</em></h3><h4 id="co_docHeaderNegativeTreatment"><span id="co_document_compositeHeader_citatorFlag" class="co_citatorFlag"></span></h4></div></div>
		<div class="co_clear"></div>
		<div id="co_docPrimaryTabNavigationContainer" class="co_docTabs">
				<a id="co_iPadKeyCiteMenuToggle">
					Toggle Menu
				</a>
			<ul id="co_docPrimaryTabNavigation" class="co_tabs">










<li id="DocumentTab" class="co_tabLeft co_tabActive co_dropdownTab">
	<h2 class="co_tabRight">
		<a id="coid_DocumentTab_link" class="co_tabLink" href="javascript:void(0);">
			<span>Document</span>
		</a>
				<div class="co_clear"></div> 
	</h2>
	</li>







<li id="riFilingsTab" class="co_tabLeft" countstatus="" categoryenum="riFilings">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_riFilings_link" class="co_tabLink" href="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/riFilings.html?originationContext=documentTab&amp;transitionType=Filings&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/riFilings.html?originationContext=documentTab&amp;transitionType=Filings&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false">
			
			<span>
				Filings 
			 (134)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcNegativeTreatmentTab" class="co_tabLeft" countstatus="" categoryenum="kcNegativeTreatment">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcNegativeTreatment_link" class="co_tabLink" href="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/kcNegativeTreatment.html?originationContext=documentTab&amp;transitionType=NegativeTreatment&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/kcNegativeTreatment.html?originationContext=documentTab&amp;transitionType=NegativeTreatment&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false">
			
			<span>
				Negative Treatment 
			 (1)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcJudicialHistoryTab" class="co_tabLeft" countstatus="" categoryenum="kcJudicialHistory">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcJudicialHistory_link" class="co_tabLink" href="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/kcJudicialHistory.html?originationContext=documentTab&amp;transitionType=History&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/kcJudicialHistory.html?originationContext=documentTab&amp;transitionType=History&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false">
			
			<span>
				History 
			 (73)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcCitingReferencesTab" class="co_tabLeft co_dropdownTab" countstatus="" categoryenum="kcCitingReferences">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcCitingReferences_link" class="co_tabLink" href="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/kcCitingReferences.html?originationContext=documentTab&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/kcCitingReferences.html?originationContext=documentTab&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false">
			
			<span>
				Citing References 
			 (143)</span>
		</a>





<span id="co_kcCitingReferencesNavAnchor" class="co_dropdownArrowCollapsed">Navigate Citing References</span>
		<div class="co_clear"></div> 
	</h2>
		<div id="co_kcCitingReferencesNavContent" class="co_dropdownBoxCollapsed" style="display:none;"></div>
</li>







<li id="kcTableOfAuthoritiesTab" class="co_tabLeft" countstatus="" categoryenum="kcTableOfAuthorities">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcTableOfAuthorities_link" class="co_tabLink" href="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/kcTableOfAuthorities.html?originationContext=documentTab&amp;transitionType=TableOfAuthorities&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I6cd77d0047f511e68e80d394640dd07e/kcTableOfAuthorities.html?originationContext=documentTab&amp;transitionType=TableOfAuthorities&amp;contextData=(sc.CustomDigest)&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;rulebookMode=false">
			
			<span>
				Table of Authorities 
			</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>




<li id="co_powByKCContainer">
	<a id="co_powByKC" href="javascript:void(0)">
		Powered by KeyCite
	</a>
</li>

			</ul>
		</div>
		<div class="co_clear"></div>
		<div id="co_docToolbarContainer" class="">
			<div id="co_docToolbar"><div><ul id="co_docToolbarMenuLeft"><li id="co_docToolbarBackToResults"><div id="co_documentFooterBreadcrumb"><a class="co_tbButton" href="/Search/Results.html?jurisdiction=CTAF&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad6ad3e0000016314b8705c8686bce0&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad6ad3a0000016314b861eab2033b51&amp;collectionSet=w_cs_cd_toc&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#I6cd77d0047f511e68e80d394640dd07e"><span class="icon25 icon_back_arrow btnOffset"></span>Return to list</a></div></li><li id="co_docToolbarDocumentNavigation"><div id="co_documentFooterResultsNavigation" class="co_prevNextNavigation"><button title="Previous Document" id="co_documentFooterResultsNavigationPrevious" class="co_prev co_tbButton">
	                <span class="icon25 icon_prev_arrow">Previous Document</span>
                </button>
                <span class="co_navigationText"><strong>166</strong> of <strong>718 results</strong></span>
                <button title="Next Document" id="co_documentFooterResultsNavigationNext" class="co_next co_tbButton">
                    <span class="icon25 icon_next_arrow">Next Document</span>
                </button></div></li></ul><ul id="co_docToolbarMenuRight"><li id="co_docToolbarMenuRightChildWidget0" class="co_hideState"></li><li id="co_docHeaderSearchGrading"></li><li id="co_docToolbarGoTo"><div class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel" role="button">Go to</a><a href="javascript:void(0);" role="button" class="co_dropdownArrowCollapsed">Open Skip to Menu</a></div></div><div id="co_docGoToWidget" class="co_dropdownBoxCollapsed"><div class="co_dropdownBoxContent" id="co_skipTo"><div class="co_dropdownBoxContentRight"><div><div><a href="#co_synopsis">Synopsis</a></div><div><a href="#co_headnoteHeader">West Headnotes</a></div><div><a href="#co_attorneysAndLawFirms">Attorneys and Law Firms</a></div><div><a href="#co_opinion">Opinion</a></div><div><a href="#co_allCitations">All Citations</a></div></div></div></div><div id="co_starPage" class="co_dropdownBoxContent"><div class="co_dropdownBoxContentRight"><label for="co_document_starPage_starPageNavInput">Page #</label><input id="co_document_starPage_starPageNavInput" maxlength="6" size="6" type="text"><span id="co_document_starPage_starPageNavGo" class="co_primaryBtn">Go</span><div id="co_document_starPage_starPageNavError"></div><div class="co_clear"></div></div></div></div></li><li id="co_docToolbarTocNavigation"></li><li id="co_docToolbarTocFlyout"></li><li id="co_docToolbarMenuRightChildWidget5"></li><li id="co_docToolbarMenuRightChildWidget6"></li><li id="co_docToolbarMenuRightChildWidget7" class="co_toolbarSeparator"></li><li id="co_docToolbarSearchWithinDocument"><div id="co_docSearchWithinContainer"><a role="button" href="javascript:void(0);" class="co_dropdownTitle" title="Search text in this document">Search Within this Document</a>
<div id="co_docSearchWithinDropdownContainer">
	<div id="co_docSearchWithinDropdownContainerInner">
		<div id="co_docSearchWithinDropdownContainerInnerContent" class="co_dropdownBoxCollapsed">
			<!-- toggle between co_dropDownBoxCollapsed and co_dropdownBoxExpanded to show/hide -->
			<div class="co_dropdownBoxHeader">
				<span></span>
			</div>
			<div class="co_dropdownBoxContent">
				<div class="co_dropdownBoxContentRight">
					<div id="co_docSearchWithin_input">
						
<div id="co_docSearchWithin_searchInputContainer_withRecentSearch">
	<a id="co_searchLast10Link" class="co_recentSearchesLink" href="javascript:void(0);" title="Recent Searches">
		Last 10 Searches
	</a>
	<div class="co_textarea">
		<textarea id="co_docSearchWithin_searchInput_withRecentSearch" rows="1" autocorrect="off" autocapitalize="off" role="textbox" aria-label="Enter term to search for in current document"></textarea>
	</div>
	<div id="co_documentRecentQueryListBox" class="co_hideState"><ul class="co_searchSuggestionContainer" id="co_documentSearchLast10List"></ul></div>
</div>

						<input id="co_docSearchWithin_searchButton" class="co_secondaryBtn" value="Search" role="button" aria-label="Search Within this Document" type="button">
					</div>
					<div class="co_prevNextNavigation co_hideState">
						<button title="Previous Term" class="co_prev co_tbButton">
							<span class="icon25 icon_prev_arrow">Previous Term</span>
						</button>
						<button title="Next Term" class="co_next co_tbButton">
							<span class="icon25 icon_next_arrow">Next Term</span>
						</button>
						<span class="co_navigationText co_hideState"></span>
					</div>
					<button id="co_docSearchWithin_help" class="co_helpLink">Terms &amp;amp; Connectors</button>
					<button id="co_docSearchWithinCloseButton" class="co_widget_closeIcon">Close</button>
					<div id="co_docSearchWithinMessage"></div>
					<div class="co_clear"></div>
				</div>
				<div id="searchWithinTncContainer" class="co_hideState"><div id="co_search_advancedSearch_tncLegendBox">  <h2 id="co_search_advancedSearch_tncHelpTitle">Connectors and Expanders</h2>  <a id="co_search_advancedSearch_tncHelpLink" href="#" class="co_hideState">Help</a>  <dl id="co_search_advancedSearch_tncLegendList">    <dt>&amp;</dt><dd>AND</dd>    <dt>/s</dt><dd>In same sentence</dd>    <dt>or</dt><dd>OR</dd>    <dt>+s</dt><dd>Preceding within sentence</dd>    <dt>/p</dt><dd>In same paragraph</dd>    <dt>""</dt><dd>Phrase</dd>    <dt>+p</dt><dd>Preceding within paragraph</dd>    <dt>%</dt><dd>But not</dd>    <dt>/n</dt><dd>Within n terms of</dd>    <dt>!</dt><dd>Root expander</dd>    <dt>+n</dt><dd>Preceding within n terms of</dd>    <dt>*</dt><dd>Universal character</dd>    <dt>#</dt><dd>Prefix to turn off plurals and equivalents</dd>  </dl></div></div>
			</div>
			<div class="co_dropdownBoxFooter">
				<span></span>
			</div>
		</div>
	</div>
</div></div></li><li id="co_docToolbarDisplayOptions"><a role="button" id="co_displayOptionsLink" class="co_tbButton" href="javascript:void(0);" title="Display Options"><span class="icon25 icon_text_resize">Display Options</span></a></li><li id="co_docToolbarDeliveryWidget"><div id="deliveryWidget1" class="co_dropDownMenu collapsed"><div class="co_dropDownButton"><a role="button" id="deliveryLink1" title="Email" class="co_tbButton" href="javascript:void(0);"><span class="icon25 icon_email">Email</span></a><a href="javascript:void(0);" class="co_tbButton co_dropDownAnchor" role="button" id="deliveryDropButton1" aria-label="Delivery menu" title="Delivery menu" aria-describedby="navigation1"><span class="icon25 icon_down_blue_arrow"></span></a><span id="navigation1" class="co_accessibilityLabel">Enter to open, tab to navigate, enter to select</span></div><div id="deliveryWidgetMenu1" class="co_dropDownMenuContent" role="document"><ul class="co_dropDownMenuList checkmarks icons" role="listbox" aria-multiselectable="true" aria-hidden="false" aria-expanded="true"><li id="deliveryRow1Email" name="Email" role="presentation" class="checked"><a title="Email" id="deliveryLinkRow1Email" role="option" aria-posinset="1" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="true"><span class="icon25 icon_email"></span>Email</a></li><li id="deliveryRow1Print" name="Print" role="presentation"><a title="Print" id="deliveryLinkRow1Print" role="option" aria-posinset="2" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_print"></span>Print</a></li><li id="deliveryRow1Download" name="Download" role="presentation"><a title="Download" id="deliveryLinkRow1Download" role="option" aria-posinset="3" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_download"></span>Download</a></li></ul><div class="co_deliveryWidgetMenuFooter"></div></div><div id="co_deliveryWidget_Message1"></div></div></li><li id="co_docToolbarReadingModeWidget"><a role="button" id="co_fullscreenModeLink" class="co_tbButton" href="javascript:void(0);" title="Fullscreen Mode"><span class="icon25 icon_fullscreen">Fullscreen Mode</span></a></li></ul></div></div> 
			<div class="co_clear"></div>
		</div>
	</div>
</div>

				<div id="coid_website_errorsSummaryPlaceHolder"><div class="co_infoBox failure" style="display: none;"><div class="co_infoBox_container"><div class="co_infoBox_outer"><div class="co_infoBox_inner"><a id="co_website_errorSumarryCloseLink" class="co_infoBox_closeButton">Close</a><div class="co_infoBox_message" tabindex="-1">Sorry, there was an error on this page.<a href="javascript:void(0);" id="co_website_errorSummaryToggleLink">More info</a><a href="javascript:void(0);" id="co_website_errorSummaryToggleLinkLessInfo" style="display: none; margin-left: 6px;">Less info</a><ul class="co_website_errorsSummaryList" style="display: none;"></ul></div></div></div></div></div></div>
				<div id="coid_website_messagePlaceholder"></div>







				<div id="test_hplink"></div>
				<div class="co_scrollWrapper">





							<div id="coid_website_documentWidgetDiv" class=" co_khSpeedReadExpandAll">
<div id="co_briefItDiv" class="co_excludeAnnotations"><button id="co_briefItButton" class="co_primaryBtn co_floatRight">Brief It</button><div class="undefined"></div></div><div id="co_document" class="co_addFocusCorrection"><div id="co_document_0" class="co_document co_caselawNRS"><div id="co_readingModeKC" class="co_keyCiteFlagWidgetContainer co_excludeAnnotations"><div id="co_readingModeCitatorFlag"><span class="co_citatorFlag"><a href="https://1.next.westlaw.com/Link/RelatedInformation/Flag?documentGuid=I6cd77d0047f511e68e80d394640dd07e&amp;transitionType=Document&amp;originationContext=docHeaderSntTitleFlag&amp;contextData=(sc.CustomDigest)"><img class="crsw_DocumentIndicator" alt="KeyCite Yellow Flag - Negative Treatment" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/flag_yellow.png" title="KeyCite Yellow Flag - Negative Treatment"></a><span class="co_citatorFlagText">KeyCite Yellow Flag - Negative Treatment</span></span></div><div id="co_readingModeNegativeTreatment"><span id="NegativeTreatmentWidget_I6cd77d0047f511e68e80d394640dd07e"><span class="co_snt_treatmentPhrase">Distinguished by </span><a href="https://1.next.westlaw.com/Document/Ib18d09d02e9311e79de0d9b9354e8e59/View/FullText.html?navigationPath=RelatedInfo%2Fv4%2Fkeycite%2Fnav%2F%3Fguid%3DIb18d09d02e9311e79de0d9b9354e8e59%26ss%3D2039349161%26ds%3D2041546452&amp;listSource=RelatedInfo&amp;list=NegativeCitingReferences&amp;rank=0&amp;originationContext=docHeader&amp;transitionType=NegativeTreatment&amp;contextData=%28sc.CustomDigest%29">Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.</a><span>, </span><span class="co_snt_courtLine">Fed.Cir., </span><span class="co_snt_dateFiled">May 1, 2017</span></span></div></div><input id="co_keyCiteFlagPlaceHolder" type="hidden"><input id="co_document_starPageMetadata" value="{ &quot;citations&quot;: { &quot;S8de6c490480b11e698e3c476f53824d9&quot;:&quot;827 F.3d 1363&quot; }, &quot;pubs&quot;: { &quot;S8de6c490480b11e698e3c476f53824d9&quot;:&quot;506&quot; } }" alt="metadata" type="hidden"><div><a href="https://1.next.westlaw.com/Link/Document/Blob/I2DBB26021DD211B2B832FD00D20B621D/827_F.3d_1363.pdf?targetType=NRS&amp;originationContext=pagepdflink&amp;transitionType=DocumentImage&amp;uniqueId=65f39919-1a10-4607-bf03-392ecc9144f4&amp;contextData=(sc.CustomDigest)" class="co_blobLink" type="application/pdf"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/co_pdf-icon.gif" class="co_pdfIcon" alt="PDF">​Original Image of 827 F.3d 1363 (PDF)</a></div><div class="co_cites">827 F.3d 1363</div><input id="co_document_paraNumbersSourceCiteMetadata" value="{ &quot;paraNumbersSourceCite&quot;: &quot;827 F.3d 1363&quot;, &quot;publicationNumber&quot;: &quot;506&quot; }" alt="metadata" type="hidden"><div class="co_contentBlock co_briefItState co_courtBlock"><div><div class="co_hAlign2">United States Court of Appeals, </div>Federal Circuit.</div></div><div class="co_contentBlock co_briefItState co_courtBlock"></div><div class="co_title"><div class="co_suit"><div class="co_partyLine">The MEDICINES COMPANY, Plaintiff–Appellant</div><div>v.</div><div class="co_partyLine">HOSPIRA, INC., Defendant–Cross–Appellant.</div></div></div><div class="co_docketDate"><div class="co_contentBlock co_briefItState co_docketBlock"><span>2014-1469, 2014-1504</span></div><div class="co_date"><span>Decided: July 11, 2016</span></div></div><div class="co_contentBlock co_briefItState co_synopsis"><h2 id="co_synopsis" class="co_printHeading">Synopsis</h2><div><div class="co_paragraph"><div class="co_paragraphText"><strong>Background:</strong> Patentee brought infringement action against competitor, claiming that competitor's abbreviated new drug applications (ANDA) infringed on its patents for producing PH-adjusted pharmaceutical batches of a drug product comprising bivalirudin, an anticoagulant used during coronary surgery. The United States District Court for the District of Delaware, <a id="co_link_Ie307ba80df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0167394901&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Richard G. Andrews</a>, J., held that the patents were not invalid and not infringed. Patentee appealed and competitor cross appealed. The Court of Appeals, <a id="co_link_Ie307ba81df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0211865201&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Hughes</a>, Circuit Judge, reversed, finding the patents invalid. Patentee petitioned for rehearing or rehearing en banc.</div></div></div><div class="co_contentBlock co_briefItState co_synopsisHolding"><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F32039349161" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures"><strong>Holding:</strong></a> The Court of Appeals, en banc, O'Malley, Circuit Judge, held that sale of manufacturing services by contract manufacturer to inventor did not constitute commercial sales and, thus, did not trigger on-sale bar.</div></div></div><div class="co_paragraph"><div class="co_paragraphText">Judgment of District Court affirmed in part and remanded.</div></div></div><div id="co_headnotes" class="co_headnotes co_fancyHeadnotes"><h2 id="co_headnoteHeader" class="co_headnoteHeader co_printHeading"><span class="co_headnoteHeaderSpan">West Headnotes (10)</span><a id="co_headnoteExpandCollapseLink" class="co_accLink co_excludeAnnotations co_disableHighlightFeatures" href="javascript:void(0);" role="button">Collapse West Headnotes</a></h2><div class="co_headnotesContentContainer"><div id="co_expandedHeadnotes"><div id="co_headnoteTools"><a id="co_headnotesShowOrHideFancy" href="javascript:void(0);" class="co_fancyHeadnotesShowHide co_excludeAnnotations co_disableHighlightFeatures">Change View</a></div><div class="co_headnoteRow" id="co_anchor_2039349161002"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F12039349161"><span class="co_headnoteNumber" id="co_anchor_headNote_1"><a href="#co_anchor_B12039349161" class="co_internalLink">1</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EBCAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ETDAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k640/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Questions of law or fact</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Whether the statutory on-sale bar to patent validity applies is a question of law based on underlying factual findings. <a id="co_link_Ie307ba88df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C.A. § 102(b)</a>.</div></div><div id="co_headnoteId_203934916100220171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ECEAC" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916100220171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 1"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">3 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba83df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba84df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba85df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba86df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)5/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)5</a></span><span class="co_headnoteTopicKey">Prior Public Use or Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba87df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k640/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k640</a></span><span class="co_headnoteTopicKey">Questions of law or fact</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2039349161003"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F22039349161"><span class="co_headnoteNumber" id="co_anchor_headNote_2"><a href="#co_anchor_B22039349161" class="co_internalLink">2</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E5EAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EMHAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1970(2)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patentability and Validity</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Court of Appeals reviews the district court's factual findings with deference, but examines the ultimate question of patent validity de novo.</div></div><div id="co_headnoteId_203934916100320171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EJIAC" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916100320171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 2"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba89df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba8adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba8bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba8cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)7/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)7</a></span><span class="co_headnoteTopicKey">Appellate Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba8ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1965/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1965</a></span><span class="co_headnoteTopicKey">Scope, Standard, and Extent of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba8edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1970/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1970</a></span><span class="co_headnoteTopicKey">Particular Matters</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba8fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1970(2)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1970(2)</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba90df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1970(3)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1970(3)</a></span><span class="co_headnoteTopicKey">In general</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2039349161010"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F32039349161"><span class="co_headnoteNumber" id="co_anchor_headNote_3"><a href="#co_anchor_B32039349161" class="co_internalLink">3</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E2IAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ENKAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k616/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">What Constitutes Sale</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">The sale of manufacturing services by a contract manufacturer to an inventor to create embodiments of a patented product for the inventor did not constitute “commercial sales” of the patented product, and thus the sale did not trigger the on-sale bar, where inventor paid manufacturer only about 1% of the market value of patented prescription drug produced, inventor retained title to the patented invention, and manufacturer was not free to use or sell the claimed products or to deliver the patented products to anyone other than inventor. <a id="co_link_Ie307ba97df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C.A. § 102(b)</a>.</div></div><div id="co_headnoteId_203934916101020171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EKLAC" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916101020171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 3"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba91df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba92df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba93df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba94df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)5/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)5</a></span><span class="co_headnoteTopicKey">Prior Public Use or Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba95df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k616/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k616</a></span><span class="co_headnoteTopicKey">What Constitutes Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba96df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k617/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k617</a></span><span class="co_headnoteTopicKey">In general</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2039349161004"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F42039349161" tabindex="0"><span class="co_headnoteNumber" id="co_anchor_headNote_4"><a href="#co_anchor_B42039349161" class="co_internalLink">4</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EJMAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E6NAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k445/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Products or results</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">For patent validity purposes, the invention in a product-by-process claim is the product.</div></div><div id="co_headnoteId_203934916100420171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EOOAC" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916100420171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 4"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba98df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba99df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba9adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(B)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(B)</a></span><span class="co_headnoteTopicKey">Eligible Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba9bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k442/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k442</a></span><span class="co_headnoteTopicKey">Classes of Invention or Discovery;  Statutory Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba9cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k445/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k445</a></span><span class="co_headnoteTopicKey">Products or results</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2039349161005"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F52039349161"><span class="co_headnoteNumber" id="co_anchor_headNote_5"><a href="#co_anchor_B52039349161" class="co_internalLink">5</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EAPAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/343/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Sales</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E5PAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/343k515/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Nature and Definition of Sale;  Other Transactions Distinguished</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">A sale under the Uniform Commercial Code (UCC) occurs when the parties give and pass rights of property for consideration.</div></div><div id="co_headnoteId_203934916100520171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E3AAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916100520171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 5"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba9ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/343/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">343</a></span><span class="co_headnoteTopicKey">Sales</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba9edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/343I/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">343I</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307ba9fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/343k515/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">343k515</a></span><span class="co_headnoteTopicKey">Nature and Definition of Sale;  Other Transactions Distinguished</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baa0df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/343k516/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">343k516</a></span><span class="co_headnoteTopicKey">In general</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2039349161006"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F62039349161"><span class="co_headnoteNumber" id="co_anchor_headNote_6"><a href="#co_anchor_B62039349161" class="co_internalLink">6</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EOBAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EODAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k618/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Attempts to sell;  offers</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Mere preparations for commercial sales are not themselves commercial sales or commercial offers for sale under the on-sale bar; instead, when no actual sale is <input id="co_docMarker_0" type="hidden">present, only an offer which rises to the level of a commercial offer for sale, one which the other party could make into a binding contract by simple acceptance, assuming consideration, triggers the on-sale bar. <a id="co_link_Ie307baa7df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C.A. § 102(b)</a>.</div></div><div id="co_headnoteId_203934916100620171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E4DAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916100620171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 6"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">6 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baa1df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baa2df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baa3df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baa4df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)5/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)5</a></span><span class="co_headnoteTopicKey">Prior Public Use or Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baa5df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k616/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k616</a></span><span class="co_headnoteTopicKey">What Constitutes Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baa6df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k618/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k618</a></span><span class="co_headnoteTopicKey">Attempts to sell;  offers</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2039349161007"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F72039349161"><span class="co_headnoteNumber" id="co_anchor_headNote_7"><a href="#co_anchor_B72039349161" class="co_internalLink">7</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E5EAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EQGAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k616/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">What Constitutes Sale</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">While the fact that a transaction is between a supplier and inventor is an important indicator that the transaction is not a commercial sale, understood as such in the commercial marketplace, it is not alone determinative of whether a sale occurred that would trigger the on-sale bar; the focus must be on the commercial character of the transaction, not solely on the identity of the participants. <a id="co_link_Ie307baaedf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C.A. § 102(b)</a>.</div></div><div id="co_headnoteId_203934916100720171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ENHAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916100720171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 7"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">5 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baa8df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baa9df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baaadf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baabdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)5/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)5</a></span><span class="co_headnoteTopicKey">Prior Public Use or Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baacdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k616/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k616</a></span><span class="co_headnoteTopicKey">What Constitutes Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baaddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k617/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k617</a></span><span class="co_headnoteTopicKey">In general</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2039349161008"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F82039349161"><span class="co_headnoteNumber" id="co_anchor_headNote_8"><a href="#co_anchor_B82039349161" class="co_internalLink">8</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EJIAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E2JAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k616/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">What Constitutes Sale</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Where the supplier has title to the patented product or process, the supplier receives blanket authority to market the product or disclose the process for manufacturing the product to others, or the transaction is a sale of product at full market value, even a transfer of product to the inventor may constitute a commercial sale that would trigger the on-sale bar. <a id="co_link_Ie307bab5df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C.A. § 102(b)</a>.</div></div><div id="co_headnoteId_203934916100820171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EYKAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916100820171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 8"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307baafdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307bab0df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307bab1df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307bab2df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)5/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)5</a></span><span class="co_headnoteTopicKey">Prior Public Use or Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307bab3df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k616/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k616</a></span><span class="co_headnoteTopicKey">What Constitutes Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307bab4df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k617/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k617</a></span><span class="co_headnoteTopicKey">In general</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2039349161009"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F92039349161"><span class="co_headnoteNumber" id="co_anchor_headNote_9"><a href="#co_anchor_B92039349161" class="co_internalLink">9</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EULAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EGNAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k616/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">What Constitutes Sale</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">A contract manufacturer's sale to the inventor of manufacturing services where neither title to the embodiments nor the right to market the same passes to the supplier does not constitute an invalidating sale under the on-sale bar. <a id="co_link_Ie307babcdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C.A. § 102(b)</a>.</div></div><div id="co_headnoteId_203934916100920171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EDOAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916100920171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 9"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307bab6df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307bab7df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307bab8df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307bab9df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)5/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)5</a></span><span class="co_headnoteTopicKey">Prior Public Use or Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307babadf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k616/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k616</a></span><span class="co_headnoteTopicKey">What Constitutes Sale</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307babbdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k617/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k617</a></span><span class="co_headnoteTopicKey">In general</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2039349161501"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2039349161"><span class="co_headnoteNumber" id="co_anchor_headNote_10">10</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E4OAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E2PAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  utility</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">US Patent <a id="co_link_Ie307bac0df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">7,582,727</a>, US Patent <a id="co_link_Ie307bac1df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">7,598,343</a>. Invalid.</div></div><div id="co_headnoteId_203934916150120171212133753" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EKQAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;headnoteId=203934916150120171212133753&amp;originationContext=document&amp;docSource=a19ddaed4d8c4e718a956c4a45b9ff44&amp;rank=166&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 10"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307babddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307babedf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_Ie307babfdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2091</a></span><span class="co_headnoteTopicKey">In general;  utility</span></div></div></div></div></div></div><div class="co_clear"></div></div></div></div><div> </div></div><a id="co_headnotesEnd"></a><div class="co_contentBlock co_briefItState co_actionBlock"><div> <span class="co_starPage" id="co_pp_sp_506_1364"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1364&quot; }" alt="metadata" type="hidden">*1364</span> Appeals from the United States District Court for the District of Delaware in No. 1:09-cv-00750-RGA, Judge Richard G. Andrews.</div></div><h2 class="co_attorneyBlockLabel co_printHeading co_briefItState" id="co_attorneysAndLawFirms">Attorneys and Law Firms</h2><div class="co_contentBlock co_briefItState co_attorneyBlock"><div><span class="co_smallCaps"><a id="co_link_Ie307bac2df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0145892301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Edgar Haug</a></span>, Frommer Lawrence &amp; Haug LLP, New York, NY, argued for plaintiff-appellant. Also represented by <span class="co_smallCaps"><a id="co_link_Ie307bac3df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0334068301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Porter F. Fleming</a></span>, <span class="co_smallCaps"><a id="co_link_Ie307bac4df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0334067301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Angus Chen</a></span>, <span class="co_smallCaps">Jason Ari Kanter</span>, <span class="co_smallCaps"><a id="co_link_Ie307bac6df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0371721301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Laura Krawczyk</a></span>, <span class="co_smallCaps">Catalin Sebastian Zonte</span>; <span class="co_smallCaps"><a id="co_link_Ie307bac8df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0372600401&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Damon Marcus Lewis</a></span>, Washington, DC.</div><div><span class="co_smallCaps"><a id="co_link_Ie307bac9df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0330907201&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Bradford Peter Lyerla</a></span>, Jenner &amp; Block LLP, Chicago, IL, argued for defendant-cross-appellant. Also represented by <span class="co_smallCaps"><a id="co_link_Ie307bacadf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0363065101&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Sara Tonnies Horton</a></span>, <span class="co_smallCaps"><a id="co_link_Ie307bacbdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0207614901&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Aaron A. Barlow</a></span>; <span class="co_smallCaps"><a id="co_link_Ie307baccdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0370536201&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Joshua Segal</a></span>, Washington, DC.</div><div><span class="co_smallCaps"><a id="co_link_Ie307bacddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0379886301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Megan Barbero</a></span>, Appellate Staff, Civil Division, United States Department of Justice, Washington, DC, argued for amicus curiae United States. Also represented by <span class="co_smallCaps">Mark R. Freeman</span>, <span class="co_smallCaps"><a id="co_link_Ie307bacfdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0307409501&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Benjamin C. Mizer</a></span>; <span class="co_smallCaps">Thomas W. Krause</span>, <span class="co_smallCaps">Robert McBride</span>, <span class="co_smallCaps"><a id="co_link_Ie307bad2df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0285363401&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Joseph Gerard Piccolo</a></span>, <span class="co_smallCaps">Kristi L. R. Sawert</span>, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA.</div><div><span class="co_smallCaps"><a id="co_link_Ie307bad4df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0325756301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Doris Hines</a></span>, Finnegan, Henderson, Farabow, Garrett &amp; Dunner, LLP, Washington, DC, for amicus curiae American Intellectual Property Law Association. Also represented by <span class="co_smallCaps"><a id="co_link_Ie307bad5df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0429915601&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">David Mroz</a></span>, <span class="co_smallCaps"><a id="co_link_Ie307bad6df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0365154701&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Erin McGeehan Sommers</a></span>; <span class="co_smallCaps"><a id="co_link_Ie307bad7df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0254859401&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Denise Whelton DeFranco</a></span>, American Intellectual Property Law Association, Arlington, VA.</div><div><span class="co_smallCaps"><a id="co_link_Ie307bad8df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0370584301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Emily Curtis Johnson<input id="co_docMarker_1" type="hidden"></a></span>, Akin, Gump, Strauss, Hauer &amp; Feld, LLP, Washington, DC, for amicus curiae Intellectual Property Owners Association. Also represented by <span class="co_smallCaps"><a id="co_link_Ie307bad9df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0404431601&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">James Edward Tysse</a></span>; <span class="co_smallCaps"><a id="co_link_Ie307badadf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0328768001&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Michael P. Kahn</a></span>, New York, NY; <span class="co_smallCaps"><a id="co_link_Ie307badbdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0336649101&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Mark W. Lauroesch</a></span>, Intellectual Property Owners Association, Washington, DC; <span class="co_smallCaps"><a id="co_link_Ie307badcdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0290899101&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Steven W. Miller</a></span>, Procter &amp; Gamble Company, Cincinnati, OH; <span class="co_smallCaps"><a id="co_link_Ie307badddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0336921101&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Kevin H. Rhodes</a></span>, 3M Innovative Properties Company, St. Paul, MN.</div><div><span class="co_smallCaps">Anthony Miller</span>, Miller, Patti, Pershern PLLC, Dallas, TX, for amicus curiae Miller, Patti, Pershern PLLC. Also represented <span class="co_starPage" id="co_pp_sp_506_1365"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1365&quot; }" alt="metadata" type="hidden">*1365</span>  by <span class="co_smallCaps"><a id="co_link_Ie307badfdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0333955601&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">John Jeffery Patti</a></span>, <span class="co_smallCaps">Steven Scott Pershern</span>.</div><div><span class="co_smallCaps"><a id="co_link_Ie307bae1df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0198553201&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Tamsen Valoir</a></span>, Boulware &amp; Valoir, Houston, TX, for amicus curiae Houston Intellectual Property Law Association. Also represented by <span class="co_smallCaps"><a id="co_link_Ie307bae2df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0330173001&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Mark John Gatschet</a></span>, <a id="co_link_Ie307bae3df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0330173001&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Mark John Gatschet</a>, PLLC, Austin, TX.</div><div><span class="co_smallCaps"><a id="co_link_Ie307bae4df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0327196201&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Eric J. Marandett</a></span>, Choate, Hall &amp; Stewart, LLP, Boston, MA, for amicus curiae Biotechnology Innovation Organization. Also represented by <span class="co_smallCaps"><a id="co_link_Ie307bae5df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0493650099&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Irene Oberman Khagi</a></span>.</div><div><span class="co_smallCaps"><a id="co_link_Ie307bae6df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0369676901&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Craig E. Countryman</a></span>, Fish &amp; Richardson, P.C., San Diego, CA, for amicus curiae Gilead Sciences, Inc. Also represented by <span class="co_smallCaps">Jared Alexander Smith</span>; <span class="co_smallCaps"><a id="co_link_Ie307bae8df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0182566101&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Jonathan Elliot Singer</a></span>, Minneapolis, MN.</div><div><span class="co_smallCaps"><a id="co_link_Ie307bae9df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0409969801&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Roberta Jean Morris</a></span>, Menlo Park, CA, for amicus curiae Roberta Jean Morris.</div><div><span class="co_smallCaps"><a id="co_link_Ie307baeadf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0235617601&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Bruce M. Wexler</a></span>, Paul Hastings LLP, New York, NY, for amicus curiae Pharmaceutical Research and Manufacturers of America. Also represented by <span class="co_smallCaps"><a id="co_link_Ie307baebdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0327877901&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Eric William Dittmann</a></span>, <span class="co_smallCaps">Joseph M. O'Malley, Jr.</span>, <span class="co_smallCaps">Young Jin Pa</span><span class="co_smallCaps">rk</span>; <span class="co_smallCaps"><a id="co_link_Ie307baeedf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0329045101&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Stephen Blake Kinnaird</a></span>, <span class="co_smallCaps"><a id="co_link_Ie307baefdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0469491801&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Anand Bipin Patel</a></span>, Washington, DC; <span class="co_smallCaps"><a id="co_link_Ie307baf0df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0143273001&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">David Even Korn</a></span>, <span class="co_smallCaps"><a id="co_link_Ie307baf1df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0114202101&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">James Milton Spears</a></span>, Pharmaceutical Research and Manufacturers Association of America, Washington, DC.</div></div><div class="co_contentBlock co_briefItState co_panelBlock"><div>Before <a id="co_link_Ie307baf2df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0324402101&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Prost</a>, Chief Judge,<a id="co_link_Ie307baf3df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0245882601&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> Newma</a>n<a id="co_link_Ie307baf4df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0225327201&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">, </a>Lo<a id="co_link_Ie307baf5df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0127930301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">u</a>rie, Dyk, Mo<a id="co_link_Ie307baf7df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0156955701&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">o</a>re, O <a id="co_link_Ie307baf8df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0126887301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'M</a>alley, <a id="co_link_Ie307baf9df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0119852901&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">R</a>eyna<a id="co_link_Ie307bafadf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0479122301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">, </a>Wal<a id="co_link_Ie307bafbdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0211865201&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">la</a>ch, Tar<a id="co_link_Ie307bafcdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0490335799&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">a</a>nto, Chen, Hughes, and Stoll, Circuit Judges.</div></div><div class="co_contentBlock co_briefItState co_opinionBlock"><h2 id="co_opinion" class="co_printHeading">Opinion</h2><div class="co_docDelivery_dottedLine"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/co_docDelivery_dottedLine.png" alt=""></div><div class="co_contentBlock x_opinionBlockBody"><div class="co_contentBlock x_opinionLead"><div class="co_contentBlock x_leadAuthorLineBlock"><div class="co_contentBlock x_leadAuthorLine"><a id="co_link_Ie307bafddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0101660301&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">O'Malley</a>, Circuit Judge.</div></div><div class="co_contentBlock x_opinionBody"><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I9338a8a8df7911e79bf099c0ee06c731"><div class="co_paragraph"><div class="co_paragraphText">Today, we consider the circumstances under which a product produced pursuant to the claims of a product-by-process patent is “on sale” under <a id="co_link_Ie307bafedf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C. § 102(b)</a>. This is important because, if “on sale” more than one year before the filing of an application for a patent on the governing claims, any issued patent is invalid and the right to exclude others from making, using, and selling the resulting product is lost. We conclude that, to be “on sale” under <a id="co_link_Ie307baffdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>, a product must be the subject of a commercial sale or offer for sale, and that a commercial sale is one that bears the general hallmarks of a sale pursuant to Section 2-106 of the Uniform Commercial Code. We conclude, moreover, that no such invalidating commercial sale occurred in this case. We, therefore, affirm the district court's judgment that the transactions at issue did not render the asserted claims of <a id="co_link_Ie307bb00df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent Nos. 7,582,727 (“the '727 patent”)</a> and <a id="co_link_Ie307bb01df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">7,598,343 (“the '343 patent”)</a>, owned by Plaintiff-Appellant The Medicines Company (“MedCo”), invalid under <a id="co_link_Ie307bb02df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I9338a8a9df7911e79bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">I. Background</span></div><div class="co_headtext co_hAlign2">A. The Patents and Transactions at Issue</div><div class="co_paragraph"><div class="co_paragraphText">This suit arises from the submission of two Abbreviated New Drug Applications (“ANDAs”), ANDA Nos. 90-811 and 90-816, by Defendant-Cross-Appellant Hospira, Inc. (“Hospira”). In these ANDAs, Hospira sought Food and Drug Administration (“FDA”) approval to sell generic bivalirudin drug products before the expiration of the patents-in-suit: the <a id="co_link_Ie307bb05df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'727 patent</a> and the <a id="co_link_Ie307bb06df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'343 patent</a>. The two patents-in-suit are listed in the FDA's Orange Book as covering <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a">Angiomax</a>, the trade name of a form of bivalirudin that MedCo markets in the United States.</div></div><div class="co_paragraph"><div class="co_paragraphText">The patents-at-suit have nearly identical specifications. They claim pH-adjusted pharmaceutical batches of a drug product comprising <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3cac27cf475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3cac27cf475111db9765f9243f53508a">bivalirudin</a>, a synthetic peptide comprised of twenty amino acid residues that is used as an anticoagulant, and a pharmaceutically acceptable carrier. <input id="co_docMarker_2" type="hidden"><a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3cac27cf475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3cac27cf475111db9765f9243f53508a_0">Bivalirudin</a> drug products are used to prevent blood from clotting and are regarded as  <span class="co_starPage" id="co_pp_sp_506_1366"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1366&quot; }" alt="metadata" type="hidden">*1366</span> highly effective anticoagulants for use during coronary surgery.</div></div><div class="co_paragraph"><div class="co_paragraphText">The bivalirudin active pharmaceutical ingredient (“API”), without further processing, is too acidic for human injection. MedCo thus prepares <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_0">Angiomax</a> using a compounding process in which it creates a bivalirudin solution, adjusts the solution's pH with a base, and then freeze-dries the solution. A potential adverse consequence of the compounding process used to make the product, however, is the degradation of bivalirudin, which may form impurities such as Asp<sup>9</sup>-bivalirudin (“Asp<sup>9</sup>”). The bivalirudin may become unusable if high levels of Asp<sup>9</sup> form. The manufacture of batches with unacceptably high Asp<sup>9</sup> levels led to the creation of the patented solution.</div></div><div class="co_paragraph"><div class="co_paragraphText">MedCo is a specialty pharmaceutical company that does not have its own manufacturing facilities and is not capable of making its products in-house. Instead, since 1997, MedCo has contracted with Ben Venue Laboratories (“Ben Venue”), a third-party provider, for Ben Venue to manufacture commercial quantities of an original formula of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_1">Angiomax</a>, which is not covered under the patents-in-suit. In June 2005, Ben Venue manufactured a batch of bivalirudin drug product with an Asp<sup>9</sup> level of 3.6%, which exceeded the FDA's approved maximum level of 1.5%. MedCo discarded that batch and shut down production of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_2">Angiomax</a> for six months to investigate the problem and revise its process. In 2006, another batch had an unacceptable Asp<sup>9</sup> level, so MedCo again shut down production of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_3">Angiomax</a> and hired a peptide specialist to investigate and resolve the issue.</div></div><div class="co_paragraph"><div class="co_paragraphText">The investigation led to the development of the new compounding process claimed in the patents-in-suit. MedCo incorporated the new process into a revised Master Batch Record, and Ben Venue has made all batches since October 2006 using the new process. According to MedCo, the new compounding process produces an improved <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_4">Angiomax</a> product that does not have randomly high Asp<sup>9</sup> levels, but instead has a maximum Asp<sup>9</sup> level of 0.6%. The <a id="co_link_Ie307bb0fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'727</a> and <a id="co_link_Ie307bb10df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'343 patents</a> contain product and product-by-process claims, respectively, for pharmaceutical batches of the improved drug product with a maximum impurity level of Asp<sup>9</sup> of 0.6%.</div></div><div class="co_paragraph"><div class="co_paragraphText">The patents, respectively, claim:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>Pharmaceutical batches of a drug product comprising bivalirudin (SEQ ID NO: 1) and a pharmaceutically acceptable carrier for use as an anticoagulant in a subject in need thereof, wherein the batches have a pH adjusted by a base, said pH is about 5-6 when reconstituted in an aqueous solution for  <span class="co_starPage" id="co_pp_sp_506_1367"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1367&quot; }" alt="metadata" type="hidden">*1367</span> injection, and wherein the batches have a maximum impurity level of Asp<sup>9</sup>-<a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3cac27cf475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3cac27cf475111db9765f9243f53508a_1">bivalirudin</a> that does not exceed about 0.6% as measured by HPLC.</div></blockquote></div></div><div class="co_paragraphText co_flush">Claim 1 of the <a id="co_link_Ie307bb12df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'727 patent</a>.</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">Pharmaceutical batches of a drug product comprising bivalirudin (SEQ ID NO: 1) and a pharmaceutically acceptable carrier, for use as an anticoagulant in a subject in need thereof, said batches prepared by a compounding process comprising:</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">(i) dissolving bivalirudin in a solvent to form a first solution;</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">(ii) efficiently mixing a pH-adjusting solution with the first solution to form a second solution, wherein the pH adjusting solution comprises a pH-adjusting solution solvent; and</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">(iii) removing the solvent and pH-adjusting solution solvent from the second solution;</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">wherein the batches have a pH adjusted by a base, said pH is about 5-6 when reconstituted in an aqueous solution for injection, and wherein the batches have a maximum impurity level of Asp<input id="co_docMarker_3" type="hidden"><sup>9</sup>-<a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3cac27cf475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3cac27cf475111db9765f9243f53508a_2">bivalirudin</a> that does not exceed about 0.6% as measured by HPLC.</div></div><div class="co_paragraphText co_flush">Claim 1 of the <a id="co_link_Ie307bb14df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'343 patent</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">The applications for the <a id="co_link_Ie307bb15df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'727</a> and <a id="co_link_Ie307bb16df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'343 patents</a> were filed on July 27, 2008. The critical date from which the on-sale bar of <a id="co_link_Ie307bb17df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> must be measured is, therefore, July 27, 2007.</div></div><div class="co_paragraph"><div class="co_paragraphText">In late 2006, MedCo paid Ben Venue $347,500 to manufacture three batches of bivalirudin according to the patents-at-issue. Ben Venue completed the first such batch on October 31, 2006 for $67,500. That batch contained 5,746 vials of commercially saleable bivalirudin. On November 21 and December 14, 2006, Ben Venue completed two more batches of bivalirudin containing 27,594 and 26,918 vials, respectively, for $140,000 each. Each full commercial-sized batch of 28,000 vials of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_5">Angiomax</a> has a market value of approximately $10 million when sold on the open market as anticoagulants. Thus, collectively, the three batches had a market value of well over $20 million. Specifically, Hospira represents that the three batches were “worth between $23 million and $45 million.” Hospira's En Banc Br. 7.</div></div><div class="co_paragraph"><div class="co_paragraphText">The manufacturing protocol between MedCo and Ben Venue governing the three batches stated that “[t]he solution will be filled for commercial use” and that the three batches “will be placed on quality hold until all testing has been successfully completed.” Joint Appendix (“J.A.”) 14884. The invoice for each of the three batches stated: “Charge to manufacture Bivalirudin lot,” and indicated that the bivalirudin lot was or will be released to MedCo. J.A. 17177-83. Each batch received a “Commercial Product Code,” a customer lot number, and each stated that the batch was “[r]eleased [to MedCo] for commercial and clinical packaging.” J.A. 14959-60; J.A. 15210-11; J.A. 15452-53.</div></div><div class="co_paragraph"><div class="co_paragraphText">Once manufactured by Ben Venue, the batches were placed in quarantine with MedCo's distributor and logistics coordinator, Integrated Commercialization Solutions (“ICS”), pending FDA approval. MedCo and ICS entered into a Distribution Agreement effective February 27, 2007. The Distribution Agreement made ICS the exclusive authorized distributor of Angiomax in the United States and stated that title and risk of loss would pass to ICS following release from quarantine. Under the Distribution Agreement, ICS would place individual purchase orders with MedCo on a weekly basis, which MedCo could accept or reject. J.A. 14676. It was not until August 2007, after the July 27, 2007 critical date, that MedCo released the three batches from quarantine and made them available for sale.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I9338a8aadf7911e79bf099c0ee06c731"><div class="co_headtext co_hAlign2">B. The Procedural History</div><div class="co_paragraph"><div class="co_paragraphText">On August 19, 2010, MedCo sued Hospira in the United States District Court for the District of Delaware, alleging that Hospira's two ANDA filings infringed claims 1-3, 7-10, and 17 of the <a id="co_link_Ie307bb19df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'727 patent</a> and claims 1-3 and 7-11 of the <a id="co_link_Ie307bb1adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'343 patent</a>. The district court construed the asserted claims, and, after a three-day bench trial in September 2013, found the patents not invalid and not infringed.</div></div><div class="co_paragraph"><div class="co_paragraphText">Hospira contended that MedCo failed to prove infringement of three claim limitations: “efficient mixing,” “pharmaceutical batches,” and “a maximum impurity level of Asp<sup>9</sup>-bivalirudin that does not exceed about 0.6%.” <a id="co_link_Ie307bb1bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2033067795&amp;pubNum=0000999&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Meds. Co. v. Hospira, Inc.</em>, No. 1:09–cv–00750–RGA, 2014 WL 1292802, at *2, 2014 U.S. Dist. LEXIS 43126, at *5 (D. Del. Mar. 31, 2014)</a>. The district court found that Hospira's generic product met the “pharmaceutical batch” and “maximum impurity level” limitations,  <span class="co_starPage" id="co_pp_sp_506_1368"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1368&quot; }" alt="metadata" type="hidden">*1368</span> but did not meet the “efficient mixing” limitation either literally or under the doctrine of equivalents. <input id="co_docMarker_4" type="hidden"><em>Id.</em> at *5–8, 2014 U.S. Dist. LEXIS 43126, at *15–26. Based on this conclusion, the district court held that Hospira's generic product did not infringe the asserted claims.</div></div><div class="co_paragraph"><div class="co_paragraphText">Hospira also alleged several grounds of invalidity. First, Hospira argued that the invention was sold or offered for sale before the critical date under <a id="co_link_Ie307bb1ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> based on two sets of transactions. Hospira contended that the on-sale bar was triggered when MedCo paid Ben Venue to manufacture <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_6">Angiomax</a> before the critical date. Hospira also contended that the on-sale bar was triggered because MedCo offered to sell the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_7">Angiomax</a> produced according to the patents to its distributor, ICS, before the critical date. Hospira also contended that the asserted claims were obvious under § 103 and invalid under § 112 because they lack written description, are not enabled, and are indefinite. <a id="co_link_Ie307bb20df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2033067795&amp;pubNum=0000999&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">Applying the two-step framework of <a id="co_link_Ie307bb21df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff v. Wells Electronics, Inc.</em>, 525 U.S. 55, 119 S.Ct. 304, 142 L.Ed.2d 261 (1998)</a>, the district court found that the three batches Ben Venue manufactured for MedCo did not trigger the on-sale bar. <a id="co_link_Ie307bb22df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>'s two-step framework requires that the claimed invention was (1) the subject of a commercial offer for sale; and (2) ready for patenting. <a id="co_link_Ie307bb23df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">525 U.S. at 67–68, 119 S.Ct. 304</a>. The court held that the claimed invention was ready for patenting under the second prong of <a id="co_link_Ie307bb24df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> because MedCo had developed two enabling disclosures prior to the critical date, or, alternatively, reduced the invention to practice before the critical date. <a id="co_link_Ie307bb25df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2033067795&amp;pubNum=0000999&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Meds. Co.</em>, 2014 WL 1292802, at *10–11, 2014 U.S. Dist. LEXIS 43126, at *33–34</a>. Specifically, the enabling disclosures were: (1) the Master Batch Record, which was printed on October 25, 2006, and which Ben Venue followed in order to manufacture a batch on October 31, 2006; and (2) the validation study protocol, which the inventors signed in November 2006. In the alternative, the court concluded that the invention was reduced to practice before the critical date because Ben Venue produced batches according to the invention in October 2006.</div></div><div class="co_paragraph"><div class="co_paragraphText">The district court concluded that the first prong of <a id="co_link_Ie307bb26df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> was not met, however, because the claimed invention was not commercially offered for sale prior to the critical date. The court agreed with MedCo that the transactions between MedCo and Ben Venue were sales of contract manufacturing services in which title to the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_8">Angiomax</a> always resided with MedCo. It found that “this does not end the inquiry,” however. <a id="co_link_Ie307bb28df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2033067795&amp;pubNum=0000999&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at *11, 2014 U.S. Dist. LEXIS 43126, at *35</a>. The district court identified the purpose of <a id="co_link_Ie307bb29df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> as precluding attempts by an inventor or its assignee to profit from the commercial use of an invention for more than a year before filing for a patent. Because the batches were for “validation purposes,” the court held—sua sponte—that the batches were not made for commercial profit, but were for experimental purposes, thereby avoiding the on-sale bar.</div></div><div class="co_paragraph"><div class="co_paragraphText">Next, the court held that MedCo's distribution agreement with ICS also did not constitute an invalidating sale. It held that the agreement was merely “an agreement for ICS to be the sole U.S. distributor of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_9">Angiomax</a>.” <a id="co_link_Ie307bb2bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2033067795&amp;pubNum=0000999&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at *12, 2014 U.S. Dist. LEXIS 43126, at *38</a>. The court concluded that the contract was merely “a contract to enter into a contract” for future sales of the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_10">Angiomax</a> product. <em>Id. See </em><a id="co_link_Ie307bb2ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002249504&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1330&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1330"><em>In re Kollar</em>, 286 F.3d 1326, 1330–1331 (Fed. Cir. 2002)</a> (“We have held that merely granting a license to an invention, without more, does not trigger the on-sale bar of <input id="co_docMarker_5" type="hidden"><a id="co_link_Ie307bb2edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>.”).</div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1369"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1369&quot; }" alt="metadata" type="hidden">*1369</span> As to Hospira's other alleged grounds of invalidity, the district court held that the asserted claims were not obvious under § 103(a). The court also held that the asserted claims satisfied the written description and enablement requirements of, and were not indefinite under, § 112.</div></div><div class="co_paragraph"><div class="co_paragraphText">MedCo appealed two of the district court's claim construction rulings and the district court's non-infringement ruling. Hospira cross-appealed the district court's decisions regarding the on-sale bar, obviousness, and indefiniteness. Because the district court found the invention was “ready for patenting,” Hospira focused only on the first prong of <a id="co_link_Ie307bb2fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> on appeal: whether the invention was the subject of a commercial offer for sale. Among other things, Hospira criticized the district court's conclusion that the batches of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_11">Angiomax</a> were for experimental purposes, pointing out that MedCo had not relied upon the experimental use exception to <a id="co_link_Ie307bb31df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> and that Hospira, accordingly, had no incentive or opportunity to address the issue. Hospira contended that, had the question of experimental use been debated before the district court, Hospira would have pointed to the fact that there were eight additional batches of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_12">Angiomax</a> manufactured by Ben Venue after the original three, all of which Hospira says occurred after MedCo was satisfied that the inventive process would result in a product that did not exceed the desired Asp <sup>9</sup> level of 0.6%. Hospira's En Banc Br. 38, 41.</div></div><div class="co_paragraph"><div class="co_paragraphText">Hospira also disagreed with the district court's conclusion that no commercial sale or offer for sale occurred. Hospira contended that any transaction that provides a commercial benefit to the inventor is enough to trigger the on-sale bar. Because MedCo was able to stockpile its product for future sale, and, thus, replenish the pipeline that had been depleted when it had to cease use of its previous manufacturing methods, Hospira argued that MedCo received a commercial benefit from the transactions with Ben Venue. According to Hospira, the fact that title did not transfer—a point the district court found important—was irrelevant because the immediate financial benefit to MedCo of having a ready supply of product for sale constituted “commercialization” or “commercial exploitation,” which is enough to trigger the on-sale bar. Hospira's Opening Br. 30-31 (citing <a id="co_link_Ie307bb33df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983138411&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1147&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1147"><em>D.L. Auld Co. v. Chroma Graphics Corp.</em>, 714 F.2d 1144, 1147 (Fed. Cir. 1983)</a>).</div></div><div class="co_paragraph"><div class="co_paragraphText">A merits panel of this court agreed with Hospira and reversed the district court's ruling regarding the applicability of the on-sale bar. <a id="co_link_Ie307bb34df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2036598888&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Meds. Co. v. Hospira, Inc.</em>, 791 F.3d 1368 (Fed. Cir. 2015)</a>. The panel acknowledged that “Ben Venue invoiced the sale as manufacturing services and title to the pharmaceutical batches did not change hands,” but disagreed with the district court's conclusion that Ben Venue's sale of services did not constitute a commercial sale of the claimed product. The panel explained that, “where the evidence clearly demonstrated that the inventor <em>commercially exploited</em> the invention before the critical date, even if the inventor did not transfer title to the commercial embodiment of the invention,” the on-sale bar applies. <a id="co_link_Ie307bb35df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2036598888&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1370&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1370"><em>Id.</em> at 1370–71</a> (emphasis added).</div></div><div class="co_paragraph"><div class="co_paragraphText">The panel found no distinction between the offer to sell products prepared by a patented method in <a id="co_link_Ie307bb36df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983138411&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1147&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1147"><em>D.L. Auld</em>, 714 F.2d at 1147</a>, and the commercial sale of services that result in a patented product-by-process. <a id="co_link_Ie307bb37df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2036598888&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1371&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1371"><em>Id.</em> at 1371</a>. The panel reasoned that, because MedCo paid Ben Venue for services that resulted in the patented product, the transactions were commercial sales. <input id="co_docMarker_6" type="hidden"><a id="co_link_Ie307bb38df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2036598888&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> According to the panel, to hold otherwise would conflict with the “no ‘supplier’ exception” under  <span class="co_starPage" id="co_pp_sp_506_1370"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1370&quot; }" alt="metadata" type="hidden">*1370</span> <a id="co_link_Ie307bb39df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001913720&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1355&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1355"><em>Special Devices, Inc. v. OEA, Inc.</em>, 270 F.3d 1353, 1355 (Fed. Cir. 2001)</a>. The panel also found that the transactions between MedCo and Ben Venue were “not the type of ‘secret, personal use’ ” described in <a id="co_link_Ie307bb3adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2021420604&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1362&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1362"><em>Trading Technologies International, Inc. v. eSpeed, Inc.</em>, 595 F.3d 1340, 1362 (Fed. Cir. 2010)</a>, but rather were “batches prepared for commercial exploitation.” <a id="co_link_Ie307bb3bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2036598888&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1371&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1371"><em>Meds. Co.</em>, 791 F.3d at 1371</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">The panel also found that the district court erred in applying the experimental use exception to Ben Venue's batches. <a id="co_link_Ie307bb3cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2036598888&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1372&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1372"><em>Id.</em> at 1372</a>. Because the invention had been reduced to practice, the panel concluded that the inventor could not have been experimenting to determine whether the process by which the product was formulated achieved the desired results. <a id="co_link_Ie307bb3ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2036598888&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">Finally, the panel affirmed the district court's determination that the claimed invention was ready for patenting prior to the critical date “because the invention was sold.” <a id="co_link_Ie307bb3edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2036598888&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1372&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1372"><em>Id.</em> at 1372</a>. Because it found that the invention was both commercially exploited and ready for patenting, the panel held the asserted claims invalid under <a id="co_link_Ie307bb3fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>. The panel neither reached the district court's claim construction and non-infringement rulings that MedCo had appealed nor addressed the other grounds of invalidity raised in Hospira's cross-appeal.</div></div><div class="co_paragraph"><div class="co_paragraphText">MedCo petitioned for panel rehearing or rehearing en banc. On November 13, 2015, we granted rehearing en banc, vacated the panel's decision, reinstated the appeal, and ordered new briefing on the following issues:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">(a) Do the circumstances presented here constitute a commercial sale under the on-sale bar of <a id="co_link_Ie307bb40df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C. § 102(b)</a>?</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText">(i) Was there a sale for the purposes of <a id="co_link_Ie307bb41df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> despite the absence of a transfer of title?</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText">(ii) Was the sale commercial in nature for the purposes of <a id="co_link_Ie307bb42df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> or an experimental use?</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">(b) Should this court overrule or revise the principle in <a id="co_link_Ie307bb43df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001913720&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Special Devices, Inc. v. OEA, Inc</em>., 270 F.3d 1353 (Fed. Cir. 2001)</a>, that there is no “supplier exception” to the on-sale bar of <a id="co_link_Ie307bb44df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C. § 102(b)</a>?</div></div><div class="co_paragraphText co_flush">Order Granting En Banc Rehearing at 2, <em>Meds. Co.</em>, 791 F.3d 1368(No. 2014-1469), ECF No. 68. MedCo asks that we hold en banc “that the on sale bar is not triggered by an inventor's retention of a third party to develop or manufacture the claimed invention confidentially and under the inventor's direction and control.” MedCo's En Banc Br. 3. MedCo contends that stockpiling does not constitute commercial activity under <a id="co_link_Ie307bb46df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> and that <a id="co_link_Ie307bb47df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> should not apply because no products were placed in the public domain prior to the critical date, which it says is the overriding concern of <a id="co_link_Ie307bb48df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">For its part, Hospira argues that MedCo's transactions with Ben Venue constitute a commercial sale under <a id="co_link_Ie307bb49df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> because “this arrangement constituted commercial exploitation from the standpoint of both companies.” Hospira's En Banc Br. 29. Hospira points to the fact that MedCo requested that the batches be “filled for commercial use,” were given a “commercial product code” and were “[r]eleased for commercial and clinical packaging.” <em>Id.</em> at 28-29. Hospira contends that the fact that title to the patented product and/or invention did not transfer is of no moment because the on-sale bar is triggered by “any commercialization” that confers a commercial benefit. <em>Id.</em> at 26. Finally, Hospira contends that the confidential nature of the relationship between Ben Venue and MedCo does not remove the transactions between them from the purview of <input id="co_docMarker_7" type="hidden"><a id="co_link_Ie307bb4cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> because this court has never held that <em>only</em> public sales can trigger the on-sale bar. Hospira's En Banc Reply Br. 22.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I9338a8abdf7911e79bf099c0ee06c731"><div class="co_headtext co_hAlign2"> <span class="co_starPage" id="co_pp_sp_506_1371"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1371&quot; }" alt="metadata" type="hidden">*1371</span> <span class="co_smallCaps">II. Discussion</span></div><div class="co_headtext co_hAlign2">A. Legal Standard</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F12039349161" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF1">1</a><a id="co_anchor_B12039349161"></a><a href="#co_anchor_F22039349161" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF2">2</a><a id="co_anchor_B22039349161"></a>Whether the on-sale bar applies is a question of law based on underlying factual findings. <em>See </em><a id="co_link_Ie307bb4ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1045&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1045"><em>Grp. One, Ltd. v. Hallmark Cards, Inc.</em>, 254 F.3d 1041, 1045–46 (Fed. Cir. 2001)</a>. We review the district court's factual findings with deference, but examine the ultimate question of validity de novo. <em>See </em><a id="co_link_Ie307bb4edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2027655311&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1305&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1305"><em>Leader Techs., Inc. v. Facebook, Inc.</em>, 678 F.3d 1300, 1305 (Fed. Cir. 2012)</a> (“Whether a patent is invalid for a public use or sale is a question of law, reviewed de novo, based on underlying facts, reviewed for substantial evidence following a jury verdict.”); <a id="co_link_Ie307bb4fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2007047500&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1209&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1209"><em>Electromotive Div. of GMC v. Transp. Sys. Div. of GE</em>, 417 F.3d 1203, 1209–10 (Fed. Cir. 2005)</a> (“Whether an invention was on sale within the meaning of <a id="co_link_Ie307bb50df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> is a question of law that we review de novo based upon underlying facts, which we review for clear error.”).</div></div><div class="co_paragraph"><div class="co_paragraphText">We provide a brief overview of the development of the on-sale bar for context. Section 1 of the Patent Act of 1793 required that an invention for which a patent was sought be “not known or used before the application.” Act of Feb. 21, 1793, ch. 11, § 1, 1 Stat. 318. The Supreme Court interpreted this statute in <a id="co_link_Ie307bb51df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1800105795&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pennock v. Dialogue</em>, 27 U.S. (2 Pet.) 1, 7 L.Ed. 327 (1829)</a>, holding that an inventor loses his right to a patent “if he suffers the thing invented to go into public use, or to be <em>publicly sold for use</em>, before he makes application for a patent. His voluntary act or acquiescence in the <em>public sale</em> and use is an abandonment of his right.” <a id="co_link_Ie307bb52df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1800105795&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_780_23&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_23"><em>Id</em>. at 23–24</a> (emphases added). The Court noted “that under the common law of England, letters patent were unavailable for the protection of articles in public commerce at the time of the application, and that this same doctrine was immediately embodied in the first patent laws passed in this country.” <a id="co_link_Ie307bb53df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1989026580&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Bonito Boats v. Thunder Craft Boats</em>, 489 U.S. 141, 149, 109 S.Ct. 971, 103 L.Ed.2d 118 (1989)</a> (describing <a id="co_link_Ie307bb54df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1800105795&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_780_20&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_20"><em>Pennock</em>, 27 U.S. at 20–22</a>); <em>see also </em><a id="co_link_Ie307bb55df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1833190796&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_780_320&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_320"><em>Shaw v. Cooper</em>, 32 U.S. 292, 320-21, 7 Pet. 292, 8 L.Ed. 689 (1833)</a> (third-party sale invalidating where statute required invention not be “known or used before the [patent] application”).</div></div><div class="co_paragraph"><div class="co_paragraphText">Against this backdrop, Congress first codified the on-sale bar in Section 6 of the Patent Act of 1836, prohibiting the patenting of any invention that, at the time the application was filed, was “in public use or on sale, with [the inventor's] consent or allowance.” Act of July 4, 1836, ch. 357, § 6, 5 Stat. 117, 119. <em>See</em> Brief for the United States as Amicus Curiae 9-11. As a leading 19th century commentator explained, the early public-use and on-sale statutory restrictions were premised on the principle that “no invention, which has already passed from the control of the inventor into the possession of the public is entitled to protection.” 1 William C. Robinson, <em>The Law of Patents for Useful Inventions</em> § 71, 109 (1890). Congress retained the public-use and on-sale bars in subsequent amendments to the patent laws, although it soon softened the effect of those bars “by enacting a 2-year grace period” after the public use or sale “in which the inventor could file an application.” <a id="co_link_Ie307bb56df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em>, 525 U.S. at 65, 119 S.Ct. 304</a>; <em>see</em> Act of Mar. 3, 1839, ch. 88, 5 Stat. 353, 354 (“1839 Act”). Congress also eliminated the “consent or allowance requirement” in 1839. <em>See</em> 1839 Act, 5 Stat. at 354; <em>see also </em><a id="co_link_Ie307bb57df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1887180266&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Andrews v. Hovey</em>, 123 U.S. 267, 274, 8 S.Ct. 101, 31 L.Ed. 160 (1887)<input id="co_docMarker_8" type="hidden"></a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">In 1939, Congress reduced the grace period from two years to one. <em>See</em> Act of Aug. 5, 1939, ch. 450, 53 Stat. 1212. And when Congress reenacted and recodified the patent laws in the Patent Act of 1952, it again provided that “[a] person shall be  <span class="co_starPage" id="co_pp_sp_506_1372"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1372&quot; }" alt="metadata" type="hidden">*1372</span> entitled to a patent unless,” <em>inter alia</em>, “the invention was ... in public use or on sale in this country, more than one year prior to the date of the application for patent.” <a id="co_link_Ie307bb58df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C. 102(b)</a>.<sup id="co_footnoteReference_B00012039349161_ID0E5CAI"><a href="#co_footnote_B00012039349161" class="co_footnoteReference">1</a></sup></div></div><div class="co_paragraph"><div class="co_paragraphText">For many years this court applied a “totality of circumstances” standard in applying the on-sale bar. <a id="co_link_Ie307bb5cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003212199&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1347&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1347"><em>Lacks Indus. v. McKechnie Vehicle Components USA, Inc.</em>, 322 F.3d 1335, 1347 (Fed. Cir. 2003)</a> (citing <a id="co_link_Ie307bb5ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990088412&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1574&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1574"><em>Envirotech Corp. v. Westech Eng'g Inc.</em>, 904 F.2d 1571, 1574 (Fed. Cir. 1990)</a>). “Under that test ‘no single finding or conclusion of law [was] a sine qua non’ to a holding that the statutory bar arose.” <a id="co_link_Ie307bb5edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003212199&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> We considered all the facts and circumstances surrounding any particular transaction and considered those in light of the policies underlying section <a id="co_link_Ie307bb5fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>, finding an on-sale bar in circumstances where the policies were furthered. <em>See, e.g.</em>, <a id="co_link_Ie307bb60df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997023623&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1544&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1544"><em>Micro Chem., Inc. v. Great Plains Chem. Co.</em>, 103 F.3d 1538, 1544 (Fed. Cir. 1997)</a> (“all of the circumstances surrounding the sale or offer to sell, including the stage of development of the invention and the nature of the invention, must be considered and weighed against the policies underlying <a id="co_link_Ie307bb61df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">section 102(b)</a>”); <a id="co_link_Ie307bb62df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995036084&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1566&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1566"><em>Ferag AG v. Quipp Inc.</em>, 45 F.3d 1562, 1566 (Fed. Cir. 1995)</a> (“While a wide variety of factors may influence the on sale determination, no single one controls the application of <a id="co_link_Ie307bb63df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">section 102(b)</a>, for the ultimate conclusion depends on the totality of the circumstances.”); <a id="co_link_Ie307bb64df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987048749&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_656&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_656"><em>UMC Elecs. Co. v. United States</em>, 816 F.2d 647, 656 (Fed. Cir. 1987)</a> (stating that the on-sale bar “does not lend itself to formulation into a set of precise requirements”). We identified several policies underlying <a id="co_link_Ie307bb65df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>: to promote the early filing of patent applications—i.e., to foster disclosure of patented inventions to the public; to prevent an inventor from profiting from the commercial use of an invention for a prolonged period before filing a patent application claiming that invention; to discourage the removal of inventions from the public domain; and to give inventors a reasonable time to discern the potential value of an invention. <em>See, e.g.</em>, <a id="co_link_Ie307bb66df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995036084&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1566&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1566"><em>Ferag AG</em>, 45 F.3d at 1566</a>; <a id="co_link_Ie307bb67df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990088412&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1574&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1574"><em>Envirotech</em>, 904 F.2d at 1574</a>; <a id="co_link_Ie307bb68df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985132442&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_860&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_860"><em>King Instrument Corp. v. Otari Corp.</em>, 767 F.2d 853, 860 (Fed. Cir. 1985)</a>; <a id="co_link_Ie307bb69df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1978119400&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_580&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_580"><em>Gould Inc. v. United States</em>, 579 F.2d 571, 580 (Ct. Cl. 1978)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Although, applying this test, we held that a “definite offer for sale” was required, we found that this did not necessarily require commercial activity that rose to the level of a formal “offer” under contract law principles. <a id="co_link_Ie307bb6adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003212199&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1347&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1347"><em>Lacks Indus.</em>, 322 F.3d at 1347</a> (citing <a id="co_link_Ie307bb6bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1989144960&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1062&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1062"><em>RCA Corp. v. Data Gen. Corp.</em>, 887 F.2d 1056, 1062 (Fed. Cir. 1989)</a>). And, we reviewed transactions and their impact without strict regard to whether they qualified as commercial activity under any definable standard. <em>See <a id="co_link_Ie307bb6cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003212199&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">id.</a></em>; <a id="co_link_Ie307bb6ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995036084&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1566&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1566"><em>Ferag AG</em>, 45 F.3d at 1566</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">This changed with <a id="co_link_Ie307bb6edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>, in which the Supreme Court replaced the “totality of the circumstances” test—which the Court noted had been criticized as “unnecessarily vague”—with a two-pronged test. <a id="co_link_Ie307bb6fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">525 U.S. at 66 n. 11, 119 S.Ct. 304</a>. As discussed above, <a id="co_link_Ie307bb70df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> clarified that the on-sale bar under <a id="co_link_Ie307bb71df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C. § 102(b)</a> applies when, before the critical date, the claimed invention (1) was the subject of a commercial offer for sale; and (2) was ready for patenting. <input id="co_docMarker_9" type="hidden"><a id="co_link_Ie307bb72df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 67–68, 119 S.Ct. 304.</a> <a id="co_link_Ie307bb73df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> itself focused on the second prong of its newly articulated test—ready for patenting. <a id="co_link_Ie307bb74df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 57, 119 S.Ct. 304</a>. It held that  <span class="co_starPage" id="co_pp_sp_506_1373"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1373&quot; }" alt="metadata" type="hidden">*1373</span> the “ready for patenting” requirement can be met in at least two ways: (1) proof of a reduction to practice; or (2) drawings or other descriptions sufficiently specific to enable a person of ordinary skill to practice the invention. <a id="co_link_Ie307bb75df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 67–68, 119 S.Ct. 304</a>. <a id="co_link_Ie307bb76df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> itself said little about the first prong of the two-prong test—what constitutes a patent-defeating “commercial offer for sale”—however. The Court did emphasize that “[a]n inventor can both understand and control the timing of the first <em>commercial marketing</em> of his invention,” and that a transaction that is “experimental in character” is distinct from one that is for purposes of such commercial marketing. <a id="co_link_Ie307bb77df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 67, 119 S.Ct. 304</a> (emphasis added).</div></div><div class="co_paragraph"><div class="co_paragraphText">Since <a id="co_link_Ie307bb78df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>, this court has applied the Supreme Court's “two-part test ‘without balancing various policies [of the bar] according to the totality of the circumstances.’ ” <a id="co_link_Ie307bb79df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2007047500&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1209&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1209"><em>Electromotive Div. of GMC</em>, 417 F.3d at 1209</a> (citation omitted); <em>see also </em><a id="co_link_Ie307bb7adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002122512&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1377&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1377"><em>Dana Corp. v. American Axle &amp; Mfg., Inc.</em>, 279 F.3d 1372, 1377 (Fed. Cir. 2002)</a> (district court “erroneously invoked the ‘totality of the circumstances' test that was disavowed by <a id="co_link_Ie307bb7bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>.”); <a id="co_link_Ie307bb7cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002067752&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1351&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1351"><em>EZ Dock, Inc. v. Schafer Systems, Inc.</em>, 276 F.3d 1347, 1351 (Fed. Cir. 2002)</a> (“Before the Supreme Court's decision in <a id="co_link_Ie307bb7ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>, this court used a multifactor, ‘totality of the circumstances' test to enforce the on-sale bar.... [This court] now follows the Supreme Court's two-part test.”) (internal quotation marks and citations omitted).</div></div><div class="co_paragraph"><div class="co_paragraphText">Unlike <a id="co_link_Ie307bb7edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> itself, the focus of this en banc appeal is on the first prong of the <a id="co_link_Ie307bb7fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> test: whether the invention was the subject of a commercial sale or offer for sale. We have held that “the question of whether an invention is the subject of a commercial offer for sale is a matter of Federal Circuit law, to be analyzed under the law of contracts as generally understood.” <a id="co_link_Ie307bb80df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1047&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1047"><em>Group One, Ltd. v. Hallmark Cards, Inc.</em>, 254 F.3d 1041, 1047 (Fed. Cir. 2001)</a>. We also have held that, to be true to <a id="co_link_Ie307bb81df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> when assessing prong one of <a id="co_link_Ie307bb82df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>, we must focus on those activities that would be understood to be commercial sales and offers for sale “in the commercial community.” <a id="co_link_Ie307bb83df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> We have also indicated that, “[a]s a general proposition, we will look to the Uniform Commercial Code (‘UCC’) to define whether ... a communication or series of communications rises to the level of a commercial offer for sale.” <a id="co_link_Ie307bb84df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> And we have made clear that, post-<a id="co_link_Ie307bb85df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>, “[t]he transaction at issue must be a ‘sale’ in a commercial law sense,” and that “[a] sale is a contract between parties to give and to pass rights of property for consideration which the buyer pays or promises to pay the seller for the thing bought or sold.” <a id="co_link_Ie307bb86df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2021420604&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1361&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1361"><em>Trading Techs.</em>, 595 F.3d at 1361</a> (quotation marks omitted).</div></div><div class="co_paragraph"><div class="co_paragraphText">Applying <a id="co_link_Ie307bb87df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> in light of <a id="co_link_Ie307bb88df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>, we conclude that the transactions between MedCo and Ben Venue in 2006 and 2007 did not constitute commercial sales of the patented product. We, thus, affirm the district court's conclusion that those transactions were not invalidating under <a id="co_link_Ie307bb89df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>. In the discussion that follows, we first clarify that the mere sale of manufacturing services by a contract manufacturer to an inventor to create embodiments of a patented product for the inventor does not constitute a “commercial sale” of the invention. We then address the issue of “stockpiling” by an inventor and clarify that “stockpiling” by the purchaser of manufacturing services is not improper commercialization under <input id="co_docMarker_10" type="hidden"><a id="co_link_Ie307bb8adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>. We explain that commercial benefit—even to both parties in a transaction—is not enough to trigger the on-sale bar of <a id="co_link_Ie307bb8bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>; the transaction must be one in which the product is “on sale” in the sense that it is “commercially marketed.” There are, broadly speaking, three reasons for  <span class="co_starPage" id="co_pp_sp_506_1374"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1374&quot; }" alt="metadata" type="hidden">*1374</span> our judgment in this case: (1) only manufacturing services were sold to the inventor—the invention was not; (2) the inventor maintained control of the invention, as shown by the retention of title to the embodiments and the absence of any authorization to Ben Venue to sell the product to others; and (3) “stockpiling,” standing alone, does not trigger the on-sale bar.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I9338a8acdf7911e79bf099c0ee06c731"><div class="co_headtext co_hAlign2">B. No Commercial Sale of the Invention</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F32039349161" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF3">3</a><a id="co_anchor_B32039349161"></a><a href="#co_anchor_F42039349161" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF4">4</a><a id="co_anchor_B42039349161"></a>We begin with the language of <a id="co_link_Ie307bb8cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>, which requires that “the invention” be “on sale.” The “invention” is defined by the patent's claims. <em>See</em> <a id="co_link_Ie307bb8ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS112&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 112</a>, ¶ 2 (“The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.”). In this case, all of the asserted claims cover products. The asserted claims of the <a id="co_link_Ie307bb8edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'727 patent</a> cover “pharmaceutical batches,” while the asserted claims of the <a id="co_link_Ie307bb8fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'343 patent</a> “claim[ ] the same subject matter as that of claim 1 of the <a id="co_link_Ie307bb90df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'727 patent</a>, but as a product-by-process,” <em>viz.</em> “pharmaceutical batches ... prepared by a compounding process comprising” the claimed steps. <a id="co_link_Ie307bb91df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2033067795&amp;pubNum=0000999&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Meds. Co.</em>, 2014 WL 1292802, at *1–2, 2014 U.S. Dist. LEXIS 43126, at *3–4</a>. For validity purposes, the “invention” in a product-by-process claim is the product. <em>See </em><a id="co_link_Ie307bb92df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019808227&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1369&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1369"><em>Amgen Inc. v. F. Hoffman</em><em>–</em><em>La Roche Ltd.</em>, 580 F.3d 1340, 1369 (Fed. Cir. 2009)</a> (“In determining validity of a product-by-process claim, the focus is on the product and not on the process of making it.”); <a id="co_link_Ie307bb93df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2008535409&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1317&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1317"><em>SmithKline Beecham Corp. v. Apotex Corp.</em>, 439 F.3d 1312, 1317 (Fed. Cir. 2006)</a> (“Regardless of how broadly or narrowly one construes a product-by-process claim, it is clear that such claims are always to a product, not a process.”); <a id="co_link_Ie307bb94df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1965103194&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1016&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1016"><em>In re </em><em>Lyons</em>, 364 F.2d 1005, 1016 (C.C.P.A. 1966)</a> (“a product-by-process claim is a product, not a process.”).</div></div><div class="co_paragraph"><div class="co_paragraphText">Hospira argues that, by manufacturing embodiments of the patented product for MedCo, Ben Venue put the invention “on sale.” But we have never espoused the notion that, where the patent is to a product, the performance of the unclaimed process of creating the product, without an accompanying “commercial sale” of the product itself, triggers the on-sale bar. The cases on which Hospira relies uniformly involve process or method patents in which the (1) inventors sought compensation (2) from the buying public for (3) performing the claimed processes or methods. In <a id="co_link_Ie307bb95df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1946114407&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Metallizing Engineering Co. v. Kenyon Bearing &amp; Auto Parts Co.</em></a>, the patentee used a secret process to recondition worn metal parts for its customers, for compensation, before the critical date. <a id="co_link_Ie307bb96df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1946114407&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_517&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_517">153 F.2d 516, 517-18 (2d Cir. 1946)</a>. In <a id="co_link_Ie307bb97df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983138411&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>D.L. Auld</em></a>, the patentee offered to sell a product made by the claimed method to prospective customers, i.e., it offered to practice the method in return for compensation. <a id="co_link_Ie307bb98df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983138411&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1148&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1148">714 F.2d at 1148</a>. Similarly, in both <a id="co_link_Ie307bb99df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2010929251&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Plumtree</em></a> and <a id="co_link_Ie307bb9adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001897822&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Scaltech</em></a>, we found that offering to perform the steps of the patented methods for customers in exchange for payment triggers the on-sale bar. <a id="co_link_Ie307bb9bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2010929251&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1163&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1163"><em>Plumtree Software, Inc. v. Datamize, LLC</em>, 473 F.3d 1152, 1163 (Fed. Cir. 2006)</a>; <a id="co_link_Ie307bb9cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001897822&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1328&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1328"><em>Scaltech, Inc. v. Retec/Tetra, LLC</em>, 269 F.3d 1321, 1328-29 (Fed. Cir. 2001)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Though those cases are distinguishable on multiple grounds, we find particularly significant the fact that the inventions-at-issue there were processes or methods. Hospira even acknowledges as much. Hospira's En Banc Br. 31 (<input id="co_docMarker_11" type="hidden">“To be sure, the above-cited cases involve patented processes or methods.”). While “a process is a series of acts, and the concept of sale as applied to those acts is ambiguous,” “[t]he sale of a tangible item is[, by contrast,] usually a straightforward event; the item is transferred from the seller to the buyer, who normally owns it outright.”  <span class="co_starPage" id="co_pp_sp_506_1375"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1375&quot; }" alt="metadata" type="hidden">*1375</span> <a id="co_link_Ie307bb9ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003522918&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1378&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1378"><em>Minton v. </em><em>Nat'l Ass'n of Sec. Dealers, Inc.</em>, 336 F.3d 1373, 1378 (Fed. Cir. 2003)</a>. Similarly, in <a id="co_link_Ie307bb9edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002249504&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Kollar</em></a>, we vacated a decision that “fail[ed] to recognize the distinction between a claim to a product, device, or apparatus, all of which are tangible items, and a claim to a process, which consists of a series of acts or steps” in applying the on-sale bar. <a id="co_link_Ie307bb9fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002249504&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1332&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1332">286 F.3d at 1332</a>. We stated that, while “[a] tangible item is on sale when ... the transaction ‘rises to the level of a commercial offer for sale’ under the Uniform Commercial Code,” “[a] process, however, is a different kind of invention ... [and] thus [is] not sold in the same sense as is a tangible item.” <a id="co_link_Ie307bba0df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002249504&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">The most natural conclusion to draw from all of the evidence presented in this case is that Ben Venue sold contract manufacturing services—not the patented invention—to MedCo. Under MedCo's instructions and using an API supplied by MedCo, Ben Venue acted as a pair of “laboratory hands” to reduce MedCo's invention to practice. The invoices for the manufacturing service stated, “Charge to <em>manufacture</em> Bivalirudin lot.” J.A. 17177-83 (emphasis added). In addition, MedCo paid Ben Venue only about 1% of the ultimate market value of the product Ben Venue manufactured. As described above, MedCo paid Ben Venue a total of $347,500 to make the three batches, even though these batches were commercially valued at well over $20 million. Unsurprisingly, therefore, the district court chose MedCo's description of the transaction as one in which “Ben Venue was paid to manufacture <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca4423475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca4423475111db9765f9243f53508a_13">Angiomax</a> for [MedCo],” over Hospira's description of the transaction as a “sale of the validation batches.” <a id="co_link_Ie307bba2df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2033067795&amp;pubNum=0000999&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Meds. Co.</em>, 2014 WL 1292802, at *11, 2014 U.S. Dist. LEXIS 43126, at *35</a>. As the original panel of this court stated, “the district court is correct that Ben Venue invoiced the sale as manufacturing services and title to the pharmaceutical batches did not change hands.” <a id="co_link_Ie307bba3df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2036598888&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1370&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1370"><em>Meds. Co.</em>, 791 F.3d at 1370</a>. Thus, under the plain text of <a id="co_link_Ie307bba4df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>, there was no sale of the “invention.”</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F52039349161" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF5">5</a><a id="co_anchor_B52039349161"></a>The absence of title transfer further underscores that the sale was only of Ben Venue's manufacturing services. Because Ben Venue lacked title, it was not free to use or sell the claimed products or to deliver the patented products to anyone other than MedCo, nor did it do so. Section 2-106(1) of the Uniform Commercial Code describes a “sale” as “the passing of title from the seller to the buyer for a price.” U.C.C. § 2-106(1). The passage of title is a helpful indicator of whether a product is “on sale,” as it suggests when the inventor gives up its interest and control over the product. A “sale” under <a id="co_link_Ie307bba5df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> “occurs when the parties ... give and pass rights of property for consideration.” <a id="co_link_Ie307bba6df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001913720&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1355&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1355"><em>Special Devices</em>, 270 F.3d at 1355</a> (quoting <a id="co_link_Ie307bba7df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2000379176&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1370&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1370"><em>Zacharin v. United States</em>, 213 F.3d 1366, 1370 (Fed. Cir. 2000)</a>); <em>see also </em><a id="co_link_Ie307bba8df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2021420604&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1361&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1361"><em>Trading Techs.</em>, 595 F.3d at 1361</a> (“The transaction at issue must be a ‘sale’ in a commercial law sense.”).</div></div><div class="co_paragraph"><div class="co_paragraphText">As noted, since <a id="co_link_Ie307bba9df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>, we have generally looked to the UCC for the definition of a “sale.” In <a id="co_link_Ie307bbaadf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Group One</em></a>, an early post-<a id="co_link_Ie307bbabdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> case reversing the district court's grant of summary judgment based on the on-sale bar, we stated that:<input id="co_docMarker_12" type="hidden"></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">As a general proposition, we will look to the Uniform Commercial Code (“UCC”) to define whether, as in this case, a communication or series of communications rises to the level of a commercial offer for sale. As this court has previously pointed out, “[t]he UCC has been recognized as the general law governing the sale of goods and is another useful, though not authoritative, source in determining the ordinary commercial meaning of” terms used by the parties.</div></div><div class="co_paragraphText co_flush"> <span class="co_starPage" id="co_pp_sp_506_1376"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1376&quot; }" alt="metadata" type="hidden">*1376</span> <a id="co_link_Ie307bbacdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1047&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1047">254 F.3d at 1047–48</a> (quoting <a id="co_link_Ie307bbaddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998168964&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1382&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1382"><em>Enercon GmbH v. Int'l Trade Comm'n</em>, 151 F.3d 1376, 1382 (Fed. Cir. 1998)</a>). We have since reaffirmed the usefulness of the UCC in analyzing the on-sale bar. <em>See </em><a id="co_link_Ie307bbaedf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002249504&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1332&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1332"><em>In re Kollar</em>, 286 F.3d at 1332</a>; <a id="co_link_Ie307bbafdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002035706&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1048&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1048"><em>Linear Tech. Corp. v. Micrel, Inc.</em>, 275 F.3d 1040, 1048 (Fed. Cir. 2001)</a> (stating that “<a id="co_link_Ie307bbb0df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Group One</em></a> further instructs that the Uniform Commercial Code (‘UCC’) should inform the analysis of the contractual issues” in connection to the on-sale bar).</div></div><div class="co_paragraph"><div class="co_paragraphText">While we agree with Hospira that the UCC does not have “talismanic significance” with respect to the on-sale bar, and we decline to draw a bright line rule making the passage of title dispositive, we find the absence of title transfer significant because, in most instances, that fact indicates an absence of commercial marketing of the product by the inventor. As Hospira points out, an inventor could commercially exploit a newly invented machine by charging others a fee to use it without transferring title to it. Hospira's En Banc Reply Br. 8. In such a case, the “invention” would still likely be considered “on-sale” because use of the invention is on-sale for a price. That is not what occurred here, however.</div></div><div class="co_paragraph"><div class="co_paragraphText">It is with vigilance that we have held that the sale of products made using patented methods triggers the on-sale bar, even though title to the claimed method itself did not pass. <em>See, e.g.</em>, <a id="co_link_Ie307bbb1df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983138411&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1147&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1147"><em>D.L. Auld</em>, 714 F.2d at 1147</a>; <a id="co_link_Ie307bbb2df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2010929251&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1163&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1163"><em>Plumtree</em>, 473 F.3d at 1163</a>. In such cases, the literal subject matter of the claims is incapable of being sold. Similarly, we held that sales of software licenses to end-users can trigger the on-sale bar. <em>See </em><a id="co_link_Ie307bbb3df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1049&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1049"><em>Group One</em>, 254 F.3d at 1049 n.2</a> (stating that “[couching] a sale of an interest that entitles the purchaser to possession and use of the machine, unrelated to any patent present or future, ... as a ‘license’[ ] would not prevent the transaction from triggering the on-sale bar”); <a id="co_link_Ie307bbb4df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002249504&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1330&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1330"><em>In re Kollar</em>, 286 F.3d at 1330 n.3</a> (stating that certain transactions framed as a “license” but that are to an embodiment of the claimed invention “may be tantamount to a sale (e.g., a standard computer software license)”).</div></div><div class="co_paragraph"><div class="co_paragraphText">Like the absence of title transfer, the confidential nature of the transactions is a factor which weighs against the conclusion that the transactions were commercial in nature. Again, this factor is not disqualifying in all instances—it too is not of talismanic significance. Indeed, we, and our predecessors, have found confidential transactions to be patent invalidating sales under <a id="co_link_Ie307bbb5df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>. <em>See </em><a id="co_link_Ie307de30df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985123562&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_676&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_676"><em>In re Caveney</em>, 761 F.2d 671, 676 (Fed.Cir.1985)</a> (“It is well established ... that a single sale or offer to sell is enough to bar patentability” even if kept secret from the trade) (citing <a id="co_link_Ie307de31df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1981131819&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_60&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_60"><em>Gen. Elec. Co. v. United States</em>, 654 F.2d 55, 60 (1981)</a>; <a id="co_link_Ie307de32df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1982127997&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1362&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1362"><em>Mfg. Research Corp. v. Graybar Elec. Corp.</em>, 679 F.2d 1355, 1362 (11th Cir. 1982)</a>); <a id="co_link_Ie307de33df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1978119400&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_580&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_580"><em>Gould</em>, 579 F.2d at 580</a> (“[A] sale ... pursuant to a secret military contract ... was still held to be a sale proscribed by <a id="co_link_Ie307de34df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">35 U.S.C. § 102(b)</a>.”) (citing <a id="co_link_Ie307de35df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1959108949&amp;pubNum=0000345&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Piet v. United States</em>, 176 F.Supp. 576 (S.D. Cal. 1959)<input id="co_docMarker_13" type="hidden"></a>, <em>aff'd</em>, <a id="co_link_Ie307de36df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1960114216&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">283 F.2d 693 (9th Cir. 1960)</a>); <a id="co_link_Ie307de37df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1971113464&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_860&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_860"><em>Hobbs v. U.S. Atomic Energy Comm'n</em>, 451 F.2d 849, 860 (5th Cir. 1971)</a> (stating that the court “cannot attach any relevance to any conditions of secrecy which may have existed at the time the [invention] was placed ‘on sale.’ ”). In this case, however, we find that the scope and nature of the confidentiality imposed on Ben Venue supports the view that the sale was not for commercial marketing purposes.</div></div><div class="co_paragraph"><div class="co_paragraphText">Rather than rest our decision on formalities, our focus is on what makes our on-sale bar jurisprudence coherent: preventing inventors from filing for patents a year or more after the invention has been commercially marketed, whether marketed by  <span class="co_starPage" id="co_pp_sp_506_1377"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1377&quot; }" alt="metadata" type="hidden">*1377</span> the inventor himself or a third party.<sup id="co_footnoteReference_B00022039349161_ID0EMACI"><a href="#co_footnote_B00022039349161" class="co_footnoteReference">2</a></sup> <a id="co_link_Ie307de38df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> itself quoted two seminal cases reciting this principle: “<em>[a]ny attempt to use it for a profit</em>, and not by way of experiment, for a longer period than two years before the application, would deprive the inventor of his right to a patent,” <a id="co_link_Ie307de39df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">525 U.S. at 65, 119 S.Ct. 304</a> (quoting <a id="co_link_Ie307de3adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1877148870&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_780_137&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_137"><em>Elizabeth</em><em> v. Nicholson Pavement Co.</em>, 97 U.S. 126, 137, 24 L.Ed. 1000 (1877)</a>) (emphasis added), and “it is a condition upon an inventor's right to a patent that he <em>shall not exploit his discovery competitively</em> after it is ready for patenting,” <a id="co_link_Ie307de3bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 68, 119 S.Ct. 304</a> (quoting <a id="co_link_Ie307de3cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1946114407&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_520&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_520"><em>Metallizing</em>, 153 F.2d at 520</a>) (emphasis added). <em>See also </em><a id="co_link_Ie307de3ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015297772&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1365&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1365"><em>Atlanta Attachment Co. v. Leggett &amp; Platt, Inc.</em>, 516 F.3d 1361, 1365 (Fed. Cir. 2008)</a> (“The overriding concern of the on-sale bar is an inventor's attempt to commercialize his invention beyond the statutory term.”) (citing <a id="co_link_Ie307de3edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002423292&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1323&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1323"><em>Netscape Commc'ns. Corp. v. </em><em>Konrad</em>, 295 F.3d 1315, 1323 (Fed. Cir. 2002)</a>); <a id="co_link_Ie307de3fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2010929251&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1163&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1163"><em>Plumtree</em>, 473 F.3d at 1163</a> (“the intent of [<a id="co_link_Ie307de40df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>] is to preclude attempts by the inventor or his assignee to <em>profit from commercial use</em> of an invention for more than a year before an application for patent is filed”) (emphasis added) (quoting <a id="co_link_Ie307de41df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983138411&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1147&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1147"><em>D.L. Auld</em>, 714 F.2d at 1147</a>) (internal quotation marks omitted).</div></div><div class="co_paragraph"><div class="co_paragraphText">Despite this fairly constant refrain in the case law, Hospira argues that finding the bar inapplicable here “would improperly permit an inventor to commercially stockpile his invention,” in order to “restock its long-depleted commercial pipeline.” Hospira's En Banc Br. 19, 47. But commercial benefit generally is not what triggers <a id="co_link_Ie307de46df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>; there must be a commercial sale or offer for sale. The statute itself says the invention must be “on sale,” or that there must be an offer for sale of the invention. <a id="co_link_Ie307de47df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> made this distinction clear and explained that we are not to look to broad policy rationales in assessing whether the on-sale bar applies; we are to apply a straightforward two-step process—one which permits an inventor to “both understand and control the first commercial marketing of his invention.” <a id="co_link_Ie307de48df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000708&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">525 U.S. at 67, 119 S.Ct. 304</a>. For this reason, we find that the mere stockpiling of a patented invention by the purchaser of manufacturing services does not constitute a “commercial sale” under <a id="co_link_Ie307de49df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>. Stockpiling—or building inventory—is, when not accompanied by an actual sale or offer for sale of the invention, mere pre-commercial activity in preparation for future sale. This is true regardless of how the stockpiled material is packaged. The on-sale bar is triggered by actual commercial marketing of the invention, not preparation for potential or eventual marketing. Contrary to Hospira's assertions, not every activity that inures some commercial benefit to the inventor can be considered a commercial sale. Instead, stockpiling by an inventor with the assistance of a contract manufacturer is no more improper than is stockpiling by an inventor in-house.<input id="co_docMarker_14" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F62039349161" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF6">6</a><a id="co_anchor_B62039349161"></a>It is well-settled that mere preparations for commercial sales are not themselves “commercial sales” or “commercial offers for sale” under the on-sale bar. <em>See, e.g.</em>, <a id="co_link_Ie307de4adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002249504&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1334&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1334"><em>In re Kollar</em>, 286 F.3d at 1334</a> (holding that “[t]he precommercialization process aimed at making the invention commercial” does not implicate the on-sale bar); <a id="co_link_Ie307de4bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991157611&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_830&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_830"><em>Intel Corp. v. Int'l Trade Comm'n</em>, 946 F.2d 821, 830 (Fed. Cir. 1991)</a> (“It is not a violation of the on-sale bar to make preparations for the sale of a claimed invention—an actual sale or offer to sell must be  <span class="co_starPage" id="co_pp_sp_506_1378"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1378&quot; }" alt="metadata" type="hidden">*1378</span> proved.”). Instead, when no actual sale is present, “[o]nly an offer which rises to the level of a commercial offer for sale, one which the other party could make into a binding contract by simple acceptance (assuming consideration)” triggers the on-sale bar. <a id="co_link_Ie307de4cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1048&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1048"><em>Group One,</em> 254 F.3d at 1048</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Indeed, we have held that an inventor that has publicized that a product will soon be placed on sale has not created an offer that another party could make binding by simple acceptance. <em>See, e.g.</em>, <a id="co_link_Ie307de4ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002035706&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1050&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1050"><em>Linear Tech. Corp. v. Micrel, Inc.</em>, 275 F.3d 1040, 1050 (Fed. Cir. 2001)</a> (holding that promotional activity was insufficient to create an on-sale event: “[p]reparation alone cannot give rise to an on-sale bar under <a id="co_link_Ie307de4edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001517727&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Group One</em></a>”). To the contrary, such an inventor has told buyers that it cannot have access to the invention yet, regardless of a customer's interest in buying.</div></div><div class="co_paragraph"><div class="co_paragraphText">And, we have never held that stockpiling by an inventor in-house triggers the on-sale bar. <em>See</em> Leah C. Fletcher, <a id="co_link_Ie307de4fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=0304598232&amp;pubNum=0102365&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=LR&amp;fi=co_pp_sp_102365_235&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_102365_235"><em>Equal Treatment Under Patent Law: A Proposed Exception To The On-Sale Bar</em>, 13 <span class="co_smallCaps">Tex. Intell. Prop. L.J.</span> 209, 235-36 (2005)</a> (“The unchallenged ability of the in-house manufacturer to stockpile strongly suggests that, in fact, the on-sale bar is not really intended to deter stockpiling.”); Christopher G. Darrow, <em>Recent Developments: </em><a id="co_link_Ie307de51df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=0289550218&amp;pubNum=0102365&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=LR&amp;fi=co_pp_sp_102365_388&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_102365_388"><em>Recent Developments in Patent Law</em>, 10 <span class="co_smallCaps">Tex. Intell. Prop. L.J.</span> 379, 388 (2002)</a> (“Inventors having manufacturing capacity can begin the sometimes long manufacturing process, and even stockpile commercial embodiments of the invention, before filing a patent application.”). Stockpiling is merely a type of preparation for <em>future</em> commercial sales. If Congress wanted to prevent stockpiling or any form of commercial benefit, it could have added “or stockpiled” or “engaged in a transaction conferring commercial benefit” to the list of statutory bars in <a id="co_link_Ie307de52df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>, in addition to “public use or on sale.” It did not. Stockpiling by the purchaser of manufacturing services is not a trigger to the on-sale bar; discouraging it is not even an identifiable goal of the on-sale bar.</div></div><div class="co_paragraph"><div class="co_paragraphText">Expanding the on-sale bar to encompass stockpiling by inventors that outsource manufacturing might encourage earlier filing of patents. But we cannot endorse any blunt instrument that rewards earlier patent applications when so doing ignores the wording Congress chose when enacting the on-sale bar. <em>See </em><a id="co_link_Ie307de53df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1978119400&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_580&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_580"><em>Gould</em>, 579 F.2d at 580</a> (“It appears certain that the purpose of the on sale bar and the 1-year grace period is an attempt by Congress to balance the interests of the inventor with the interests of the public.”). Unlike those in cases to which Hospira cites, such as <a id="co_link_Ie307de54df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983138411&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>D.L. Auld</em></a>, in which we applied the on-sale bar to the performance of patented methods for commercial gain, MedCo's transactions with Ben Venue did not involve invalidating sales or offers for sale of the invention. MedCo did not market or release its invention to any purchasers by contracting with Ben Venue, nor did it give Ben Venue approval to do so. Rather, MedCo made a pre-commercial investment—an outlay of $347,500—when it paid Ben Venue for the service of reducing its invention to practice. We see no reason to treat MedCo differently than we would a company with in-house manufacturing capabilities.<input id="co_docMarker_15" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText">Hospira itself concedes that “[w]hether the on-sale bar applies should not depend on differences that do not alter a transaction's basic economics.” Hospira's En Banc Br. 32, 35. Yet, penalizing a company for relying, by choice or by necessity, on the confidential services of a contract manufacturer, does exactly that. Applying the on-sale bar to the transaction-at-issue would be: (1) arbitrary, as it treats companies making the same pre-commercial preparations differently; (2) ineffective to discourage <span class="co_starPage" id="co_pp_sp_506_1379"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1379&quot; }" alt="metadata" type="hidden">*1379</span>  stockpiling, as it does not penalize or prevent companies with in-house manufacturing capabilities from stockpiling; (3) and unnecessary, as stockpiling by the purchaser of manufacturing services is not the type of commercial activity with which the on-sale bar is concerned. <em>See</em> Brief for Roberta J. Morris as Amicus Curiae 6-7. There is no room in the statute and no principled reason raised by the parties or any of the amici to apply a different set of on-sale bar rules to inventors depending on whether their business model is to outsource manufacturing or to manufacture in-house. In fact, the amici uniformly argue that applying the on-sale bar to the type of transaction that occurred here would only make the drug development process more costly, punish efficient use of resources, and deter future investments in innovation. <em>See e.g.</em>, Brief for Biotechnology Innovation Organization as Amicus Curiae 11; Brief for American Intellectual Property Law Association as Amicus Curiae 3, 19; Brief for Gilead Sciences, Inc. as Amicus Curiae 17-18; Brief of Pharmaceutical Research and Manufacturers of America as Amicus Curiae 4, 6.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I9338a8addf7911e79bf099c0ee06c731"><div class="co_headtext co_hAlign2">C. Post-<em>Pfaff</em> Cases Applying <a id="co_link_Ie307de55df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> to Supplier/Inventor Transactions</div><div class="co_paragraph"><div class="co_paragraphText">Hospira argues that a number of our post-<a id="co_link_Ie307de56df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a> cases are inconsistent with the district court's failure to find <a id="co_link_Ie307de57df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> to have been triggered by MedCo's transactions with Ben Venue and, by extension, would be inconsistent with the conclusion we reach here. Specifically, Hospira points to <a id="co_link_Ie307de58df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999160581&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_891&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_891"><em>Brasseler, U.S.A. I, L.P. v. Stryker Sales Corp.</em>, 182 F.3d 888, 891 (Fed. Cir. 1999)</a>, <a id="co_link_Ie307de59df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001913720&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Special Devices, Inc. v. OEA, Inc.</em>, 270 F.3d 1353 (Fed. Cir. 2001)</a>, and <a id="co_link_Ie307de5adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2031280970&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1375&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1375"><em>Hamilton Beach Brands, Inc. v. Sunbeam Products</em>, 726 F.3d 1370, 1375 (Fed. Cir. 2013)</a>. In each, according to Hospira, we invalidated patent claims under <a id="co_link_Ie307de5bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> based on transfers of product by a supplier to an inventor. Indeed, as Hospira emphasizes, in <a id="co_link_Ie307de5cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001913720&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Special Devices</em></a>, we expressly held that there is no “supplier exception” to the on-sale bar, <a id="co_link_Ie307de5ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001913720&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1357&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1357"><em>Special Devices</em>, 270 F.3d at 1357</a>, a point we reiterated in <a id="co_link_Ie307de5edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2031280970&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Hamilton Beach</em></a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">In none of those cases were the precise facts and arguments we consider today presented by the parties. In <a id="co_link_Ie307de5fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999160581&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Brasseler</em></a>, we noted that the transaction was indisputably one in which the rights in the patented invention passed between the parties for consideration. <a id="co_link_Ie307de60df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999160581&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_890&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_890"><em>Brasseler</em>, 182 F.3d at 890</a> (“The transaction at issue undisputedly was a ‘sale’ in a commercial law sense.”). In <a id="co_link_Ie307de61df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999160581&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Brasseler</em></a>, we found that “[t]he transaction was invoiced as a sale of product, and the parties understood the transaction to be such,” <a id="co_link_Ie307de62df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999160581&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_891&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_891"><em>id.</em> at 891</a>, and that the transaction was for purposes of marketing by Brasseler. <a id="co_link_Ie307de63df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999160581&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Brasseler argued that it and the supplier from whom the purchase was made were not truly separate entities, that we should apply a joint development exception to the on-sale bar because Brasseler and its supplier each employed co-inventors, and that the fact that Brasseler retained equitable, though not legal, title to the patented product was meaningful. We rejected each of those specific contentions, but did not say transactions with suppliers should always be deemed commercial sales.<input id="co_docMarker_16" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText">Similarly, in <a id="co_link_Ie307de64df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001913720&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Special Devices</em></a>, while we declined to adopt a “supplier exception” to the on-sale bar, we did so in the face of a concession by the inventor that the transaction between it and its supplier was a commercial sale. Thus, the import of <a id="co_link_Ie307de65df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001913720&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Special</em> <em>Devices</em></a> is simply that the fact that a sale is made by a supplier is not, <em>standing alone</em>, sufficient grounds upon which to characterize a transaction having all of the hallmarks of a commercial sale under the UCC as something other than a commercial sale.</div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1380"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1380&quot; }" alt="metadata" type="hidden">*1380</span> So, too, in <a id="co_link_Ie307de66df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2031280970&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Hamilton Beach</em></a>. The inventor made only two arguments against the application of <a id="co_link_Ie307de67df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>: (1) that the offer for sale was insufficiently firm under contract law and the UCC to constitute a commercial offer for sale; and (2) that the invention was not yet ready for patenting under the second prong of <a id="co_link_Ie307de68df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>. The inventor did not even urge a supplier exception to <a id="co_link_Ie307de69df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> or argue that no commercial sale of the patented product would occur if the inventor purchased it from its supplier.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F72039349161" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF7">7</a><a id="co_anchor_B72039349161"></a><a href="#co_anchor_F82039349161" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF8">8</a><a id="co_anchor_B82039349161"></a>Thus, examining the arguments made by the parties and the facts not in dispute in those cases, the precise holdings in those cases are not inconsistent with the analysis we employ or conclusions we reach here. Lest there be any doubt, however, to the extent language in those cases might be viewed as dictating a different result here, they are overruled with one important caveat. We still do not recognize a blanket “supplier exception” to what would otherwise constitute a commercial sale as we have characterized it today. While the fact that a transaction is between a supplier and inventor is an important indicator that the transaction is not a commercial sale, understood as such in the commercial marketplace, it is not alone determinative. Where the supplier has title to the patented product or process, the supplier receives blanket authority to market the product or disclose the process for manufacturing the product to others, or the transaction is a sale of product at full market value, even a transfer of product to the inventor may constitute a commercial sale under <a id="co_link_Ie307de6adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>. The focus must be on the commercial character of the transaction, not solely on the identity of the participants.</div></div><div class="co_paragraph"><div class="co_paragraphText">We believe our focus on those characteristics that make a sale “commercial” in the most well-understood sense of that term and on what constitutes commercial marketing of a product, as distinct from merely obtaining some commercial benefit from a transaction, best adheres to the language of <a id="co_link_Ie307de6bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>, the Supreme Court's guidance in <a id="co_link_Ie307de6cdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998228564&amp;pubNum=0000780&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfaff</em></a>, and the policy and jurisprudential concerns, respectively, underlying both.<sup id="co_footnoteReference_B00032039349161_ID0ERBDI"><a href="#co_footnote_B00032039349161" class="co_footnoteReference">3</a></sup></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I9338a8aedf7911e79bf099c0ee06c731"><div class="co_headtext co_hAlign2">D. Experimental Use</div><div class="co_paragraph"><div class="co_paragraphText">MedCo argues that because its transactions with Ben Venue were for purposes of validating whether its processes (1) would continue to work as claimed and (2) generate consistently acceptable product, those transactions were for experimental purposes. Specifically, it asserts that, even if ready for patenting, the transactions with Ben Venue were not for commercial purposes, only experimental ones. Hospira counters that MedCo never asserted an experimental use exception below and cannot do so now, especially when Hospira was never given an opportunity to present evidence regarding the other eight batches of product prepared for MedCo by Ben Venue. Hospira also argues that validation of a manufacturing process for purposes of satisfying FDA requirements is not experimental within the meaning of <a id="co_link_Ie307de6edf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">While the parties spend significant time addressing the question, most amici, including the government, urge that, if we conclude the transactions between Ben Venue and MedCo were not commercial sales for other reasons, we refrain from reaching the district court's experimental use finding. The only exception to this <input id="co_docMarker_17" type="hidden"> <span class="co_starPage" id="co_pp_sp_506_1381"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1381&quot; }" alt="metadata" type="hidden">*1381</span> fairly unanimous view is an oft-repeated request that we make clear that the panel's statement that there can be no experimental use after a reduction to practice is inaccurate. <em>See, e.g.</em>, Brief for the United States as Amicus Curiae 25-26; Brief for the Houston Intellectual Property Law Association 9-12; Brief for Gilead Sciences, Inc. as Amicus Curiae 10-11.</div></div><div class="co_paragraph"><div class="co_paragraphText">Given our conclusion that there was no “commercial sale” of the inventions in the <a id="co_link_Ie307de6fdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'727</a> and <a id="co_link_Ie307de70df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'343 patents</a>, we agree that we need not reach the question of experimental use. Since the panel opinion has been vacated, we also decline to parse individual statements therein that are not determinative of the question presented. For the same reason, we do not reach the second prong of <em>Pfaff</em>—whether the invention was ready for patenting—despite the fact that MedCo argued at the district court that it was not and challenges the district court's finding to the contrary on appeal.</div></div><div class="co_paragraph"><div class="co_paragraphText">Ultimately, we reach the same conclusion the district court did regarding the inapplicability of the on-sale bar to MedCo's transactions with Ben Venue, but do so on modified grounds. All other issues are remanded to the merits panel for consideration in the first instance.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I9338a8afdf7911e79bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">Conclusion</span></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F92039349161" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF9">9</a><a id="co_anchor_B92039349161"></a>We hold today that a contract manufacturer's sale to the inventor of manufacturing services where neither title to the embodiments nor the right to market the same passes to the supplier does not constitute an invalidating sale under <a id="co_link_Ie307de71df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a>. We, therefore, affirm the district court's holding that the transactions between Ben Venue and MedCo did not trigger the on-sale bar. Because the original panel held that the <a id="co_link_Ie307de72df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019724104&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=Ic1a7e537974f11deabded03f2b83b8a4&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'727 patent</a> and the <a id="co_link_Ie307de73df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019963816&amp;pubNum=0004074&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=PA&amp;docFamilyGuid=I9c68f855b2c511dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'343 patent</a> were invalid under the on-sale bar as a result of MedCo's transactions with Ben Venue, it did not reach the other issues raised on appeal. Specifically, the original panel did not reach the issue of whether the invention was ready for patenting at the time of the 2006 and 2007 transactions, or whether the Distribution Agreement between MedCo and ICS triggered the on-sale bar. It also did not reach either MedCo's appeal of the district court's claim construction and non-infringement rulings or Hospira's cross-appeal of the district court's obviousness and indefiniteness rulings. We, therefore, remand the appeal to the original panel for further proceedings consistent with this opinion.</div></div><div class="co_paragraph"><div class="co_paragraphText"><strong>AFFIRMED-IN-PART AND REMANDED TO THE MERITS PANEL</strong></div></div></div></div></div></div></div><div class="co_parallelCites"><h2 id="co_allCitations" class="co_parallelCitesBlockLabel co_printHeading">All Citations</h2>827 F.3d 1363, 119 U.S.P.Q.2d 1329</div><div id="co_footnoteSection" class="co_footnoteSection co_briefItState"><h2 class="co_footnoteSectionTitle co_printHeading">Footnotes</h2><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1372&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00012039349161"><a href="#co_footnoteReference_B00012039349161_ID0E5CAI">1</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">Congress amended <a id="co_link_Ie307bb59df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 102</a> in 2011 as part of the America Invents Act (“AIA”). <em>See</em> Leahy-Smith America Invents Act, <a id="co_link_Ie307bb5adf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=l&amp;pubNum=1077005&amp;cite=UUID(I4EC254D0E2-C811E09C69A-E09CBDB48B5)&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SL&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Pub. L. No. 112-29, § 35, 125 Stat. 84</a>, 341 (2011). References to <a id="co_link_Ie307bb5bdf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 102</a> and other sections of Title 35 of the United States Code in this opinion refer to the pre-AIA version of the statute, the version that applies here.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1377&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00022039349161"><a href="#co_footnoteReference_B00022039349161_ID0EMACI">2</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">We have held that sales by third parties can be invalidating sales under <a id="co_link_Ie307de42df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> in certain circumstances. <em>See, e.g.</em>, <a id="co_link_Ie307de43df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1986120054&amp;pubNum=0000350&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_350_1581&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1581"><em>J.A. LaPorte, Inc. v. Norfolk Dredging Co.</em>, 787 F.2d 1577, 1581 (Fed. Cir. 1986)</a>; <em>see also </em><a id="co_link_Ie307de44df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2000379176&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1371&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1371"><em>Zacharin v. United States</em>, 213 F.3d 1366, 1371 (Fed. Cir. 2000)</a>; <a id="co_link_Ie307de45df7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997191176&amp;pubNum=0000506&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=RP&amp;fi=co_pp_sp_506_1453&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1453"><em>Evans Cooling Sys., Inc. v. Gen. Motors Corp.</em>, 125 F.3d 1448, 1453 (Fed. Cir. 1997)</a>.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S8de6c490480b11e698e3c476f53824d9&quot;, &quot;pageNumber&quot;: &quot;1380&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00032039349161"><a href="#co_footnoteReference_B00032039349161_ID0ERBDI">3</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">The government argues that recent amendments to § 102 in the AIA reflects Congress's view that the public use bar and the on-sale bar both turn on the “public” nature of the activity at issue. We do not address here whether or to what extent <a id="co_link_Ie307de6ddf7911e79bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I6cd77d0047f511e68e80d394640dd07e&amp;refType=SP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_a83b000018c76">§ 102(b)</a> may differ post-AIA from the pre-AIA description we now employ.</div></div></div></div></div><table id="co_endOfDocument"><tbody><tr><td>End of Document<input id="co_docMarker_18" type="hidden"></td><td class="co_endOfDocCopyright">© 2018 Thomson Reuters. No claim to original U.S. Government Works.</td></tr></tbody></table></div><input class="co_chunkNumber" value="0" type="hidden"><input id="co_finalChunkMarker" type="hidden"></div><input id="co_document_metaInfo_I6cd77d0047f511e68e80d394640dd07e" value="{&quot;FirstLineCite&quot;:null,&quot;PU&quot;:null,&quot;accessControl&quot;:null,&quot;accessionNumber&quot;:&quot;&quot;,&quot;acquirerCompany&quot;:null,&quot;activeDate&quot;:null,&quot;additionalLinks&quot;:null,&quot;agreementDisplayDate&quot;:null,&quot;announcementDate&quot;:null,&quot;articleTitle&quot;:null,&quot;borrower&quot;:null,&quot;caseRequired&quot;:null,&quot;ciCompany&quot;:null,&quot;cicOfficer&quot;:null,&quot;cipOfficer&quot;:null,&quot;cite&quot;:&quot;827 F.3d 1363&quot;,&quot;citeAbbreviation&quot;:null,&quot;citePrimary&quot;:null,&quot;city&quot;:null,&quot;collection&quot;:&quot;w_cs_fed3&quot;,&quot;compoundTitle&quot;:null,&quot;containerId&quot;:null,&quot;containerType&quot;:null,&quot;contentType&quot;:&quot;Cases&quot;,&quot;contentTypeId&quot;:&quot;1&quot;,&quot;correlationIds&quot;:null,&quot;country&quot;:null,&quot;countryDocumentCountry&quot;:null,&quot;countryDocumentGuid&quot;:null,&quot;court&quot;:&quot;C.A.Fed. (Del.)&quot;,&quot;courtDocumentType&quot;:null,&quot;courtNumber&quot;:&quot;4217&quot;,&quot;courtYear&quot;:&quot;C.A.Fed. (Del.), 2016&quot;,&quot;date&quot;:&quot;July 11, 2016&quot;,&quot;dateFile&quot;:&quot;July 11, 2016&quot;,&quot;dealDate&quot;:null,&quot;dealTrackPublishDate&quot;:null,&quot;dealType&quot;:null,&quot;dealValue&quot;:null,&quot;description&quot;:null,&quot;docFamilyGuid&quot;:&quot;I8db99a10480b11e698e3c476f53824d9&quot;,&quot;docGuid&quot;:&quot;I6cd77d0047f511e68e80d394640dd07e&quot;,&quot;docLink&quot;:&quot;https://1.next.westlaw.com/Document/I6cd77d0047f511e68e80d394640dd07e/View/FullText.html?originationContext=document&amp;contextData=(sc.CustomDigest)&amp;needToInjectTerms=False&quot;,&quot;documentTitle&quot;:null,&quot;edgarFileNumber&quot;:null,&quot;entityId&quot;:null,&quot;expertType&quot;:null,&quot;fileName&quot;:null,&quot;fileNumber&quot;:&quot;&quot;,&quot;fileSize&quot;:0,&quot;fileType&quot;:null,&quot;filerCik&quot;:null,&quot;filerName&quot;:null,&quot;filingDate&quot;:null,&quot;filingYear&quot;:null,&quot;firmName&quot;:null,&quot;formNumber&quot;:null,&quot;formSubType&quot;:null,&quot;formType&quot;:null,&quot;formTypeDisplay&quot;:null,&quot;formVolume&quot;:null,&quot;functionalCite&quot;:&quot;827 F.3d 1363&quot;,&quot;fundFirmCompoundTitle&quot;:null,&quot;fundLocation&quot;:null,&quot;fundName&quot;:null,&quot;fundTargetSize&quot;:null,&quot;fundType&quot;:null,&quot;fundYear&quot;:null,&quot;fundraisingStatus&quot;:null,&quot;getTocData&quot;:false,&quot;hasDraftingNotes&quot;:null,&quot;hasVideoContent&quot;:null,&quot;impersonationKey&quot;:null,&quot;inlineKeyCiteFlagsIncluded&quot;:false,&quot;inlineKeyCiteFlagsResolutionStatus&quot;:null,&quot;insiderName&quot;:null,&quot;ip_assignmentsAction&quot;:null,&quot;ip_citeParallel&quot;:null,&quot;ip_derwentPublishedDate&quot;:null,&quot;ip_docket&quot;:null,&quot;ip_documentDate&quot;:&quot;July 11, 2016&quot;,&quot;ip_issuedDate&quot;:null,&quot;ip_litAlertAttorney&quot;:null,&quot;ip_patStatCode&quot;:null,&quot;ip_patentOwner&quot;:null,&quot;ip_publishedDate&quot;:null,&quot;ip_shortTitle&quot;:null,&quot;isDisplayMiniReport&quot;:false,&quot;isGatewayDocument&quot;:false,&quot;isLargeDocument&quot;:false,&quot;isPersistedContent&quot;:false,&quot;isPublicRecordsBlockedByPermissibleUse&quot;:false,&quot;isPublicRecordsBlockedBySocialSecurityAdmin&quot;:false,&quot;isPublicRecordsDocument&quot;:false,&quot;isRefsAndAnnos&quot;:false,&quot;isRegChangeDocument&quot;:false,&quot;isSearchable&quot;:null,&quot;isSecureContent&quot;:false,&quot;issueDate&quot;:null,&quot;issuerName&quot;:null,&quot;jobDescription&quot;:null,&quot;judge&quot;:&quot;O'Malley, Circuit Judge.&quot;,&quot;jurisAbbrev&quot;:null,&quot;jurisdiction&quot;:&quot;DE&quot;,&quot;jurisdictionFacet&quot;:&quot;Federal|**|Cts. of Appeals|**|Federal Cir.&quot;,&quot;jurisdictionText&quot;:&quot;Delaware&quot;,&quot;knos&quot;:null,&quot;lastRoundExitComb&quot;:null,&quot;legacyId&quot;:&quot;2039349161&quot;,&quot;letterType&quot;:null,&quot;locationOfIncorporation&quot;:null,&quot;maxOfferingPrice&quot;:null,&quot;natureOfTransaction&quot;:null,&quot;newsImageHrefLarge&quot;:null,&quot;newsImageHrefSmall&quot;:null,&quot;normalizedDocType&quot;:null,&quot;normalizedFormType&quot;:null,&quot;offeringType&quot;:null,&quot;organizationName&quot;:null,&quot;originatingDoc&quot;:null,&quot;pageCount&quot;:null,&quot;persistedDocGuid&quot;:null,&quot;plcFirmStyleAvailable&quot;:false,&quot;plcResourceName&quot;:&quot;&quot;,&quot;portfolioCompanyLocation&quot;:null,&quot;portfolioCompanyName&quot;:null,&quot;prMetaInfo1&quot;:null,&quot;prMetaInfo2&quot;:null,&quot;prMetaInfo3&quot;:null,&quot;prMetaInfo4&quot;:null,&quot;prMetaInfo5&quot;:null,&quot;primaryEditorialService&quot;:null,&quot;profileType&quot;:null,&quot;pubSeries&quot;:null,&quot;publishDate&quot;:null,&quot;questionText&quot;:null,&quot;redlined&quot;:false,&quot;registrationDate&quot;:null,&quot;renditionId&quot;:&quot;I2DBB26021DD211B2B832FD00D20B621D&quot;,&quot;royaltyId&quot;:&quot;0&quot;,&quot;rulebookNViews&quot;:null,&quot;serialNumber&quot;:&quot;2039349161&quot;,&quot;status&quot;:null,&quot;subContentType&quot;:&quot;Caselaw - NRS&quot;,&quot;subContentTypeId&quot;:&quot;27&quot;,&quot;subTitle&quot;:null,&quot;targetCompany&quot;:null,&quot;testimonyType&quot;:null,&quot;titleHtml&quot;:&quot;Medicines Company v. Hospira, Inc.&quot;,&quot;titleText&quot;:&quot;Medicines Company v. Hospira, Inc.&quot;,&quot;totalAmountIssuedWithCurrency&quot;:null,&quot;totalPages&quot;:&quot;&quot;,&quot;trademarkStatus&quot;:null,&quot;transactionAmountWithCurrency&quot;:null,&quot;transactionValue&quot;:null,&quot;valuationComb&quot;:null,&quot;viewExpressions&quot;:&quot;EZ5|E3I|000&quot;,&quot;westlawDatabaseIdentifier&quot;:&quot;AWFED2&quot;,&quot;westlawDocumentNumber&quot;:&quot;1451553&quot;}" type="hidden"><input id="co_document_documentNavigation_Search_Search-v1-results-navigation-i0ad6ad3e0000016314b8705c8686bce0-Nav-CUSTOMDIGEST-fragmentIdentifier-I6cd77d0047f511e68e80d394640dd07e-startIndex-1-contextData--28sc.CustomDigest-29-transitionType-CustomDigestItem_CUSTOMDIGEST_166" value="{&quot;AnswerSnippetId&quot;:null,&quot;CurrentDocumentGuid&quot;:&quot;I6cd77d0047f511e68e80d394640dd07e&quot;,&quot;CurrentPosition&quot;:166,&quot;CurrentWatsonAnswerText&quot;:null,&quot;EnableConceptCounts&quot;:false,&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;InPlanUrl&quot;:null,&quot;IsSnapSnippet&quot;:false,&quot;ListCount&quot;:718,&quot;Message&quot;:null,&quot;NextDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;Greenliant Systems, Inc. v. Xicor LLC&quot;,&quot;Url&quot;:&quot;/Document/I0309e8f3ec7711e18757b822cf994add/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad6ad3e0000016314b8705c8686bce0%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DI0309e8f3ec7711e18757b822cf994add%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=167&amp;grading=na&amp;sessionScopeId=35b024c40cf4110fbdaaf6a30272ec9b29310adb8108a3d6fb727f98020766f7&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=1b34510ac2bede0102300be6a61ae1f3#co_anchor_F72028457105&quot;},&quot;NovusQueryType&quot;:null,&quot;NovusSearchResult&quot;:null,&quot;NumberOfSnips&quot;:0,&quot;ParagraphId&quot;:null,&quot;PreviousDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;McRO, Inc. v. Bandai Namco Games America Inc.&quot;,&quot;Url&quot;:&quot;/Document/I20e1cc107bb311e6b63ccfe393a33906/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad6ad3e0000016314b8705c8686bce0%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DI20e1cc107bb311e6b63ccfe393a33906%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=165&amp;grading=na&amp;sessionScopeId=35b024c40cf4110fbdaaf6a30272ec9b29310adb8108a3d6fb727f98020766f7&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=1b34510ac2bede0102300be6a61ae1f3#co_anchor_F162039786030&quot;},&quot;ReturnTo&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;list&quot;,&quot;Url&quot;:&quot;/Search/Results.html?jurisdiction=CTAF&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad6ad3e0000016314b8705c8686bce0&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad6ad3a0000016314b861eab2033b51&amp;collectionSet=w_cs_cd_toc&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#I6cd77d0047f511e68e80d394640dd07e&quot;},&quot;SearchQuery&quot;:null,&quot;SearchQueryType&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null,&quot;ShowSkipOutOfPlanOption&quot;:false}" type="hidden"><div id="co_nrsOutline" class="co_hideState"></div><input id="co_documentContentCacheKey" value="WestlawNext|none|I6cd77d0047f511e68e80d394640dd07e|||||||Search|Search/v1/results/navigation/i0ad6ad3e0000016314b8705c8686bce0?Nav=CUSTOMDIGEST&amp;fragmentIdentifier=I6cd77d0047f511e68e80d394640dd07e&amp;startIndex=1&amp;contextData=%28sc.CustomDigest%29&amp;transitionType=CustomDigestItem|CUSTOMDIGEST|166|False|True|{&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null}|False|||False|False|||True|S|False|Core|||001|False|False|False|False|False|" type="hidden"><input id="co_documentFlagInfo" value="{&quot;docGuid&quot;:&quot;I6cd77d0047f511e68e80d394640dd07e&quot;,&quot;flags&quot;:[{&quot;categoryId&quot;:&quot;kcJudicialHistory&quot;,&quot;id&quot;:&quot;negative.indirect.history.mild&quot;,&quot;link&quot;:&quot;https://1.next.westlaw.com/Link/RelatedInformation/Flag?docGuid=I6cd77d0047f511e68e80d394640dd07e&amp;originationContext=docHeaderFlag&amp;transitionType=Document&amp;contextData=%28sc.CustomDigest%29&quot;,&quot;metadata&quot;:{&quot;citation&quot;:&quot;123 U.S.P.Q.2d 1,045&quot;,&quot;court&quot;:&quot;Fed.Cir.&quot;,&quot;docFamilyGuid&quot;:&quot;Ib252cad02e9311e784e487841eaf5caa&quot;,&quot;docGuid&quot;:&quot;Ib18d09d02e9311e79de0d9b9354e8e59&quot;,&quot;liveDate&quot;:&quot;May 1, 2017&quot;,&quot;title&quot;:&quot;Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.&quot;,&quot;titleLink&quot;:&quot;https://1.next.westlaw.com/Document/Ib18d09d02e9311e79de0d9b9354e8e59/View/FullText.html?navigationPath=RelatedInfo%2Fv4%2Fkeycite%2Fnav%2F%3Fguid%3DIb18d09d02e9311e79de0d9b9354e8e59%26ss%3D2039349161%26ds%3D2041546452&amp;listSource=RelatedInfo&amp;list=NegativeCitingReferences&amp;rank=0&amp;originationContext=docHeader&amp;transitionType=NegativeTreatment&amp;contextData=%28sc.CustomDigest%29&quot;,&quot;treatmentPhrase&quot;:&quot;Distinguished by&quot;},&quot;type&quot;:&quot;negative.indirect.history&quot;,&quot;value&quot;:&quot;mild&quot;}],&quot;metas&quot;:[{&quot;contentType&quot;:&quot;CASELAW&quot;,&quot;docCollection&quot;:&quot;w_cs_fed3&quot;,&quot;docFamilyGuid&quot;:&quot;I8db99a10480b11e698e3c476f53824d9&quot;,&quot;legacyId&quot;:&quot;2039349161&quot;,&quot;sourcePubId&quot;:&quot;506&quot;}]}" type="hidden">




							</div>

				</div>
			</div>
		</div>
	</div>
	<!-- LEFT COLUMN -->  
	<div id="co_leftColumn">
		<div class="co_innertube">
			<div id="coid_website_folderingWidgetDiv"></div>
		</div>
	</div>
			<!-- RIGHT COLUMN -->
			<div id="co_rightColumn" class="co_addFocusCorrection">
				<div class="co_innertube">		
					<div id="coid_website_relatedInfoIPWidgetDiv" style="display: none;" aria-expanded="false">
					</div>




<div id="coid_website_documentToolWidgetDiv"></div>
		<div id="coid_website_relatedInfoWidgetDiv"> </div>
		<div id="coid_website_recommendedDocuments" class="co_recommendedDocumentContainer">
		</div>

<div id="downloadUserDocument"></div>
					<div id="downloadUserDocument"></div>
				</div>
			</div>

 <input class="hideTopTopics" id="hideTopTopics" name="hideTopTopics" type="hidden">
		<div class="co_clear"></div>
	</div>


	<!-- BEGIN FOOTER -->
	<div id="co_footerContainer"><div id="co_cookiePolicyContainer">
	<div class="co_cookiePolicyContent">
			<h3><b>Our policy towards the use of cookies</b></h3>
			<p>All Thomson Reuters websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.</p>
			<ul class="co_inlineList">
				<li>
					<a id="coid_website_cookiePolicyLinkOut" href="javascript:void(0)">Read cookie policy</a>
				</li>
				<li>
					<a id="coid_website_closeCookiePolicy" href="javascript:void(0)">Close</a>
				</li>
			<p></p>
			<button type="button" id="coid_website_cookiePolicyAcknowledged" title="Close message to acknowledge cookie policy" class="co_absolute">
				<span class="icon25 icon_close_x"></span>
			</button>
	</ul></div>
</div>


		
		<div class="co_innertube co_clearfix" id="co_footer" style="display: block;">







<div class="co_floatLeft">
	<div id="co_footerLinks">
		<ul class="co_inlineList">
					<li><a id="coid_websiteFooter_userSettings" href="javascript:void(0);"><span class="icon25 icon_gear_document"></span>Preferences</a></li>
				<li><a id="coid_websiteFooter_helplink" href="javascript:void(0);"><span class="icon25 icon_question_mark"></span>Training &amp; Support</a></li>
				
					<li><a id="coid_websiteFooter_signofflink" href="javascript:void(0);"><span class="icon25 icon_exit_door"></span>Sign Off</a></li>

		</ul>
	</div>
	<div id="co_footerCopyright">
		<ul class="co_inlineList">

			<li>Westlaw. <a href="/Copyright?transitionType=Default&amp;contextData=(sc.Default)"> © 2018</a> Thomson Reuters</li>
			<li><a id="coid_websiteFooter_privacyPolicyLink" href="javascript:void(0)">Privacy Statement</a></li>
			<li><a href="/Accessibility?transitionType=Default&amp;contextData=(sc.Default)">Accessibility</a></li>
				<li id="co_footer_supplier"><a id="coid_website_supplierTerms" href="javascript:void(0);">Supplier Terms</a></li>
				<li id="co_footerContactUs"><a href="/ContactUs?transitionType=Default&amp;contextData=(sc.Default)">Contact Us</a></li>
				<li id="co_footerCs">1-800-REF-ATTY (1-800-733-2889)</li>
				<li id="co_footer_improve"><strong><a id="coid_websiteFooter_pageSurvey" href="javascript:void(0);">Improve Westlaw</a></strong></li>
		</ul>


	</div>
</div>





<div id="co_trLogo" class="co_floatRight">

	<a id="co_trLogo_link" href="#">
		<img alt="Thomson Reuters" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/co_logo_thomsonReuters.png" width="134" height="30">
	</a>
</div>



		</div>
	</div>
			<div id="coid_Trmr" style="display:none; visibility:hidden"></div>
		</div>
	</div>
	
	<!--static content version number-->
<script type="text/javascript">





	
		window['Server/Routing'] = {
			Search: 'search.int.next.westlaw.com',
			TypeAhead: 'typeahead.int.next.westlaw.com',
			Nlu: 'nlu.int.next.westlaw.com',
			Document: 'document.int.next.westlaw.com',
			Foldering: 'foldering.int.next.westlaw.com',
			CSS: 'ca.next.westlaw.com/StaticContent_40.1.1015',
			Images: 'ia.next.westlaw.com/StaticContent_40.1.1015',
			JavaScript: 'ja.next.westlaw.com/StaticContent_40.1.1015',
			RelatedInfo: 'relatedinfo.int.next.westlaw.com',
			Events: 'events.int.next.westlaw.com',
			KM: 'NONE',
			RequestDirector: 'www.westlaw.com',
			SocialPlatform: 'https://community-sso.thomsonreuters.com',
			Sync: 'sync.westlaw.com',
			Video: 'v1.next.westlaw.com',
			FormsAssembly: 'formsassembly.int.forms.westlaw.com',
			Publishing: 'publishing.int.next.westlaw.com',
			WebContent: 'webcontent.int.next.westlaw.com',
			Alert: 'alert.int.next.westlaw.com',
			Report: 'report.int.next.westlaw.com',
			ProductMetadata: 'pmd.int.next.westlaw.com/pmd',
			Website: '1.next.westlaw.com',
			WebsiteDefault: '1.next.westlaw.com',
			HistoryListener: 'historylistener.int.next.westlaw.com',
			FormsAssemblyTest: ''
		};
	
		
			if (window.location.host !== '1.next.westlaw.com') {
				window['Server/Routing'].ProxiedWebsite = '1.next.westlaw.com';
				window['Server/Routing'].Website = window.location.host;
				window['Server/Routing'].WebsiteDefault = window.location.host;
			}
		
</script>

<script type="text/javascript"></script>

	<script type="text/javascript" src="https://1.next.westlaw.com/v2/js/UrlRouting.40.1.1013.0.js"></script>
	
	<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/External/vendor/datejs@1.0/cultures/en-US.js"></script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/v2/Products/WestlawNext/js/LocalizationResources/Localized/Messages.js"></script>

	
<script type="text/javascript">

	







</script>





















	
	














<script type="text/javascript">
window['Server/User'] = {
  "FirmName": "SEOUL NATIONAL UNIV (LV A)",
  "_AlertsIsAdmin": false,
  "_FeatureExposure": "Released",
  "ClientId": "SEOUL NU - WL NEXT",
  "_AlertsAccessFunctionalityTurnedOn": true,
  "_AlertsAccessCategoryApplied": false,
  "_ShowErrorDetails": false,
  "OnePassUserName": "5405685",
  "OnePassUserNameEncoded": "5405685",
  "ClientMatter": {
    "ClientId": "SEOUL NU - WL NEXT",
    "CompositeClientMatter": "SEOUL NU - WL NEXT",
    "DefaultClientId": "Seoul NU - WL Next",
    "ClientIdPromptText": "",
    "IsClientNonChargeable": "False",
    "NoClientId": "False",
    "TrackableCode": "D",
    "UserTurnedTrackingOn": false
  },
  "ClientReportingAttributes": {
    "PracticeArea": "",
    "ResearchReasonCode": "",
    "ResearchDescription": ""
  },
  "BillingMethodForDisplayOnly": "TRANSACTIONAL",
  "HasFlashPlayer": false,
  "IsUltra": true,
  "CustomerStorageKey": "E41F133AB8A01ED395E1D85D67D9406C",
  "SessionCreatedDateTime": "04/30/2018 04:03:25",
  "HasLoggedAggregateNotificationCount": false
};


window['Server/ViewModelData'] = {
  "DocumentGuid": "I6cd77d0047f511e68e80d394640dd07e",
  "DocumentCitation": "827 F.3d 1363",
  "DocumentTitle": "Medicines Company v. Hospira, Inc.",
  "DocumentMetaDescription": "View on Westlaw or start a FREE TRIAL today, Medicines Company v. Hospira, Inc., Cases",
  "ViewType": "FullText",
  "Rank": 166,
  "Grading": "na",
  "KMEnableTermNavigation": false,
  "KMEnableDocumentNavigation": false,
  "LegacyId": "2039349161",
  "DocumentSource": {
    "Key": "a19ddaed4d8c4e718a956c4a45b9ff44",
    "NavigationPath": "Search/v1/results/navigation/i0ad6ad3e0000016314b8705c8686bce0?Nav=CUSTOMDIGEST&fragmentIdentifier=I6cd77d0047f511e68e80d394640dd07e&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "ListPageSourceKey": "1b34510ac2bede0102300be6a61ae1f3"
  },
  "HasDraftingNotes": false,
  "HasDocumentSections": false,
  "EnableBestPortion": true,
  "SubContentTypeId": "27",
  "DisableDocMetaInfoRetrievalOnWarningPage": false,
  "TermNavigationPreference": "AllTerms",
  "ShowMainToolbar": true,
  "ShowRelatedAnalysis": false,
  "ListSource": "Search",
  "IsRelatedFullTextView": false,
  "KeyCiteAlertWarning": "None",
  "DocketTrackWarning": "None",
  "DocumentSections": [],
  "RulebookMode": false,
  "RulebookModeContent": false,
  "NotesOfDecisionsCount": 0,
  "TocReportDocGuids": [],
  "TocReportViewMode": false,
  "IsMedLitStubDocument": false,
  "TrackableCode": "D",
  "NonTrackableCode": "H",
  "FullTocOnDoc": false,
  "ViewExpressions": []
};


window['Server/WidgetDomIds'] = {
  "DocToolbar": "co_docToolbar",
  "DocDisplay": "coid_website_documentWidgetDiv",
  "DocTools": "coid_website_documentToolWidgetDiv",
  "DocTopToolbar": "co_docTopToolbar",
  "DocRightToolbar": "co_newDocToolbar",
  "TopTopics": "coid_website_relatedInfoWidgetDiv",
  "DocBottomToolbar": "co_docFooterToolbar"
};


window['Server/PageData'] = {
  "DocumentTabView": {
    "IsSkipOutOfPlanChecked": false,
    "IsUserDocument": false,
    "UserDocumentData": {
      "documentGuid": "I6cd77d0047f511e68e80d394640dd07e"
    },
    "HasProfileSubTab": false,
    "DisplayOptions": {
      "showMainToolbar": true,
      "isNewDocumentView": false,
      "disableDocToolbar": false,
      "isAbstractView": false,
      "chunkSize": "L",
      "chunkableHeadnotes": false,
      "doCompleteSizeChecking": true,
      "ViewType": "FullText",
      "stickyHeader": true,
      "displayRelatedContentLink": true,
      "snippetRelocationInfo": {
        "contentType": "Cases",
        "subContentTypeId": "27"
      }
    },
    "ShowMainToolbar": true,
    "DocumentPersisted": false,
    "DocumentGuidNotFound": false,
    "ContentType": "Cases",
    "ExpandDocumentLevelTOC": true
  },
  "CobaltPageHeader": {
    "ShowPauseLink": false,
    "ShowCommunityContainer": false,
    "EnablePageHeaderV2": true,
    "ShowBetaFeedbackLink": false,
    "Notifications": {
      "HideNotificationToastAfterDuration": false,
      "NotificationClickGoDirectlyToAlerts": false
    }
  },
  "CompartmentStartPageId": "",
  "CobaltMasterFooterInSession": {
    "TRLogoImageLinkUrl": "http://www.thomsonreuters.com",
    "ShowWhatIsNewLink": false,
    "Unreleased": false,
    "IsAnonymousSession": false,
    "ShowMyContacts": false,
    "ShowPromotions": false,
    "ShowResetPromotions": false,
    "ShowCampusPolicy": false,
    "IsTransferContentAvailable": false,
    "ShowProductStartGuide": false,
    "HelpGuideDisplayName": "",
    "HelpGuideFileName": "",
    "HelpGuidePath": "",
    "CampusPolicyDisplayName": "",
    "CampusPolicyPath": "",
    "ShowAnalyticsLink": false,
    "AnalyticsPath": "Session/SignOn.html?transitionType=Default&contextData=(sc.Default)",
    "ShowMyAccountLink": false,
    "MyAccountPath": "WESTLAW/Common/Landing/MyAccountLanding",
    "LegalSolutionsLink": "http://legalsolutions.thomsonreuters.com/law-products/westlaw-legal-research/training-support",
    "SupplierTermsUrl": "http://legalsolutions.com/westlaw-additional-terms",
    "PrivacyPolicyPath": "https://www.thomsonreuters.com/en/privacy-statement.html"
  },
  "ActOnTracking": {
    "EnableActOnTracking": false,
    "ActOnTrackingInstanceId": ""
  },
  "CobaltPage": {
    "SetInCache": [
      {
        "Vertical": "Global",
        "Name": "ResultsPerPage",
        "Value": 20
      },
      {
        "Vertical": "Global",
        "Name": "ResultsPerPageAllowableValues",
        "Value": [
          "100",
          "20",
          "50"
        ]
      },
      {
        "Vertical": "Global",
        "Name": "Locale",
        "Value": ""
      },
      {
        "Vertical": "Global",
        "Name": "TimeZone",
        "Value": "Central Standard Time"
      },
      {
        "Vertical": "Global",
        "Name": "MultiFacetsEnabled",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_CASE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ANALYTICAL",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGREG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGLEG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_KNOWHOW",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsContentType",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_DOCKET",
        "Value": "CASE_TITLE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_BRIEF",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TRIAL-TRANSCRIPTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ADMINDECISION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_FORM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_NEWS",
        "Value": "DATE_DESCENDING"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ORAL-ARGUMENTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "InstantSuggestions",
        "Value": true
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TCO",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultNews_DuplicateIdentifier",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_REGULATION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_EXPERTWITNESS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SliderDetail",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "ViewExpression",
        "Value": ""
      },
      {
        "Vertical": "Search",
        "Name": "DefaultPage",
        "Value": "ALL"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsGlobal",
        "Value": "CTAF"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PMM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_STATUTE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_JURYVERDICT",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SuppressRecentFiltersTooltip",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "HeadnotesDualColumnView",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorRulesSet",
        "Value": "standard"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorItalicizeTitle",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorParallelCites",
        "Value": "CAFormat"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUseForCopyWithReference",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorCitationStyle",
        "Value": "LegalBriefs"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorIncludeHistory",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUnderlineTitle",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "HideHeadnotesBox",
        "Value": false
      },
      {
        "Vertical": "Foldering",
        "Name": "ShowAnnotationsPreferenceKey",
        "Value": "checked"
      },
      {
        "Vertical": "Website",
        "Name": "ShowKeyboardInstructions",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "NewFeatureLightboxDisplayBlackList",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DeliveryOptionSelected",
        "Value": "None"
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowLinks",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "LastViewNotificationDate",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DisplaySearchTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "KnowHowSpeedReadExpandAll",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayFont",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenFont",
        "Value": ""
      },
      {
        "Vertical": "SAP",
        "Name": "PLAN ICONS",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "SKIP OUT OF PLAN",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "WARNING FLAG",
        "Value": "N"
      }
    ],
    "PingSync": "false",
    "ViewData": {
      "IsSponsorSession": true,
      "SearchWidgetParameters": {
        "search": {
          "renderCustomPageSearchWidget": false,
          "categoryPageTitle": "291 PATENTS",
          "isCategoryPageTopical": false,
          "topicKeyText": "291 PATENTS",
          "filters": {
            "jurisdiction": "CTAF",
            "sequence": 0,
            "content": "CUSTOMDIGEST",
            "index": false,
            "customDigest": true,
            "collectionSets": [
              "w_cs_cd_toc"
            ],
            "tocNode": "I4aee2539c6f64c1812a4c2f3395c2607",
            "keyNumber": "291",
            "displayJurisdictionSelector": true,
            "displayAdvancedSearchLink": false,
            "categoryPageUrl": "Home/WestKeyNumberSystem",
            "categoryPageContentType": "CUSTOMDIGEST",
            "categoryPageCheckboxLimit": 0,
            "resultsLimit": 0,
            "categoryPageAlertClippable": false,
            "isAdvancedSearchTemplatePage": false
          },
          "CustomPageSetForZone": false,
          "supportedFeatures": [],
          "skipSpellCheck": false,
          "browseHierarchyPathFromRoot": []
        },
        "SearchCompartmentName": "WestlawNext",
        "SearchDropDownItems": [],
        "grading": "na",
        "searchWidgetPosition": "Default",
        "hideSearchWidget": false,
        "makeSearchWidget": true,
        "prefersForceTnc": false,
        "prefersForceTncSingleQuote": true,
        "forceTncCounter": 0,
        "forceTncCounterThreshold": 5,
        "enableFavoriteSearch": false,
        "dynamicPage": false,
        "isAdvancedSearchTemplatePage": false
      },
      "ShowClientIdWidget": true,
      "OpenFindDropDown": false,
      "TimeoutInMinutes": 90,
      "FeatureConfigurations": {
        "FOLDERS": false,
        "HISTORY": true,
        "FOLDER_SHARING": false,
        "HIGHLIGHTS": false,
        "NOTES": false,
        "ANNOTATIONS": false,
        "BLOCK NOTES SHARING": false,
        "CONTACTS": false,
        "FAVORITES": false,
        "USER PROFILE": false,
        "KM": false,
        "FolderCachingDisabled": true,
        "KM IPAD": false,
        "SAO_INVITING": true,
        "SAO_SAMEEMAILDOMAIN": false,
        "CASENOTEBOOKEXPORT": false,
        "DOWNLOADDELIVERY": true,
        "DROPBOXDELIVERY": false,
        "EMAILDELIVERY": true,
        "EMAILWITHREFERENCEDELIVERY": false,
        "KINDLEDELIVERY": false,
        "PRINTDELIVERY": true,
        "KEYCITEALERTS": false,
        "LEGACYALERTACCESS": false,
        "BLOCKPERSISTENTINFO": true,
        "BLOCK100KANCILLARY": false,
        "DISPLAYMASHUPCHARGEWARNING": false,
        "SHOWCHARGEONWARNINGSCREEN": false,
        "SHOWCHARGELINKONWARNINGSCREEN": false,
        "USERISTRANSACTIONAL": true,
        "USER FORM UPLOAD": false,
        "MATTERUPLOADUSERDOC": false,
        "FOLDERUPLOADUSERDOC": false,
        "DISPLAY SESSION PAUSE LINK": false,
        "PASSTHRUPDFS": false,
        "processRIHistoryAsynchronously": true,
        "processDocumentHistoryAsynchronously": true,
        "PRINTBLANKFORMS": false,
        "WFBTRIALBLOCKSHARE": false,
        "ATTORNEY PORTAL": false,
        "SMALLLAWWORKBENCHMATTERTREE": false,
        "JUDICIALCHAMBERS": false,
        "CITATIONUS": false,
        "CITATIONCAN": false,
        "MYPLANSTATICDOC": true,
        "ALLOWFOLDERSHAREACROSSORGS": true,
        "BLOCKFOLDERSHAREFROMORGS": true,
        "ALLOWOFFLINEACCESS": false,
        "WEBHOSTEDCLIENTID": false,
        "WEBHOSTEDCLIENTIDIPAD": false,
        "WEBHOSTEDCLIENTIDSELECTION": false,
        "PRERELCONTENTFEAT": false,
        "ALERTS": false,
        "ALERTS ENHANCED": false,
        "ISEMULATEUSER": false,
        "WCLP": false,
        "NEWSLETTER": false,
        "KCALERT": false,
        "COINV ALERTS": false,
        "CITRANSITION": false,
        "BLCALERT": false,
        "DKTALERT": false,
        "DKTTRACK": true,
        "PUBALERT": false,
        "CWALERT": false,
        "POB ALERT": false,
        "POB WATCH": false,
        "CWALERTPremium": false,
        "CAPITOLWATCH": false,
        "ALERT SUMMARY REPORT": false,
        "WCLP CONTINUOUS": false,
        "KCALERT CONTINUOUS": false,
        "CWALERT CONTINUOUS": false,
        "POBA CONTINUOUS": false,
        "POBW CONTINUOUS": false,
        "NEWSLETTER DLY": false,
        "NEWSLETTER WKDY": false,
        "KCALERT DLY SINGLE": false,
        "KCALERT WKDY SINGLE": false,
        "BIALERT DLY SINGLE": false,
        "BLCALERT DAILY": false,
        "BLCALERT MULTI DAILY": false,
        "CWALERT DAILY": false,
        "BIALERT WKDY SINGLE": false,
        "BLCALERT BIWEEKLY": false,
        "BLCALERT CONTINUOUS": false,
        "WCLP WEEKLY": false,
        "NEWSLETTER WEEKLY": false,
        "KCALERT WEEKLY": false,
        "BIALERT WEEKLY": false,
        "BLCALERT WEEKLY": false,
        "DKTALERT WEEKLY": false,
        "DKTTRACK WEEKLY": true,
        "POBA WEEKLY": false,
        "POBW WEEKLY": false,
        "WCLP BIWEEKLY": false,
        "KCALERT BIWEEKLY": false,
        "BIALERT BIWEEKLY": false,
        "DKTALERT BIWEEKLY": false,
        "DKTTRACK BIWEEKLY": true,
        "NEWSLETTER BIWEEKLY": false,
        "POBA BIWEEKLY": false,
        "POBW BIWEEKLY": false,
        "WCLP MONTHLY": false,
        "NEWSLETTER MONTHLY": false,
        "KCALERT MONTHLY": false,
        "BIALERT MONTHLY": false,
        "BLCALERT MONTHLY": false,
        "DKTALERT MONTHLY": false,
        "DKTTRACK MONTHLY": true,
        "POBA MONTHLY": false,
        "POBW MONTHLY": false,
        "WCLP DLY SINGLE": false,
        "WCLP DLY MULT": false,
        "WCLP WKDY SINGLE": false,
        "WCLP WKDY MULT": false,
        "PUBALERT DLY SINGLE": false,
        "PUBALERT WKDY SINGLE": false,
        "DKTALERT WKDY SINGLE": false,
        "DKTALERT DLY SINGLE": false,
        "DKTTRACK WKDY SINGLE": true,
        "DKTTRACK DLY SINGLE": true,
        "CAPITOLWATCHTRACK DLY SINGLE": false,
        "CAPITOLWATCHTRACK DLY MULT": false,
        "CAPITOLWATCHTRACK WKDY SINGLE": false,
        "CAPITOLWATCHTRACK WKDY MULT": false,
        "CAPITOLWATCHTRACK WEEKLY": false,
        "CAPITOLWATCHTRACK BIWEEKLY": false,
        "CAPITOLWATCHTRACK MONTHLY": false,
        "POBA DLY SINGLE": false,
        "POBA DLY MULT": false,
        "POBA WKDY SINGLE": false,
        "POBA WKDY MULT": false,
        "POBW DLY SINGLE": false,
        "POBW DLY MULT": false,
        "POBW WKDY SINGLE": false,
        "POBW WKDY MULT": false,
        "showMatterTree": false,
        "WELCOME TO WLN BOX": false,
        "dataRoomReadSource": "Original",
        "dataRoomWriteDestination": "Single",
        "dataRoomFoldersWriteDestination": "SingleDataRoom",
        "showNapaContent": true,
        "PublicRecordsAccess": false,
        "PublicRecordsEnhancedSecurity": false,
        "PublicRecordsBlockRoaming": false,
        "PublicRecordsBlockHomeTrust": false,
        "PublicRecordsAllowRoamTrust": false,
        "PublicRecordsBypassCountry": false,
        "PublicRecordsBlockIPUndefined": false,
        "PublicRecordsBlockUndefinedTrust": false,
        "PublicRecordsDowngradeEmailIPRoaming": false,
        "PublicRecordsDowngradeEmailIPUndefined": false,
        "PublicRecordsUnmaskRoam": false,
        "DISABLE PR ANC MASK": false,
        "PublicRecordsSsnOnlyOK": false,
        "ReversePhoneGateway": false,
        "QSentReport": false,
        "CreditHeaderContentDatabaseGroup": false,
        "PolkGateway": false,
        "PolkReport": false,
        "DriversLicenseRecordsContentDatabaseGroup": false,
        "UCC COLUMN RESULTS": false,
        "matterTreeType": "None",
        "ISCAMPUSUSER": false,
        "ISCAMPUSNEWSUSER": false,
        "ISCAMPUSBUSINESSUSER": false,
        "isUnreleasedFeatureExposure": false,
        "WLANALYTICS ACCESS": false,
        "NEWSALERTAUTHOR": false,
        "NEWSALERTEDITOR": false,
        "UNRELEASED CAT PAGES": false,
        "INTERNAL ADMIN LIMITS": false,
        "DATAROOMALERTS": false,
        "DLVRY SESSION LIMIT": false,
        "DLVRY DAILY LIMIT": false,
        "DLVRY SESSION LIMIT PRAC LAW": false,
        "DLVRY DAILY LIMIT PRAC LAW": false,
        "DLVRY SESSN LIMIT PRAC LAW TRL": false,
        "DLVRY DAILY LIMIT PRAC LAW TRL": false,
        "CONTENT DLVRY RSTRCT": true,
        "BLOCKAUWLN": false,
        "BLOCKCANWLN": false,
        "BLOCKHKWLN": false,
        "BLOCKUKWLN": false,
        "ALERTS ADDRESS BOOK": true,
        "ALERTS BATCH PROCESSING": false,
        "ALERTS CALENDARING": true,
        "ALERTS FUNCTIONALITY": true,
        "ECHACCESS": false,
        "PMD VERSION": "5209",
        "USER ACADEMIC": true,
        "USER CORPORATE": false,
        "USER DEVELOPER": false,
        "USER GOVERNMENT": false,
        "USER INTERNAL": false,
        "USER LARGE LAW": false,
        "USER MEDIUM LAW": false,
        "USER SMALL LAW": false,
        "SIGNOFF SURVEY": false,
        "INLINE KC CASES BRIEF": false,
        "BYPASS WARN INLINE KC": false,
        "BLOCK PL ITEMS": false,
        "PRACTICAL LAW": false,
        "PRDCT PLCUK": false,
        "PRDCT PLCAU": false,
        "DISABLE PL REL CONTENT CACHE": false,
        "HISTORY UI": true,
        "EDSECTIONALLOW": false,
        "TAPSELECTED": false,
        "REDLINING": false,
        "WLNBYPASSBLOCK": false,
        "BLOCK NATIVE SIGNIN": false,
        "BLC ZONE": false,
        "CUSTOM PAGES": false,
        "CUSTOM PAGES READ": false,
        "CUSTOM PAGE ADMIN": false,
        "ELIBRARIES CP ZONE": false,
        "TYPE AHEAD": false,
        "PATRONHELP": false,
        "HISTORY RETENTION 1": false,
        "HISTORY RETENTION 180": false,
        "BLC POWERSEARCH": false,
        "PRDCT CORRECTIONAL": false,
        "EASY EDIT": false,
        "ENHANCED RB": false,
        "ENHANCED RB STICKY": false,
        "WMGRAPHICAL": false,
        "PRPTSUBSCRIBER": false,
        "BLOCK PRPT BLC": false,
        "PLCT DISPLAY LEGAL ANALYTICS": false,
        "PRPT SMALL": false,
        "PRPT CORPCOUNSEL": false,
        "PRPT LARGE": false,
        "BLOCK PRPT LARGE PAGES": false,
        "PRPT GOVT": false,
        "PRPT NONTRACKABLE": false,
        "PRPT KM LITIGATION": false,
        "PRPT KM TRANSACTIONAL": false,
        "WAYWO": false,
        "AnonymousSession": false,
        "AnonymousSessionBlock": false,
        "SOCIAL PLATFORM": false,
        "BLOCK TNP PLUS": false,
        "TNP TEPC CALC": false,
        "TNP CORTC CALC": false,
        "APFF ACCESS": false,
        "TDRC": false,
        "FPC": false,
        "FPP": false,
        "TAXHYPERION NLTR": false,
        "WCO ACCESS": false,
        "BLOCKMYSTARTPAGELINK": false,
        "TNP CEC CALC": false,
        "TNPNATLANG": false,
        "TAXNEWSCATEGORIES": false,
        "TNPDIGMCMECHAN": false,
        "TNPDIGBROWN": false,
        "TNPDIGNIKOLAKAKIS": false,
        "TNPDIGHAYHOETAXATION": false,
        "TNPDIGKERZNER": false,
        "TNPDIGSCHWARTZ": false,
        "TNPDIGINNES": false,
        "TNPDIGARON": false,
        "TNPDIGCARR": false,
        "TNPDIGGAMBLE": false,
        "TNPDIGTAXATIONOFREALESTATE": false,
        "TNPDIGBROOKS": false,
        "TNPDIGMUNRO": false,
        "TNPDIGTHAW": false,
        "TNPDIGVINER": false,
        "TNPDIGFRIEDLANDER": false,
        "TNPDIGBUTCHER": false,
        "TNPDIGALEXANDER": false,
        "TNPDIGHAYHOECASELAW": false,
        "TNPDIGHAYHOEFEDPROVLEGIS": false,
        "TNPDIGHAYHOEGOVPUBLICATIONS": false,
        "TNPDIGJOLIN": false,
        "TNPDIGSTILLABOWER": false,
        "TNPDIGCASESINDEXCITATOR": false,
        "TNPDIGSEGUIN": false,
        "TNPDIGWISE": false,
        "TNPDIGBOWEN": false,
        "TNPDIGBISCOTT": false,
        "TNPDIGEDMUNDS": false,
        "TNPDIGMANNGUIDETOREVIEW": false,
        "TNPDIGCOMPILATIONENGAGEMENTS": false,
        "TNPDIGGUIDETOESTATEANDTRUSTS": false,
        "TNPDIGITIZATION": false,
        "TNPLITIGATOR": false,
        "TNPCROSSREFFILTER": false,
        "RESULTLISTEASYEDIT": false,
        "RESULTLISTQDRAFT": false,
        "DISPLAY TEST PREF TAB": false,
        "BlindLog": false,
        "EncryptLog": false,
        "MASS EMAILER": false,
        "ADCVERREDLININGTOGGLE": false,
        "ENVHEALTHSAFETYPRACPG": false,
        "INSURCOMPLIANCEPRACPG": false,
        "BLOCK WLN PATRON": false,
        "DSP INT HEADNOTE INFO": false,
        "PRDCT WLNLINKS": false,
        "GAO LH PDFS OPEN IN LINKS": false,
        "WLNLINKS UK": false,
        "BLOCK WLNLINKS EMBEDDED LINKS": false,
        "BLOCK LICENSE AGREEMENT": false,
        "FIRMSTYLE": false,
        "SMART BREADCRUMB DISPLAY": false,
        "IRS WLN PAGE": false,
        "FORMSAUTOSHAREOFF": false,
        "WLNPLTRACK": false,
        "WLNPL GOVTHOMEPAGE": false,
        "WLNPL CORPHOMEPAGE": false,
        "WLNPL DEFAULTHOMEPAGE": true,
        "ENABLE-LEGI-GOV-LINKS": false,
        "ENABLE BAILII LINKS": false,
        "BLOCK SHARE NOTE LINK": false,
        "BLCCAN ZONE": false,
        "BLCCAN SUBSCRIBER": false,
        "BLOCKBLCCAN": true,
        "BLOCKBLC": false,
        "WM SEARCH RESULTS": false,
        "WMHK SEARCH RESULTS": false,
        "WMAU SEARCH RESULTS": false,
        "TAX PWC USER": false,
        "TAX KPMG USER": false,
        "COPY USER DATA": false,
        "ASSIGNCLIENTFILE": false,
        "RESEARCH REPORT": false,
        "FOLDER ANALYSIS": false,
        "FOLDER ANALYSIS ADDL CONTENT": false,
        "TIME ZONE AUSTRALIA": false,
        "TIME ZONE NEW ZEALAND": false,
        "EY WLN PAGE": false,
        "FOLDER DESCRIPTION": false,
        "ENABLE CONTRACT EXPRESS": false,
        "CONTRACT EXPRESS PL AU": false,
        "CONTRACT EXPRESS PL US": false,
        "ASK-EDITOR": false,
        "BLOCK OPEN WEB": false,
        "PLUK SUBSCRIBER": false,
        "WLUK SUBSCRIBER": false,
        "LIBRARY SUBSCRIBER": false,
        "CHECKPOINTDIRECTLINK": false,
        "BLOCKCHECKPOINTLINKS": false,
        "LINK BUILDER": false,
        "BCICALCULATOR": false,
        "PLUK-ENAB-ALLCONTACTS": false,
        "ALLOW ICLR": true,
        "BLOCK PROVIEW FEDERATED SEARCH": false,
        "DOC ANALYSIS": false,
        "DT DocAnalysis": false,
        "GENERATE WLUK TRANSTOKEN": false,
        "WFB USEMOCKFORMS": false,
        "BLOCKSESSIONPAUSEDISPLAY": false,
        "PWC WLN PAGE": false,
        "KPMG WLN PAGE": false,
        "CROSSBORDER DASHBOARD": false,
        "TR DISCOVER SEARCH": false,
        "VIRTUAL ASSISTANT": false,
        "BLCDEALTRACKALERT": false,
        "BLCDEALTRACKALERT BIWEEKLY": false,
        "BLCDEALTRACKALERT CONTINUOUS": false,
        "BLCDEALTRACKALERT DAILY": false,
        "BLCDEALTRACKALERT MONTHLY": false,
        "BLCDEALTRACKALERT MULTIDAY": false,
        "BLCDEALTRACKALERT WEEKLY": false,
        "EY MIGRATION POP UP": false,
        "KPMG MIGRATION POP UP": false,
        "PWC MIGRATION POP UP": false,
        "IRS MIGRATION POP UP": false,
        "TAX MIGRATE": false,
        "SEARCH TABS": false,
        "JOURNAL PURCHASE FORM": false,
        "WLUK EDITORS PICKS TAB": false,
        "LEGAL LIT ANALYTICS": false,
        "UKMATTERMAPS": false,
        "USMATTERMAPS": false,
        "DISPLAY PL MESSAGE 1": false,
        "DISPLAY PL MESSAGE 2": false,
        "GRADING TOOL": false,
        "MODERN DOC DISPLAY": false,
        "INDIGO SEARCH": false,
        "INDIGO DISPLAY": false,
        "PSEUDO BLOCK INDIGO DISPLAY": true,
        "INDIGO DISPLAY PREF": false,
        "INDIGO HOT DOCS": false,
        "INDIGO RESEARCH REPORT": false,
        "COMPARE BLACKLINING": false,
        "NOTIFICATION CENTER": false,
        "PRIOR USER INTERACTIONS": false,
        "COLD START": false,
        "TOC FOR CASES": false,
        "MATERIAL KEY FACT FILTER": false,
        "PROCEDURAL POSTURE FILTER": false,
        "FAVORITE SEARCHES": false,
        "FOLDER KEYCITE CHANGE": false,
        "FOLDER RECOMMEND CHANGE": false,
        "FOLDER RECOMMEND ALERT": false,
        "RECENT FILTERS": false,
        "SEARCH RESULT CITING REFS": false,
        "SEARCH RESULT NEG HISTORY": false,
        "QUESTIONANSWERING": false,
        "ITDEPENDS": false,
        "ITDEPENDSQUESTIONANSWER": false,
        "WLUK DOC ALERTS": false,
        "WLUK JCL ALERTS": false,
        "PA REGULATIONS STATUS FILTER": false,
        "ALWAYS CLIENT ID PROMPT": false,
        "PL US BANNER": false,
        "ANSWERS FEEDBACK": false,
        "KC IMPLIED OVERRULINGS": false,
        "ENHANCED THEME": false,
        "DOC ANALYZER TOUR": false,
        "LIT ANALYTICS TOUR": false,
        "HOME PAGE TOUR": false,
        "BUSINESS DEVELOPMENT PL US": false,
        "WLNPL SLF HOMEPAGE": false
      },
      "IsUserMigrated": false,
      "SupportedFeatures": [
        "PRACTICALLAW",
        "ALERTS",
        "BROWSE",
        "BROWSEPREVIEW",
        "CASEEVALUATORWLN",
        "CDN",
        "CLIENTID",
        "CONTACTS",
        "CONTENTTYPEDELIVERYLIMIT",
        "COREUI",
        "CUSTOMPAGES",
        "DELIVERY",
        "DOCKETS",
        "DOCUMENTORDERING",
        "DOCUMENTS",
        "DROPBOX",
        "ERRORS",
        "FAVORITESORGANIZER",
        "FINDANDPRINT",
        "FOLDERS",
        "FOLDERSEXTERNALSHARING",
        "GLOSSARY",
        "WAYWO",
        "IOS",
        "IPAD",
        "FACTORANALYSIS",
        "KEYNUMBERSEARCH",
        "KM",
        "LINKIN",
        "LINKOUT",
        "LIVECHAT",
        "MOBILE",
        "MYPLAN",
        "NYOFFICALDIGEST",
        "PRICINGGUIDE",
        "PROMOTIONS",
        "PUBLICATIONFAVORITES",
        "RELATEDINFORMATION",
        "RELATEDTOPICS",
        "REPORTSHARED",
        "REVERSEPROXY",
        "SEARCH",
        "SHAREPOINTSEARCH",
        "SHAREPOINTWIDGETS",
        "SOCIALPLATFORM",
        "SURVEY",
        "USERAGREEMENT",
        "USERDOCUMENTS",
        "USEREMULATION",
        "USERSETTINGS",
        "BANKRUPTCYEXPLORER",
        "BUSINESSINVESTIGATOR",
        "BUSINESSLAWCENTER",
        "CASENOTEBOOK",
        "DUNANDBRADSTREETBUSINESS",
        "EXPERIANBUSINESSCREDIT",
        "EXPERTDUEDILIGENCE",
        "EXPERTEVALUATOR",
        "MATTERBENCHMARKING",
        "RECENTHISTORY",
        "WEB2MASHUP",
        "AUTHORITYCOMPILER",
        "SEARCHTEMPLATEPREVIEW",
        "PEOPLEMAP",
        "PUBLICRECORDS",
        "DOCKETGATEWAY",
        "WEBCONTENT",
        "PROFESSIONAL",
        "SUGGESTEDDOCUMENTS",
        "EMBEDDEDTEXT",
        "PRODUCTVIEW",
        "PRIVATEFILES",
        "STATEQACOMPARE",
        "SOURCELINK",
        "PMDPROTECTEDCONTENT",
        "ROADRUNNER",
        "REDLINE",
        "SUPERBROWSE",
        "TOCREPORTVIEW",
        "DATACOMPARISONREPORT",
        "GRAPHICALFACETS",
        "COPYUSERDATA",
        "SHAREDNOTES",
        "RESEARCHACCELERATOR",
        "WEBINARS",
        "READINGMODE",
        "ANALYTICS",
        "HIDESEARCHTERMHIGHLIGHTINGPREFERENCE",
        "MONETIZATION",
        "SHOWDOCUMENTANALYZEROVERVIEWPREFERENCE",
        "SHOWLITANALYTICSOVERVIEWPREFERENCE",
        "SHOWHOMEPAGEOVERVIEWPREFERENCE",
        "FOUNDATION"
      ],
      "ActiveBrowserPingInitialWaitInMinutes": 3,
      "ActiveBrowserPingFrequencyInMinutes": 3,
      "ShowClientIdToast": false,
      "DataRoomFeatures": [],
      "SocialPlatformProductId": "140",
      "MaxFileUploadSize": 157286400,
      "SnapEngageScriptUrl": "",
      "DeliveryQueueQueried": false,
      "DeliveryQueueTotal": 0,
      "DeliveryQueueInProgress": 0,
      "DeliveryQueueDocketsInProgress": 0,
      "DeliveryQueueInError": 0,
      "DeliveryQueueNotification": 0
    },
    "WidgetDomIds": {
      "FooterDivId": "co_footer",
      "ErrorSummaryWidget": "coid_website_errorsSummaryPlaceHolder",
      "DockWidget": "co_dockContainer",
      "RecentFoldersWidget": "co_recentFoldersContainer",
      "RecentHistoryWidget": "co_recentHistoryContainer",
      "FrequentFavoritesWidget": "co_frequentFavoritesContainer",
      "AlertsCenter": "co_alertsCenterContainer",
      "ClientIdWidget": "co_clientIdContainer",
      "SignOff": "co_signOffContainer",
      "WhatIsNext": "co_whatIsNextContainer",
      "SearchWidget": "coid_website_searchWidget"
    },
    "RedirectError": {
      "Show": false
    },
    "DomStorageHasBeenCleared": false,
    "LiveChat": {
      "Show": false,
      "Options": {
        "QueueNumber": 0
      }
    },
    "WelcomeLightbox": {
      "Show": false
    },
    "SyncInitiated": false,
    "SyncCapable": false,
    "SubscriptionRenewalBanner": {
      "Show": false
    },
    "IsBusinessLawCenter": false
  },
  "TabScripts": {
    "DocSource": "a19ddaed4d8c4e718a956c4a45b9ff44",
    "DocGuid": "I6cd77d0047f511e68e80d394640dd07e",
    "NavigationPath": "Search/v1/results/navigation/i0ad6ad3e0000016314b8705c8686bce0?Nav=CUSTOMDIGEST&fragmentIdentifier=I6cd77d0047f511e68e80d394640dd07e&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "Rank": 166,
    "DocumentVersionNumber": 0
  }
};


window['Server/KM'] = {
  "SessionId": "",
  "FirmName": "",
  "FirmLogoUri": "",
  "FirmWelcomeUri": "",
  "Protocol": "http"
};


window['Server/Configuration'] = {
  "CompartmentName": "WestlawNext",
  "CookieDomain": "next.westlaw.com",
  "EnableIpad": false,
  "EnableIphone": false,
  "IsIPadAppRenderingMode": false,
  "IsIPhoneAppRenderingMode": false,
  "IOSNativeVersion": "0.0.0",
  "EnableSync": false,
  "EnableDeliveryQueue": true,
  "EnableDeliveryWidget": true,
  "ProductName": "WestlawNext",
  "ProductDisplayName": "Westlaw",
  "ProductDisplayDelimiter": "|",
  "ProductViewName": "none",
  "DailyDeliveryLimit": -1,
  "DailyDeliveryCount": -1,
  "SessionDeliveryLimit": 20,
  "SupportedAlertTypes": [
    "WestClip",
    "KeyCite",
    "DocketAlert",
    "DocketTrack",
    "DealTrack",
    "PublicationAlert",
    "Newsletter",
    "BusinessInvestigator",
    "CourtWire",
    "BusinessLawCenterAlert",
    "PeopleMap",
    "CapitolWatchTrack"
  ],
  "EnableDataRoomAlerts": true,
  "GlobalizationKeyMode": "Default",
  "IsAnonymousSession": false,
  "EnableAccessibleLightbox": true,
  "EnableContactsPaging": true,
  "IsCrawlerSession": false,
  "IsGlobalizationI18NLocaleEnabled": false,
  "IsGlobalizationI18NLibraryLookupEnabled": true,
  "IsProcessCategoryPagesWithDifferentLocalesOn": false,
  "OverrideResultsPerPage": 0,
  "UseExpandableToc": true,
  "Locale": "en-US",
  "IsSmartFoldersEnabled": true,
  "IsFeatureOverlayEnabled": true,
  "IsTRDiscoverEnabled": true,
  "IsVideoTourEnabled": true,
  "IsBestPortionNavigationEnabled": true,
  "UsePageHeaderV2": true,
  "UseTypeAhead": true,
  "UseSnapshots": true,
  "IsBriefAnalyzerEnabled": true,
  "IsChargeableByDefaultForSession": true,
  "IsIssueFinderEnabled": true,
  "IsWestlawAnswersEnabled": true,
  "IsSharedHighlightsEnabled": true,
  "IsRealTimeNotificationEnabled": true,
  "EnableA11YLightboxKeyboardScroll": true,
  "IsA11YRedesignedHeaderEnabled": true,
  "IsA11YPreferencesLightboxEnabled": true,
  "SpeechToTextCustomizationIdOverride": "default",
  "InfrastructureAccessControls": [
    "iac-a11y-asbuilder-tmpl",
    "iac-a11y-header-redesign",
    "iac-accessible-clientid-widget",
    "iac-add-timezone",
    "iac-alert-admin-settings",
    "iac-alert-ny-sct-hourly",
    "iac-alerts-cal",
    "iac-alerts-customerinfo-olc",
    "iac-alerts-cw",
    "iac-alerts-docket-guid",
    "iac-alerts-productaware-history",
    "iac-alerts-standart-email-format",
    "iac-all-citations",
    "iac-allow-robots-indexing-sitemap-wln",
    "iac-analyticsclientidfeaturesenabled",
    "iac-analytics-related-filings",
    "iac-annotation-filtering",
    "iac-anonymous-cdn",
    "iac-appcommand",
    "iac-asm-policy",
    "iac-au-compartments",
    "iac-au-seo",
    "iac-autosuggest-au",
    "iac-batch-getsynopsis",
    "iac-bestlaw-tracking",
    "iac-blc-filersearch",
    "iac-blc-fs-next",
    "iac-blc-redlining",
    "iac-blc-ri-agreementsenh",
    "iac-blc-ri-newpathway",
    "iac-blc-ri-privateequity",
    "iac-blind-encrypted",
    "iac-blind-encrypted-header-enabled",
    "iac-block-uk-westlaw",
    "iac-blt-alertfulltext",
    "iac-blt-alert-type-mna-trans",
    "iac-blt-alert-type-sec-insider",
    "iac-blt-alert-type-sec-noninsider",
    "iac-blt-feature18",
    "iac-blt-feature3",
    "iac-blt-hoovers",
    "iac-blt-incorporationdata",
    "iac-blt-news",
    "iac-blt-oct2014-release",
    "iac-blt-officerlinks",
    "iac-blt-report-advisors",
    "iac-blt-securities",
    "iac-blt-securities-alerts",
    "iac-blt-subsidiaries",
    "iac-blt-table-sections",
    "iac-blt-tagged-sections",
    "iac-blt-tickercik",
    "iac-blt-webkitpdf",
    "iac-blt-xmlmindrtf",
    "iac-businesslawcenter-tdr",
    "iac-canadian-content",
    "iac-casetracking",
    "iac-change-uk-ntz-clientid",
    "iac-cig-addfoldereditem",
    "iac-cig-facet-orphan",
    "iac-cig-group-orphan",
    "iac-cig-orphan",
    "iac-cig-orphan-ind",
    "iac-cig-report-orphan",
    "iac-ci-resultlist",
    "iac-citation-reordering",
    "iac-client-chargeable-by-default",
    "iac-clientid-new-validation",
    "iac-concourselibrary-wln",
    "iac-content-finder",
    "iac-correct-dock-user-property-value",
    "iac-courtexpress",
    "iac-cpet-browseparts-novus",
    "iac-cr-effective-date-display",
    "iac-crossborder-dashboard",
    "iac-crossborder-itg",
    "iac-display-applied-filter-names-on-ssp",
    "iac-display-recent-items",
    "iac-docanalyzer-caselc-atlaslc",
    "iac-docanalyzer-cited-statutes",
    "iac-docanalyzer-filter",
    "iac-docanalyzer-footnotes",
    "iac-docanalyzer-rdintegration",
    "iac-docanalyzer-relevantportion",
    "iac-docanalyzer-secondarysources",
    "iac-docanalyzer-statutes",
    "iac-docanalyzer-ui-march-release",
    "iac-doc-medical-entities-link-out",
    "iac-docversioning-wln",
    "iac-dpa-browse-juris-landing-pg",
    "iac-dpa-curated",
    "iac-dpa-delivery-watson-answer",
    "iac-dpa-enforcementmap",
    "iac-dpa-featured-content",
    "iac-dpa-keyword-newjurs",
    "iac-dpa-keyword-novus",
    "iac-dpa-knowledgegraph",
    "iac-dpa-related-concepts",
    "iac-dpa-usabilla",
    "iac-dpa-watson-v11",
    "iac-dpa-watson-v12",
    "iac-dr-client-missed",
    "iac-dtp-bankruptcy-claims",
    "iac-dtp-dktptynmtbl",
    "iac-dtp-experts",
    "iac-dtp-openweb",
    "iac-dyn-stem-exceptions",
    "iac-enable-news-summary-alerts-delivery",
    "iac-enacted-legislation-link",
    "iac-enhanced-search-term-tooltip",
    "iac-factoranalysis-history",
    "iac-fa-searchbilling",
    "iac-fastdom-standarddocument",
    "iac-feature-overlay",
    "iac-findandprint",
    "iac-firmlibrary-wln",
    "iac-foldering-get-descendants-new",
    "iac-folderingshareacrossorgs",
    "iac-forcesignon-orphansession",
    "iac-gateway-do",
    "iac-get-renewalandtrialdata",
    "iac-grantonlyfacsinsessionbindings",
    "iac-guid-chasing-disable",
    "iac-hide-docket-monthly-frequency",
    "iac-hide-territorial-options",
    "iac-historical-datacorrections",
    "iac-image-module",
    "iac-improved-navigation",
    "iac-indigo-coldstart",
    "iac-indigo-cpet-browseparts",
    "iac-indigo-display-pref",
    "iac-indigo-fav-searches",
    "iac-indigo-folder-kc-change",
    "iac-indigo-folder-recommend-change",
    "iac-indigo-hot-docs",
    "iac-indigo-notification-center",
    "iac-indigo-paymenttype",
    "iac-indigo-pui",
    "iac-indigo-recent-filters",
    "iac-indigo-research-report",
    "iac-indigo-statutes-compare",
    "iac-indigo-typeahead",
    "iac-inlinehtmldelivery-dockettrackalert",
    "iac-internationalfind",
    "iac-ios-newadvancedsearch",
    "iac-ip2-markman",
    "iac-ip-trademark-viennacode-facet",
    "iac-itdepends",
    "iac-itg-tab",
    "iac-kc-alerts-patents",
    "iac-kc-citing-references",
    "iac-kc-citing-refs-enhanced-sw",
    "iac-kc-flags",
    "iac-kc-flags-green-c-by-boolean",
    "iac-kc-judicial-history",
    "iac-kc-negative-treatment",
    "iac-kc-rules-affected-by",
    "iac-kc-statutes-affected-by",
    "iac-kc-table-of-authorities",
    "iac-kc-validity",
    "iac-kc-wave-the-white-flag",
    "iac-keycite-nod-redesign-old-rels",
    "iac-keycite-sort-by-court-level",
    "iac-keynumber-facets",
    "iac-km-aliveserverconnection",
    "iac-km-fiacctprefs",
    "iac-la-case-outcomes",
    "iac-la-case-types",
    "iac-la-courts",
    "iac-la-delivery",
    "iac-la-law-firms",
    "iac-linkbuilder-docandcatpages",
    "iac-linkbuilder-searchresultspages",
    "iac-linkbuilder-topic-search",
    "iac-linkouturl-pubandserial",
    "iac-log-prdct-wlus-deny",
    "iac-lt-dpa-watson-integration",
    "iac-master-page",
    "iac-mattermaps-deliver-image",
    "iac-mattermaps-editmap",
    "iac-matters-by-number-wln",
    "iac-medlit",
    "iac-modal-footnotes",
    "iac-modernization-wln-ios-doc",
    "iac-most-cited-sort",
    "iac-move-menus-down",
    "iac-multipart-pdf",
    "iac-new-newsletter-template",
    "iac-newsroom-images",
    "iac-non-unique-cites",
    "iac-novustimezone",
    "iac-nyofficial-digestlink",
    "iac-oversized-and-error-email-delivery",
    "iac-pa-regulations-status-facets",
    "iac-partytype-checkbox",
    "iac-patron-category-page",
    "iac-pdf-multipart-check",
    "iac-planz-application-enabled",
    "iac-plconnect-tasks-and-synonyms",
    "iac-plconnect-tasks-ux-redesign",
    "iac-plc-rss-feeds",
    "iac-plct-crossclientid",
    "iac-plct-crossproductclientid",
    "iac-plct-globalsearch",
    "iac-plct-linkbuilder",
    "iac-plct-smalllawfirmmgmt",
    "iac-plct-ssrulebooks",
    "iac-plct-startupssmallbus",
    "iac-plct-viewalltasks",
    "iac-plc-viewonlydraftingnotes",
    "iac-plc-waywo",
    "iac-plplus-application-enabled",
    "iac-plplus-calendar",
    "iac-pl-scrollissues",
    "iac-pluk-asset-page-enable-wln-links",
    "iac-pluk-cdn-available-for-ip",
    "iac-plus-clientidinsession",
    "iac-plus-clientidpromptpltowl",
    "iac-plus-documentononepage",
    "iac-plus-feedback",
    "iac-plus-homebanner",
    "iac-plus-knowhowbooleanquery",
    "iac-plus-linkbuilder",
    "iac-plus-notesformating",
    "iac-plus-searchcontext",
    "iac-plus-truncatejurinsearch",
    "iac-plus-unhideannotations",
    "iac-plus-viewmorelessdetails",
    "iac-portalmanager-combined",
    "iac-portalmanager-contentlinks",
    "iac-portalmanager-findbypartyname",
    "iac-portalmanager-search",
    "iac-practical-law-display-changes",
    "iac-practicallaw-itg-dropdown",
    "iac-practical-law-subheadings",
    "iac-practiceareas-asterisknote",
    "iac-practicepoint-smartsearch-onesynonym",
    "iac-practicepoint-smartsearch-synonyms",
    "iac-practicepoint-smartsearch-treatises",
    "iac-practitioner-insights-alerts-no-logo",
    "iac-pr-add-bing",
    "iac-pr-addfoldereditem",
    "iac-pr-entity-extraction",
    "iac-pr-fein-plus3",
    "iac-price-guide-link",
    "iac-pricing-guide-redirect",
    "iac-privacy-policy",
    "iac-pr-polkrpt",
    "iac-pr-qsentrpt",
    "iac-pr-section-delivery",
    "iac-pr-ssn-only-search",
    "iac-pr-use-pipl-v5",
    "iac-public-record-prod-gateway",
    "iac-public-records",
    "iac-public-records-alerts",
    "iac-public-records-firstamerican",
    "iac-public-records-report-excel-delivery",
    "iac-public-records-report-filtering",
    "iac-pubrec-real-time-monitor",
    "iac-qanda",
    "iac-qanda-pinpoint",
    "iac-qanda-typeahead",
    "iac-raise-document-limit",
    "iac-ra-no-rank1docs-cache",
    "iac-remove-nyor-hard-coded-collections",
    "iac-remove-securedatatoken",
    "iac-research-accel",
    "iac-research-accel-synopsis",
    "iac-ri-bill-activity",
    "iac-ri-bill-tracking",
    "iac-ri-capitol-watch",
    "iac-ri-category-delivery",
    "iac-ri-citestyles-endpoint-v2-enable",
    "iac-ri-context-analysis",
    "iac-ri-editorial-materials",
    "iac-ri-filings",
    "iac-ri-fnd-newpathway",
    "iac-ri-form-families",
    "iac-ri-legislative-timeline",
    "iac-ri-no-single-rn-uds-post",
    "iac-ri-notes-of-decisions",
    "iac-ri-opinions",
    "iac-ri-professional-references",
    "iac-ri-reduce-uds-rn-data",
    "iac-ri-topics",
    "iac-ri-versions",
    "iac-sb-list-items-delivery",
    "iac-search-como-group1",
    "iac-search-como-group2",
    "iac-search-como-group3",
    "iac-search-como-group4",
    "iac-search-como-group6",
    "iac-search-como-group7",
    "iac-search-como-group8",
    "iac-search-como-public-records",
    "iac-search-como-recodocs",
    "iac-search-como-reghist",
    "iac-search-custom-nyor-reranking",
    "iac-search-delivery-group1",
    "iac-search-delivery-group2",
    "iac-search-delivery-group3",
    "iac-search-delivery-group4",
    "iac-search-delivery-group5",
    "iac-search-firmcentral",
    "iac-search-knowhowrankoption",
    "iac-search-matterroom",
    "iac-search-nl-thresholding-option",
    "iac-search-pmd-result-types",
    "iac-search-result-duplicate-identifier",
    "iac-search-suggestions",
    "iac-search-within-favourites-plcuk",
    "iac-searchwithin-ios",
    "iac-shared-highlights",
    "iac-share-folders-with-cobalt-contacts",
    "iac-sharing-with-the-same-domain",
    "iac-show50statesurvey-inlineflags",
    "iac-small-law-survey-redirect",
    "iac-smartbreadcrumb-add-navid",
    "iac-smartbreadcrumbs-au",
    "iac-smartfolders-ss",
    "iac-snapshots-state",
    "iac-snowdonia-beta",
    "iac-sortoption-courtlevel-pref",
    "iac-starpages-plcuk",
    "iac-staticqa",
    "iac-staticqa-history",
    "iac-staticqa-searchbilling",
    "iac-statutes-new-ast-pdfs",
    "iac-superbrowse-mult-gradeheads",
    "iac-superbrowse-paging",
    "iac-taxpage-eylogo",
    "iac-term-frequency-sorting",
    "iac-transfer-content",
    "iac-trd-alternate-search",
    "iac-trd-juris-facet",
    "iac-trd-legalanalytics",
    "iac-trd-lpafacet-subsearch",
    "iac-trillium-crsw-doc-enhance",
    "iac-trillium-link",
    "iac-uk-a11y-clientid-lightbox",
    "iac-uk-clientid",
    "iac-uk-compartments",
    "iac-uk-fd-and-fs",
    "iac-uk-keywordfinder",
    "iac-uk-linkbuilder",
    "iac-uk-linkbuilder-copy",
    "iac-uk-nonpltracking",
    "iac-uk-performance-new-static-content-or",
    "iac-unlink-unmigrated",
    "iac-use-new-training-user",
    "iac-userdoclink-wln",
    "iac-us-knowhow-algorithm",
    "iac-v3inapplibrary",
    "iac-validity-highlighting",
    "iac-verify-eaddress-against-existance",
    "iac-webinars",
    "iac-website-throttle",
    "iac-westsearch-cases-keynumberfacet",
    "iac-westsearch-cases-partyfacet",
    "iac-westsearch-cases-synopsis",
    "iac-westsearch-cases-topicfacet",
    "iac-westsearch-enhancements",
    "iac-without-flash-dependencies",
    "iac-wln-cig-linkedreport",
    "iac-wlndoc-sharednotes",
    "iac-wln-global-search-judicial-chambers",
    "iac-wln-historicalheader",
    "iac-wln-ios-display-toa",
    "iac-wln-newfiletype",
    "iac-wlnopenweb-serverbrowsepage",
    "iac-wln-ri-tabs",
    "iac-wln-save-snippet",
    "iac-wln-strong-downgrade-email",
    "iac-wlntax-blue-flag",
    "iac-wln-toc-keyciteflag",
    "iac-wl-startpage",
    "iac-wl-striphash",
    "iac-wordsphrases-snippet-support"
  ],
  "IsTypeAheadNewUiEnabled": true,
  "ContactsPageSize": 300,
  "ShowPrivacyPolicy": true,
  "ShowCookiePolicy": true,
  "ResearchReportDocumentLimit": 1000,
  "IsSaveSnippetEnabled": true,
  "IsHideAnnotationsSharedByInactiveUsersEnabled": true,
  "AllowPauseOnLinkOut": true,
  "IsMaintainDocumentPositionRIEnabled": true,
  "IsFormsEngine2Enabled": false,
  "IsFormsEngine2DownloadEnabled": false,
  "IsIndigoDisplayEnabled": false
};


window['Server/Mobile'] = {
  "IsNativeIPad": false,
  "IsNativeIPhone": false
};


window['Server/Messages'] = {
  "ProductName": "Westlaw",
  "ProductSupportNumber": "1-800-WESTLAW (1-800-937-8529)"
};


window['Server/Net'] = {
  "PageContextData": "(sc.CustomDigest)",
  "CacheScopeList": [
    "^/RelatedInfo/v[3456]/keycite/content/",
    "^/RelatedInfo/v3/content/json/",
    "^/RelatedInfo/v1/wlncCaselawHistory\\\\?",
    "^/RelatedInfo/v1/wlncCitingReferences\\\\?",
    "^/RelatedInfo/v1/wlncCourtDocs\\\\?",
    "^/RelatedInfo/v1/wlncLegalMemos\\\\?",
    "^/RelatedInfo/v1/kcJudicialHistory\\\\?",
    "^/RelatedInfo/v1/kcCitingReferences\\\\?",
    "^/RelatedInfo/v1/riFilings\\\\?",
    "^/RelatedInfo/v1/kcNegativeTreatment\\\\?",
    "^/RelatedInfo/v1/kcTableOfAuthorities\\\\?",
    "^/RelatedInfo/v1/kcBillDrafts\\\\?",
    "^/RelatedInfo/v1/kcLegislativeMaterials\\\\?",
    "^/RelatedInfo/v1/kcRegulatoryHistory\\\\?",
    "^/RelatedInfo/v1/kcValidity\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreements\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLetters\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLettersTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosures\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibits\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStepViaMAAndFD\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitions\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhanced\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhancedTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsRelated\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategoryTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestments\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsV2\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaFDAndMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnPefundsFundsFirms\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnh\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/tnpCases\\\\?",
    "^/RelatedInfo/v1/tnpCommentary\\\\?",
    "^/RelatedInfo/v1/tnpCompliance\\\\?",
    "^/RelatedInfo/v1/tnpGovernmentDocuments\\\\?",
    "^/RelatedInfo/v1/tnpHistory\\\\?",
    "^/RelatedInfo/v1/tnpHistoryAndTreatments\\\\?",
    "^/RelatedInfo/v1/tnpLegislation\\\\?",
    "^/Search/v1/search/external/results",
    "^/Search/v3/search/results",
    "^/Search/v1/results",
    "^/Document/v1/fulltext/",
    "^/Document/v1/list/fulltext/",
    "^/Document/v1/Mobile/FullText/",
    "^/Document/v1/fixedheader/",
    "^/Document/v1/list/fixedheader/",
    "^/Document/v1/list/Mobile/Fulltext/",
    "^/Document/v[12]/MetaInfo/"
  ],
  "SessionScope": "35b024c40cf4110fbdaaf6a30272ec9b29310adb8108a3d6fb727f98020766f7",
  "UserScope": "5405685",
  "CacheScope": "1b3dc39c6b90e0e3109816ce65f28d27"
};


window['Server/Events'] = {
  "PageEventIdentifier": "539db52005b74d0ea3d6fdf40e1c0356",
  "PageName": "Cobalt.Website.ServerPage.Document",
  "ResourceToken": "v1|cab0ec6feb60e1d3951b7fe91c92b7ae23e28a81659eefcb2fcc0d5346fac3ca"
};

</script>


	
	

<!-- View Path: ~/Document/Views/DocumentTabView.cshtml -->
<script type="text/javascript">
window.__viewName = '~/Document/Views/DocumentTabView.cshtml';
</script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/webpack-loader.js"></script>

	

<div id="co_searchDisableDiv" class="co_screenOverlay co_hideState"></div></body></html>